title,url,date
Alexion’s Preliminary Injunction Motion Denied in Eculizumab BPCIA Litigation Against Samsung Bioepis,https://www.goodwinlaw.com/en/insights/blogs/2024/05/alexions-preliminary-injunction-motion-denied-in-eculizumab-bpcia-litigation-against-samsung-bioepis,2024-05-14
Scrutiny of U.S. Defense Contractor-Related M&A Activities Will Soon Intensify,https://www.goodwinlaw.com/en/insights/publications/2024/05/alerts-otherindustries-scrutiny-of-us-defense-contractor-related-ma-activities,2024-05-14
CFPB and European Commission Release Report Regarding “Critical” Priority Areas for Consumer Financial Protection Issues,https://www.goodwinlaw.com/en/insights/blogs/2024/05/cfpb-and-european-commission-release-report-regarding-critical-priority-areas-for-consumer-financial,2024-05-11
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders,https://www.goodwinlaw.com/en/insights/blogs/2024/05/court-cancels-injunction-hearings-in-aflibercept-bpcia-litigation-regeneron-may-seek-temporary-restr,2024-05-10
2nd BCLT Advanced Life Sciences Institute,https://www.goodwinlaw.com/en/insights/blogs/2024/05/2nd-bclt-advanced-life-sciences-institute,2024-05-10
IRA Litigation Updates: D.N.J. Rejects Challenges from BMS and Janssen; Four Cases Now on Appeal,https://www.goodwinlaw.com/en/insights/blogs/2024/05/ira-litigation-updates-dnj-rejects-challenges-from-bms-and-janssen-four-cases-now-on-appeal,2024-05-09
IRS Finalizes Regulations for Domestically Controlled REITs and other Qualified Investment Entities,https://www.goodwinlaw.com/en/insights/publications/2024/05/alerts-realestate-irs-finalizes-regulations-domestically-controlled-reit,2024-05-08
CFPB Enters Into Consent Order With Financial Technology Company,https://www.goodwinlaw.com/en/insights/blogs/2024/05/cfpb-enters-into-consent-order-with-financial-technology-company,2024-05-07
Equity on Ice: A Solution for the Repurchase Conundrum,https://www.goodwinlaw.com/en/insights/publications/2024/05/insights-practices-ma-equity-on-ice-a-solution-for-the-repurchase,2024-05-07
Top NYC Developer Shares Three Keys to Successful Office Conversions,https://www.goodwinlaw.com/en/insights/publications/2024/05/insights-realestate-nyc-developer-three-tips-office-conversions,2024-05-07
CFPB Files Complaint and Proposed Final Judgments Against Higher Education Assistance Agency and National Collegiate Student Loan Trusts,https://www.goodwinlaw.com/en/insights/blogs/2024/05/cfpb-files-complaint-and-proposed-final-judgments-against-higher-education-assistance-agency-and-nat,2024-05-06
Which Jobs More Frequently Require Non-Compete Agreements?,https://www.goodwinlaw.com/en/insights/publications/2024/05/insights-otherindustries-jobs-frequently-require-non-compete-agreements,2024-05-06
FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2024/05/fda-updates-draft-guidance-on-promotional-communications-of-prescription-biologics-and-biosimilars,2024-05-03
CFPB Bemoans “Junk Fees” in Mortgage Servicing,https://www.goodwinlaw.com/en/insights/blogs/2024/05/cfpb-bemoans-junk-fees-in-mortgage-servicing,2024-05-03
Series 2: How to Determine Your Risk Category and What It Means to Be ‘High-Risk’,https://www.goodwinlaw.com/en/insights/publications/2024/05/alerts-technology-aiml-series-2-how-to-determine-your-risk,2024-05-03
FINRA Proposes Extending the MQP CE Window,https://www.goodwinlaw.com/en/insights/publications/2024/05/alerts-finance-cfs-finra-proposes-extending-the-mqp-ce-window,2024-05-03
"Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf)",https://www.goodwinlaw.com/en/insights/blogs/2024/05/accord-biopharma-inc-announces-fda-approval-of-hercessi-trastuzumabstrf,2024-05-02
FDIC’s Board of Directors Considers Proposed Rulemaking Amending Regulations Implementing the Change in Bank Control Act,https://www.goodwinlaw.com/en/insights/newsletters/2024/05/newsletters-finance-fs-weekly-roundup-050224,2024-05-02
PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid,https://www.goodwinlaw.com/en/insights/blogs/2024/05/ptab-issues-final-written-decisions-finding-claims-of-recombinant-lentiviral-vector-patents-valid,2024-05-01
Does the EU AI Act Classify Your AI System as High Risk?,https://www.goodwinlaw.com/en/insights/publications/2024/05/insights-technology-aiml-does-the-eu-ai-act-classify-your-ai,2024-05-01
FDA Issues Final Rule on Regulation of Laboratory Developed Tests,https://www.goodwinlaw.com/en/insights/blogs/2024/04/fda-issues-final-rule-on-regulation-of-laboratory-developed-tests,2024-04-30
Biosimilar Approval Updates in Europe and China,https://www.goodwinlaw.com/en/insights/blogs/2024/04/biosimilar-approval-updates-in-europe-and-china,2024-04-30
Significant State Regulatory Development in the Virtual Currency Industry in California and New York,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-finance-ftec-significant-state-regulatory-development,2024-04-30
"The Continued Rise of Branded Residences: Opportunities and Structuring Considerations For Developers, Hotel Owners, and Brands",https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-realestate-continued-rise-branded-residences-opportunities,2024-04-30
Digital Currency & Blockchain Quarterly Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-digital-currency-blockchain-q1-2024,2024-04-30
Navigating Bank Failures: Lessons Learned,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-practices-fs-svb-bank-failure-lessons-learned,2024-04-30
"GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents",https://www.goodwinlaw.com/en/insights/blogs/2024/04/gsk-sues-pfizer-pharmacia--upjohn--biontech-for-infringing-mrna-vaccine-patents,2024-04-29
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR,https://www.goodwinlaw.com/en/insights/blogs/2024/04/moderna-litigation-against-biontech-and-pfizer-stayed-pending-ipr,2024-04-29
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-practices-df-debt-download-042924,2024-04-29
CFPB Updates its Procedures for Determining Which Nonbanks it Can Supervise,https://www.goodwinlaw.com/en/insights/blogs/2024/04/cfpb-updates-its-procedures-for-determining-which-nonbanks-it-can-supervise,2024-04-26
Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2024/04/alvotech-announces-positive-topline-results-from-confirmatory-clinical-study-for-its-proposed-golimu,2024-04-26
Sustainability Disclosure Rules in the UK: Extending the FCA’s Regime to Portfolio Managers,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-practices-pif-sustainability-disclosure-rules-in-the-uk,2024-04-26
DOL Issues New Rule Raising Minimum Salary Thresholds for Overtime Exemptions,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-practices-emp-dol-rule-raising-minimum-salary-overtime-exemptions,2024-04-26
FTC Files Suit Against Third-Party Bill Payment Company,https://www.goodwinlaw.com/en/insights/blogs/2024/04/ftc-files-suit-against-third-party-bill-payment-company,2024-04-25
FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-otherindustries-ftc-issues-final-rule-prohibiting,2024-04-25
FinCEN Proposed the Renewal of its Existing Information Collection Requirements Previously Promulgated Under the BSA,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-finance-fs-weekly-roundup-042524,2024-04-25
The FCA’s AI Update: Integrating The UK Government’s 5 Principles,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-finance-aiml-the-fca-ai-update,2024-04-25
DFPI Enters Into Consent Order With Higher Education Loan Authority,https://www.goodwinlaw.com/en/insights/blogs/2024/04/dfpi-enters-into-consent-order-with-higher-education-loan-authority,2024-04-24
California Attorney General Warns California-Chartered Banks and Credit Unions On Surprise Overdraft Fees and Returned Deposited Item Fees,https://www.goodwinlaw.com/en/insights/blogs/2024/04/california-attorney-general-warns-californiachartered-banks-and-credit-unions-on-surprise-overdraft,2024-04-24
European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-otherindustries-european-commission-launches-antitrust-investigation,2024-04-24
Subscription-Secured Credit Facilities: Recent Developments in the US Market and Considerations for Real Estate Funds,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-realestate-fs-subscription-secured-credit-real-estate-funds,2024-04-24
Healthcare M&A and Financing Trends and Predictions for 2024,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-healthcare-ma-financing-trends-and-predictions-for-2024,2024-04-24
The European Parliament Adopts Position on the European Commission’s Proposal for the First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years,https://www.goodwinlaw.com/en/insights/blogs/2024/04/the-european-parliament-adopts-position-on-the-european-commissions-proposal-for-the-first-major-ove,2024-04-23
Recap: Goodwin Rare Disease Symposium 2024,https://www.goodwinlaw.com/en/insights/blogs/2024/04/recap-goodwin-rare-disease-symposium-2024,2024-04-23
"DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing",https://www.goodwinlaw.com/en/insights/blogs/2024/04/doj-files-false-claims-act-complaint-against-regeneron-alleging-fraudulent-eylea-drug-pricing,2024-04-22
Federal Circuit Dismisses Appeals in Regeneron v. Mylan (Aflibercept) BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/04/federal-circuit-dismisses-appeals-in-regeneron-v-mylan-aflibercept-bpcia-litigation,2024-04-22
Kansas Becomes Fourth State to Enact Law Regulating Earned Wage Access Services,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-finance-ftec-kansas-becomes-fourth-state-to-enact,2024-04-22
The European Parliament Adopts Position on the European Commission’s Proposal for the First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-lifesciences-european-parliament-adopts-medicines-regulatory,2024-04-22
National Bank Settles with NY Attorney General for $700K,https://www.goodwinlaw.com/en/insights/blogs/2024/04/national-bank-settles-with-ny-attorney-general-for-$700k,2024-04-20
CFPB Enters Into Consent Order with For-Profit Coding School,https://www.goodwinlaw.com/en/insights/blogs/2024/04/cfpb-enters-into-consent-order-with-for-profit-coding-school,2024-04-20
CFPB Issues Circular about Deceptive Marketing Practices in Connection with Remittance Transfers,https://www.goodwinlaw.com/en/insights/blogs/2024/04/cfpb-issues-circular-about-deceptive-marketing-practices-in-connection-with-remittance-transfers,2024-04-19
"Fresenius Kabi Announces Launch of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA",https://www.goodwinlaw.com/en/insights/blogs/2024/04/fresenius-kabi-announces-launch-of-tyenne-a-tocilizumab-biosimilar-referencing-actemra,2024-04-19
Supreme Court Adopts New Standard for Establishing Adverse Employment Action Element in Title VII Cases,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-otherindustries-supreme-court-adopts-new-standard,2024-04-19
How Long Do Funds Suspend the Investment Period Due to “Key Person Events”?,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-privateequity-pif-how-long-do-funds-suspend-investment-period-due,2024-04-19
The SEC Amends the Internet Adviser Exemption,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-finance-pif-the-sec-amends-the-internet-adviser-exemption,2024-04-19
Paying for Buy-Side Investment Research: Will the FCA’s Third Way Ease the US-UK Divide?,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-finance-pif-investment-research-fca-third-way-easing-us-uk-divide,2024-04-19
Genentech and Dr. Reddy’s Settle BPCIA Rituximab Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/04/genentech-and-dr-reddys-settle-bpcia-rituximab-litigation,2024-04-18
Acquiring or Investing in EU Crypto-Asset Businesses: Further Clarity on MiCA,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-finance-acquiring-or-investing-in-eu-crypto-asset-businesses,2024-04-18
CFPB Updates Supervision Designation Procedures,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-finance-fs-weekly-roundup-041824,2024-04-18
MDL Panel Grants Transfer of Aflibercept BPCIA Case,https://www.goodwinlaw.com/en/insights/blogs/2024/04/mdl-panel-grants-transfer-of-aflibercept-bpcia-case,2024-04-17
SEC Speaks Conference 2024,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-otherindustries-sec-speaks-conference-2024,2024-04-17
15 Questions Fintechs Should Ask Potential Bank Partners in Due Diligence,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-finance-ftec-questions-potential-bank-partners-in-due-diligence,2024-04-16
Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-practices-ma-delaware-supreme-court-holds-that-boards,2024-04-15
California Insurance Reform Creates Opportunity,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-practices-ftec-california-insurance-reform-creates-opportunity,2024-04-15
Supreme Court Rejects Securities Lawsuit Based On “Pure Omission” From SEC Filings,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-otherindustries-supreme-court-rejects-securities-lawsuit,2024-04-15
FDA Approves BMS and J&J CAR-T Cell Therapies for the Earlier Treatment of Multiple Myeloma,https://www.goodwinlaw.com/en/insights/blogs/2024/04/fda-approves-bms-and-jj-cart-cell-therapies-for-the-earlier-treatment-of-multiple-myeloma,2024-04-11
Matt Campobasso: “The legal team has to be able to see around corners”,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-practices-the-legal-has-to-be-able-to-see-around-corners,2024-04-11
OCC Extends Comment Period for Proposed Rulemaking and Policy Statement on Bank Mergers,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-finance-fs-weekly-roundup-041124,2024-04-11
Janssen v. Teva: Not an April Fool’s Day Joke for Life Sciences Companies,https://www.goodwinlaw.com/en/insights/blogs/2024/04/janssen-v-teva-not-an-april-fools-day-joke-for-life-sciences-companies,2024-04-10
"‘Office Is Not Dead’, and Other Takeaways on the Real Estate Outlook",https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-realestate-propt-hed-office-is-not-dead-and-other-takeaways,2024-04-10
FDA Approves New Indication for AstraZeneca and Daiichi Sankyo’s Cancer Drug ENHERTU,https://www.goodwinlaw.com/en/insights/blogs/2024/04/fda-approves-new-indication-for-astrazeneca-and-daiichi-sankyos-cancer-drug-enhertu,2024-04-09
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-erisa-litigation-update-q1-2024,2024-04-09
The Department of Labor Finalizes Changes to the QPAM Exemption – A Favored Management Tool Gets Less User-Friendly,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-practices-erisa-the-department-of-labor-finalizes-changes,2024-04-09
5 Essential Tips for Tailoring Your Diligence Plan to Secure R&W Insurance in Manufacturing Deals,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-otherindustries-five-essential-tips-for-tailoring-your-diligence,2024-04-05
SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet,https://www.goodwinlaw.com/en/insights/newsletters/2024/04/newsletters-finance-fs-weekly-roundup-040424,2024-04-04
Issue 44: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2024/04/alerts-otherindustries-ptab-issue-44,2024-04-04
Commercial real estate investors expect the market to improve and transactions to increase,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-realestate-reit-commercial-real-estate-investors-expect,2024-04-03
A Look Ahead in Life Sciences: What We Are Tracking in Q2 2024 and Beyond,https://www.goodwinlaw.com/en/insights/blogs/2024/04/a-look-ahead-in-life-sciences-what-we-are-tracking-in-q2-2024-and-beyond,2024-04-01
A Look Ahead in Life Sciences: What We Are Tracking in Q2 2024 and Beyond,https://www.goodwinlaw.com/en/insights/publications/2024/04/insights-lifesciences-a-look-ahead-in-life-sciences-q2,2024-04-01
REGENXBIO and Sarepta Agree to Stay Litigation Pending Outcome of Sarepta’s IPR Petition,https://www.goodwinlaw.com/en/insights/blogs/2024/03/regenxbio-and-sarepta-agree-to-stay-litigation-pending-outcome-of-sareptas-ipr-petition,2024-03-29
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-practices-df-debt-download-032924,2024-03-29
USPTO Emphasizes Searches of FDA Databases for Pharmaceutical Patent Applications,https://www.goodwinlaw.com/en/insights/blogs/2024/03/uspto-emphasizes-searches-of-fda-databases-for-pharmaceutical-patent-applications,2024-03-28
Fresenius Kabi and Formycon Reach Settlement Agreement for Ustekinumab Biosimilar Candidate in Europe and Canada,https://www.goodwinlaw.com/en/insights/blogs/2024/03/fresenius-kabi-and-formycon-reach-settlement-agreement-for-ustekinumab-biosimilar-candidate-in-europ,2024-03-28
Interpretable Algorithms as a Potential Solution to CFPB’s Guidance on AI-driven Credit Denials,https://www.goodwinlaw.com/en/insights/blogs/2024/03/interpretable-algorithms-as-a-potential-solution-to-cfpbs-guidance-on-ai-driven-credit-denials,2024-03-28
FDA Approves First Gene Therapy to Treat Children with Metachromatic Leukodystrophy,https://www.goodwinlaw.com/en/insights/blogs/2024/03/fda-approves-first-gene-therapy-to-treat-children-with-metachromatic-leukodystrophy,2024-03-28
"Washington’s My Health My Data Act Comes Into Force – What You Need to Know, and Do",https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-technology-hltc-my-health-my-data-act-mhmda,2024-03-28
At the Intersection of ‘S’ and ‘G’ of ESG: London Leading the Way on Board Diversity — An Update on Latest FTSE Women Leaders Review and Parker Review Reports,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-otherindustries-at-the-intersection-of-s-and-g-of-esg,2024-03-28
Agencies Extend Applicability Date of Certain Provisions of their CRA Final Rule,https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-finance-fs-weekly-roundup-032824,2024-03-28
Biden Administration Proposes Biosimilar Substitution Without Interchangeability,https://www.goodwinlaw.com/en/insights/blogs/2024/03/biden-administration-proposes-biosimilar-substitution-without-interchangeability,2024-03-27
A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs,2024-03-27
"In Updated Guidance on Use of Tracking Technologies by HIPAA Regulated Entities, HHS-OCR Takes Expansive View of When Information Related to Unauthenticated Individuals Is PHI",https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-hltc-updated-guidance-tracking-technologies-hipaa-entities,2024-03-27
"Featured Speaker: State of the Real Estate Capital Markets, REIT, Private and IPO Market",https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-featured-speaker-state-of-the-real-estate-capital-markets,2024-03-27
Global Flows of Capital,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-global-flows-of-capital,2024-03-27
Burst Session I: Hospitality + Hybrid Hospitality,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-burst-session-i-hospitality-hybrid-hospitality,2024-03-27
Burst Session II: Trends in the Office Sector,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-burst-session-ii-trends-in-the-office-sector,2024-03-27
Keynote Session: Matt Anderson,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-keynote-session-matt-anderson,2024-03-27
European Health Data Space: European Council and European Parliament Strike A Deal,https://www.goodwinlaw.com/en/insights/blogs/2024/03/european-health-data-space-european-council-and-european-parliament-strike-a-deal,2024-03-26
Traps for the Unwary: Using Alternative Credit Data to Expand Credit Access to LMI Individuals and Underrepresented Communities,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-finance-ftec-traps-for-the-unwary-using-alternative,2024-03-26
2023-2024 Key Trends and Updates: Securities Litigation Against Life Sciences Companies Webinar,https://www.goodwinlaw.com/en/insights/blogs/2024/03/2023-2024-key-trends-and-updates-securities-litigation-against-life-sciences-companies-webinar,2024-03-25
Incentive Equity: Vesting Criteria for Management Teams of PE-Backed Portfolio Companies,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-privateequity-incentive-equity-vesting-criteria,2024-03-25
Charting the DOJ’s Record Breaking Year for False Claims Act Enforcement,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-otherindustries-gie-charting-the-doj-record-breaking-year,2024-03-25
Charting the DOJ’s Record Breaking Year for False Claims Act Enforcement,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-practices-charting-the-dojs-for-false-claims-act-enforcement,2024-03-25
Antitrust & Competition Technology 2023 Year in Review,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-technology-antitrust-competition-technology-2023-year-in-review,2024-03-25
Women’s History Month Spotlight: Emmanuelle Charpentier and Jennifer Doudna,https://www.goodwinlaw.com/en/insights/blogs/2024/03/womens-history-month-spotlight-emmanuelle-charpentier-and-jennifer-doudna,2024-03-22
Wisconsin Becomes Third State to Enact Law Regulating Earned Wage Access Services,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-finance-ftec-wisconsin-to-enact-regulating-earned-wage-access-services,2024-03-22
FinCEN Publishes an Administrative Ruling Regarding Customer Identification Program and Customer Due Diligence Requirements for Designated Beneficiaries of Individual Retirement Accounts,https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-finance-fs-weekly-roundup-032124,2024-03-21
ELTIF 2.0 RTS: Commission Orders ESMA to Think Again,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-pif-eltif-2-0-rts-commission-orders-esma-to-think-again,2024-03-21
The New UK Public Offers Regime: Three Key Takeaways and Next Steps,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-technology-new-uk-public-offers-regime-three-key-takeaways-next-steps,2024-03-20
Celltrion Announces Commercial Availability of ZYMFENTRA™ (infliximab-dyyb),https://www.goodwinlaw.com/en/insights/blogs/2024/03/celltrion-announces-commercial-availability-of-zymfentra-infliximabdyyb,2024-03-19
Updates on Aflibercept BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/03/updates-on-aflibercept-bpcia-litigation,2024-03-19
"What's Hot in Commercial Real Estate, in Charts",https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-realestate-whats-hot-in-commercial-real-estate-in-charts,2024-03-19
Germany Set To Legalize Adult-Use Cannabis,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-can-germany-legalizes-adult-use-cannabis,2024-03-19
Celltrion Submits BLA for Omalizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2024/03/celltrion-submits-bla-for-omalizumab-biosimilar,2024-03-18
FinTech Companies Settle PPP-related Claims with FTC,https://www.goodwinlaw.com/en/insights/blogs/2024/03/fintech-companies-settle-ppp-related-claims-with-ftc,2024-03-18
New SEC Climate Rules Stayed by Fifth Circuit – For Now,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-pca-new-sec-climate-rules,2024-03-18
Chamber of Commerce Sues CFPB To Eliminate or Enjoin $8 Late Fee Cap,https://www.goodwinlaw.com/en/insights/blogs/2024/03/chamber-of-commerce-sues-cfpb-to-eliminate-or-enjoin-$8-late-fee-cap,2024-03-15
"Fresenius Kabi Announces FDA Approval of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA",https://www.goodwinlaw.com/en/insights/blogs/2024/03/fresenius-kabi-announces-fda-approval-of-tyenne-a-tocilizumab-biosimilar-referencing-actemra,2024-03-15
"In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers",https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-otherindustries-doj-announces-pilot-program,2024-03-15
FDA’s Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee on Health to Hold Hearing on Regulation of Diagnostic Tests,https://www.goodwinlaw.com/en/insights/blogs/2024/03/fdas-laboratory-developed-test-ldt-final-rule-under-oira-review,2024-03-14
Series 1 - The World’s First AI Regulation Is Here,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-aiml-series-1-the-worlds-first-ai-regulation-is-here,2024-03-14
Federal Reserve Announces Final Rule Updating Risk Management Requirements for Certain Systemically Important Financial Market Utilities,https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-finance-fs-weekly-roundup-031424,2024-03-14
Digital Markets Act: Mandatory Compliance for Big Tech Companies,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-technology-digital-markets-act-mandatory-compliance,2024-03-14
DoD Significantly Expands Voluntary Cybersecurity Program for Defense Contractors,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-dpc-dod-expands-cybersecurity-program-defense-contractors,2024-03-14
Dos and Don'ts of Interacting with Bank Regulators,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-finance-dos-and-donts-of-interacting-with-bank-regulators,2024-03-14
Major Life Sciences Licensing Deal Trends in China in 2023,https://www.goodwinlaw.com/en/insights/blogs/2024/03/major-life-sciences-licensing-deal-trends-in-china-in-2023,2024-03-13
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences,https://www.goodwinlaw.com/en/insights/blogs/2024/03/usptos-new-guidance-on-ai-assisted-inventions-the-impact-on-the-use-of-ai-in-the-life-sciences,2024-03-13
Major Life Sciences Licensing Deal Trends in China in 2023,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-lifesciences-major-life-sciences-licensing-deal-trends,2024-03-13
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-practices-ip-uspto-new-guidance-on-ai-assisted-inventions,2024-03-12
Forward to the Past: HNW and Sophisticated Exemptions for UK Investors,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-otherindustries-fs-forward-to-the-past-hnw-and-sophisticated,2024-03-12
The Coming Storm: Preparing for The SEC's Final Climate-Related Disclosure Rules,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-otherindustries-pca-the-coming-storm-preparing-for-the-sec,2024-03-12
Antitrust & Competition Healthcare Year in Review 2023,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-otherindustries-hltc-antitrust-competition-year-in-review-2023,2024-03-11
The CFPB’s Final Rule Imposes Significant Restrictions on Credit Card Late Fees,https://www.goodwinlaw.com/en/insights/blogs/2024/03/the-cfpbs-final-rule-imposes-significant-restrictions-on-credit-card-late-fees,2024-03-10
Minnesota AG Sues Solar Lending Companies Over Hidden Fees,https://www.goodwinlaw.com/en/insights/blogs/2024/03/minnesota-ag-sues-solar-lending-companies-over-hidden-fees,2024-03-08
FDA Approves Sandoz Denosumab Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2024/03/fda-approves-sandoz-denosumab-biosimilars,2024-03-08
The CFPB’s “Junk Fees” Initiative: Recent Developments and Trends,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-finance-ftec-the-cfpbs-junk-fees-initiative-recent,2024-03-08
"Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar",https://www.goodwinlaw.com/en/insights/blogs/2024/03/biocon-settles-with-bayer-and-regeneron-securing-canada-market-entry-date-for-aflibercept-biosimilar,2024-03-07
"Biocon Settles with Janssen, Securing U.S. Market Entry Date for Ustekinumab Biosimilar",https://www.goodwinlaw.com/en/insights/blogs/2024/03/biocon-settles-with-janssen-securing-us-market-entry-date-for-ustekinumab-biosimilar,2024-03-07
CFPB Issues Guidance Regarding Comparison-Shopping Results for Credit Cards and Other Financial Products,https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-finance-fs-weekly-roundup-030724,2024-03-07
"In This Issue: In re Sears Hometown and Outlet Stores, Inc. Stockholder Litigation, 2024 WL 262322 (Del. Ch. Jan. 24, 2024); Mi v. Waterdrop Inc., 2024 WL 159191 (2nd Cir. Jan. 16, 2024).",https://www.goodwinlaw.com/en/insights/newsletters/2024/03/newsletters-sslit-securities-snapshot-030724,2024-03-07
Approaches Funds Take to Catch-Up Payments Vary by Asset Class,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-practices-pif-funds-catchup-payments-asset-class,2024-03-07
Developments in W&I Insurance in Asia,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-privateequity-practices-developments-in-wi-insurance-in-asia,2024-03-07
FTC and DOJ Launch New Cross-Government Inquiry on the Role of Private Equity in Healthcare,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-privateequity-hltc-ftc-and-doj-launch-new-cross-government-inquiry,2024-03-07
Q&A with TusPark’s Wei Meng on Life Sciences and Operational Real Estate,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-privateequity-q-and-a-with-tusparks-wei-meng,2024-03-07
US Government Moves to Regulate Cross-Border Transactions Involving Sensitive Data,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-otherindustries-us-government-moves-to-regulate,2024-03-06
Employment Status — A View From Both Sides of the Pond,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-practices-emp-employment-status-a-view-from-both-sides,2024-03-06
Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDA,https://www.goodwinlaw.com/en/insights/blogs/2024/03/teva-and-alvotechs-adalimumab-biosimilar-receives-interchangeable-status-at-fda,2024-03-05
The BIOSECURE Act and Its Potential Implications,https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-the-biosecure-act-and-its-potential-implications,2024-03-05
Navigating the Hazy Landscape: Challenges and Solutions in Cannabis Payment Processing,https://www.goodwinlaw.com/en/insights/publications/2024/03/insights-finance-ftec-navigating-challenges-solutions-cannabis-payment-processing,2024-03-05
West Virginia Proposes Mini-TCPA Law,https://www.goodwinlaw.com/en/insights/blogs/2024/03/west-virginia-proposes-mini-tcpa-law,2024-03-03
Court Grants Summary Judgment Ending AstraZeneca’s Lawsuit Challenging the IRA,https://www.goodwinlaw.com/en/insights/blogs/2024/03/court-grants-summary-judgment-ending-astrazenecas-lawsuit-challenging-the-ira,2024-03-01
Post-Trial Updates on Regeneron v. Mylan (Aflibercept) BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/03/posttrial-updates-on-regeneron-v-mylan-aflibercept-bpcia-litigation,2024-03-01
Genentech and Partners Voluntarily Dismiss IPR Appeals Related to Genentech’s ACTEMRA® (Tocilizumab),https://www.goodwinlaw.com/en/insights/blogs/2024/03/genentech-and-partners-voluntarily-dismiss-ipr-appeals-related-to-genentechs-actemra-tocilizumab,2024-03-01
Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK in Lupus Nephritis,https://www.goodwinlaw.com/en/insights/blogs/2024/02/artiva-biotherapeutics-receives-fda-fast-track-designation-for-allonk-in-lupus-nephritis,2024-02-29
CFPB Revises Supervisory Appeals Process,https://www.goodwinlaw.com/en/insights/blogs/2024/02/cfpb-revises-supervisory-appeals-process,2024-02-29
OCC Amends FOIA Regulations,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-finance-fs-weekly-roundup-022924,2024-02-29
SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth and Take-Home Medication Flexibilities,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-hltc-samhsa-final-rule-codifies-opioid-treatment,2024-02-29
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-practices-df-debt-download-022924,2024-02-29
California DFPI Settles with Financial Services Company Over Customer Service Complaints,https://www.goodwinlaw.com/en/insights/blogs/2024/02/california-dfpi-settles-with-financial-services-company-over-customer-service-complaints,2024-02-28
Delaware Court of Chancery Invalidates Governance Rights in Stockholder Agreement,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-privateequity-delaware-court-of-chancery-invalidates-governance-rights,2024-02-28
FINRA Proposes to Add ‘Knowledgeable Employees’ to Category of Persons Who May Receive Projections and Targeted Returns Under Rule 2210,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-privateequity-ftec-finra-proposes-to-add-knowledgeable-employees,2024-02-28
Goodwin’s Annual Rare Disease Symposium,https://www.goodwinlaw.com/en/insights/blogs/2024/02/goodwins-annual-rare-disease-symposium,2024-02-26
Use of Equity Rollovers Continues to Rise Amid Market Uncertainty,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-privateequity-use-equity-rollovers-continues-to-rise,2024-02-26
DOJ Renews Focus on Private Equity Amid Record False Claims Act Enforcement,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-privateequity-hltc-doj-renews-focus-on-private-equity,2024-02-26
Healthcare Experts See Promising Signs of Rebound in M&A and IPO Activity,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-technology-vc-healthcare-experts-see-promising-signs,2024-02-26
"Alvotech Announces More Settlements and Expected Launch Dates Regarding Biosimilar to STELARA (ustekinumab), AVT04",https://www.goodwinlaw.com/en/insights/blogs/2024/02/alvotech-announces-more-settlements-and-expected-launch-dates-regarding-biosimilar-to-stelara-usteki,2024-02-23
FDA Approves First Cellular Therapy for Treatment of Unresectable or Metastatic Melanoma,https://www.goodwinlaw.com/en/insights/blogs/2024/02/fda-approves-first-cellular-therapy-for-treatment-of-unresectable-or-metastatic-melanoma,2024-02-23
Alabama IVF Clinics: Potential Implications of the LePage Case,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-lifesciences-hltc-lepage-implications,2024-02-23
Antitrust & Competition Life Sciences Year in Review 2023,https://www.goodwinlaw.com/en/insights/blogs/2024/02/antitrust--competition-life-sciences-year-in-review-2023,2024-02-22
FTC Provides Annual Letter to CFPB On 2023 Equal Credit Opportunity Act Activities,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-finance-fs-weekly-roundup-022224,2024-02-22
Antitrust & Competition Life Sciences Year in Review 2023,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-lifesciences-cldr-antitrust-and-competition-in-lifesciences-2023-yir,2024-02-22
Fund Finance: 2023 Reflections and Looking Ahead to 2024,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-pif-fund-finance-2023-reflections-looking-ahead-2024,2024-02-22
FDA Approves XOLAIR to Treat Children and Adults With One or More Food Allergies,https://www.goodwinlaw.com/en/insights/blogs/2024/02/fda-approves-xolair-to-treat-children-and-adults-with-one-or-more-food-allergies,2024-02-21
PTAB Institutes Celltrion and Biocon IPRs on Regeneron Aflibercept Dosing Patent,https://www.goodwinlaw.com/en/insights/blogs/2024/02/ptab-institutes-celltrion-and-biocon-iprs-on-regeneron-aflibercept-dosing-patent,2024-02-21
"FDA Issues a Final Rule on Biologics License Applications, Investigational New Drug Applications and Master Files",https://www.goodwinlaw.com/en/insights/blogs/2024/02/fda-issues-a-final-rule-on-biologics-license-applications-investigational-new-drug-applications-and,2024-02-20
SEC to Ban Exchange Volume-Based Pricing Tiers,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-sec-to-ban-exchange-volume-based-pricing-tiers,2024-02-20
Pick Up the Indemnification Stick for Your True Lender Bundle,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-ftec-pick-up-the-indemnification-stick,2024-02-20
Recent Bayh-Dole Act News: Comments on the Draft Framework; HHS Refuses to March-In on Xtandi; and Delayed Contracting Doesn’t Avoid Bayh-Dole,https://www.goodwinlaw.com/en/insights/blogs/2024/02/recent-bayhdole-act-news-comments-on-the-draft-framework-hhs-refuses-to-marchin-on-xtandi-and-delaye,2024-02-16
FCC Confirms A.I.-Generated Robocall Voices Are “Artificial” under the TCPA,https://www.goodwinlaw.com/en/insights/blogs/2024/02/fcc-confirms-aigenerated-robocall-voices-are-artificial-under-the-tcpa,2024-02-16
FinCEN Proposes AML Program Rule for Investment Advisers,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-fincen-proposes-aml-program-rule,2024-02-16
A Brief Defense of COMI,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-otherindustries-a-brief-defense-of-comi,2024-02-16
"2023 Year in Review: Market Overview — Lessons from 2023, Emerging Issues for 2024",https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-2023-lessons-2024-emerging-issues,2024-02-15
2023 Year in Review: Data Privacy and Cybersecurity,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-data-privacy-cybersecurity,2024-02-15
2023 Year in Review: Credit Reporting,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-credit-reporting,2024-02-15
"2023 Year in Review: Credit, Debit, or Prepaid Cards and Consumer Banking",https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-credit-debit-prepaid-cards-consumer-banking,2024-02-15
2023 Year in Review: Auto Loan Origination and Servicing,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-auto-loan-origination-servicing,2024-02-15
2023 Year in Review: Mortgage Origination and Servicing,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-mortgage-origination-and-servicing,2024-02-15
2023 Year in Review: Major U.S. Supreme Court and Appellate Cases,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-major-us-supreme-court-appellate-cases,2024-02-15
2023 Year in Review: Payday and Small-Dollar Lending,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-payday-small-dollar-lending,2024-02-15
2023 Year in Review: Fintech,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-fintech,2024-02-15
2023 Year in Review: Telephone Consumer Protection Act,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-telephone-consumer-protection-act,2024-02-15
2023 Year in Review: Debt Collection and Debt Settlement,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-debt-collection-debt-settlement,2024-02-15
2023 Year in Review: Student Lending,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cfs-yir-student-lending,2024-02-15
Bigger Fish to Fry: BIS Refines Voluntary Self-Disclosure Process for Minor EAR Violations,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-bigger-fish-to-fry-bis-refines-voluntary,2024-02-14
FINRA Approves Remote Branch Inspection Pilot Program,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-privateequity-fs-finra-approves-remote-branch-inspection,2024-02-14
The EU AI Act Is (Almost) Here. What It Means for Your Business,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-technology-aiml-the-eu-ai-act-is-almost-here,2024-02-14
Payment Trends in 2024,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-ftec-payment-trends,2024-02-13
End of the Beginning: AIFMD II’s Final Text,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-pif-end-of-the-beginning-aifmd,2024-02-13
USPTO Issues New Guidance on Patenting AI-Assisted Inventions,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-aiml-uspto-issues-new-guidance,2024-02-13
Cash Management in Hotel Financing,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-finance-cash-management-in-hotel-financing,2024-02-13
Court Dismisses PhRMA Lawsuit Challenging IRA,https://www.goodwinlaw.com/en/insights/blogs/2024/02/court-dismisses-phrma-lawsuit-challenging-ira,2024-02-12
Shaping the Future: the European Health Data Space,https://www.goodwinlaw.com/en/insights/blogs/2024/02/shaping-the-future-the-european-health-data-space,2024-02-12
FINRA (Finally) Adopts Work-From-Home Supervisory Location Category and Requirements,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-finance-fs-finra-adopts-work-from-home-supervisory,2024-02-12
In This Issue: Goodwin Again Secures Dismissal of Putative Securities Class Action for Plug Power Inc.; Former Twitter Stockholder Denied Mootness Fees,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-sslit-securities-snapshot-020924,2024-02-12
SEC Expands Dealer Definition to Capture Large Traders Regularly Providing Liquidity to the Markets,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-finance-ftec-sec-expands-dealer-definition,2024-02-09
Assessing Preferred Equity as Part of the Financing Toolkit,https://www.goodwinlaw.com/en/insights/publications/2024/02/insights-otherindustries-assessing-preferred-equity,2024-02-09
SEC Issues Updated Marketing Rule FAQ on IRRs for Funds With Subscription Facilities,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-pif-sec-issues-updated-marketing-rule-faq,2024-02-09
Updates on Aflibercept BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/02/updates-on-aflibercept-bpcia-litigation,2024-02-08
Federal Bank Regulatory Agencies Seek Comment on Interagency Effort to Reduce Regulatory Burden,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-finance-fs-weekly-roundup-020824,2024-02-08
What Has Changed in the New Corporate Governance Code?: Five Key Things to Know about the New Code and Associated Guidance,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-technology-changed-new-corporate-governance-code-five-things-to-know,2024-02-08
Taking Stock of the Private Funds Rules Litigation After Oral Arguments at the Fifth Circuit,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-pif-private-funds-litigation-oral-arguments-fifth-circuit,2024-02-07
Sandoz to Acquire CIMERLI from Coherus for $170 Million,https://www.goodwinlaw.com/en/insights/blogs/2024/02/sandoz-to-acquire-cimerli-from-coherus-for-$170-million,2024-02-06
Delaware Court of Chancery Rescinds Elon Musk’s $55.8 Billion Compensation Package in Cautionary Tale About Director Independence and Executive Compensation,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-pca-delaware-court-of-chancery-rescinds-elon,2024-02-06
California Federal Court Bans Mortgage Operators as Result of Joint FTC and DFPI Case,https://www.goodwinlaw.com/en/insights/blogs/2024/02/california-federal-court-bans-mortgage-operators-as-result-of-joint-ftc-and-dfpi-case,2024-02-05
CFPB Announces New Proposed Rule to Target Junk Fees,https://www.goodwinlaw.com/en/insights/blogs/2024/02/cfpb-announces-new-proposed-rule-to-target-junk-fees,2024-02-03
Foreign Extortion Prevention Act (FEPA) Expands US Authority to Reach Foreign Bribery,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-lifesciences-hltc-foreign-extortion-prevention-act-expands,2024-02-02
Biosimilar Regulatory Updates,https://www.goodwinlaw.com/en/insights/blogs/2024/02/biosimilar-regulatory-updates,2024-02-01
Life Sciences Companies Make Up a Small Portion of the Companies Opting-In to the Unitary Patent; Ireland Announces Referendum Date,https://www.goodwinlaw.com/en/insights/blogs/2024/02/life-sciences-companies-make-up-a-small-portion-of-the-companies-optingin-to-the-unitary-patent-irel,2024-02-01
Federal Reserve Announces the Bank Term Funding Program will Cease Making New Loans as Scheduled on March 11,https://www.goodwinlaw.com/en/insights/newsletters/2024/02/newsletters-finance-fs-weekly-roundup-020124,2024-02-01
Marketing Crypto Assets to EU Investors Under MICA: ESMA’s First Take on Reverse Solicitation,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-practices-ftec-marketing-crypto-assets-to-eu-investors-under-mica,2024-02-01
Horizon Scan for Private Investment Funds,https://www.goodwinlaw.com/en/insights/publications/2024/02/alerts-otherindustries-pif-horizon-scan-for-private-investment-funds,2024-02-01
Illinois Federal Court Issues Injunction and $28.7 Million Judgment Against Telemarketing Operation,https://www.goodwinlaw.com/en/insights/blogs/2024/01/illinois-federal-court-issues-injunction-and-287-million-judgment-against-telemarketing-operation,2024-01-31
Crypt-D’OH! FINRA says 70% of BD Crypto Asset Communications Are Deficient,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-finance-aiml-finra-bd-crypto-asset-communications-are-deficient,2024-01-31
Data Privacy Day 2024: What’s Hot in Privacy? Everything,https://www.goodwinlaw.com/en/insights/blogs/2024/01/data-privacy-day-2024-whats-hot-in-privacy-everything,2024-01-30
New Jersey Privacy Law Helps Expand US Consumer Privacy System,https://www.goodwinlaw.com/en/insights/blogs/2024/01/new-jersey-privacy-law-helps-expand-us-consumer-privacy-system,2024-01-30
Playing the ‘What If’ Game When Reviewing Fintech–Bank Partnership Agreements,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-finance-ftec-playing-the-what-if-game-when-reviewing,2024-01-30
How Different Funds Approach Hurdle Rate Calculations,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-otherindustries-pif-how-different-funds-approach-hurdle-rate-calculations,2024-01-30
USPTO Publishes Enablement Guidelines in view of Amgen v. Sanofi,https://www.goodwinlaw.com/en/insights/blogs/2024/01/uspto-publishes-enablement-guidelines-in-view-of-amgen-v-sanofi,2024-01-29
"Goodwin’s 2024 Data, Privacy & Cybersecurity Outlook",https://www.goodwinlaw.com/en/insights/blogs/2024/01/goodwins-2024-data-privacy--cybersecurity-outlook,2024-01-29
Federal Circuit Remands to USPTO to Clarify Analysis of Jepson-Format and Means-Plus-Function Claims in the Field of Biotechnology,https://www.goodwinlaw.com/en/insights/blogs/2024/01/federal-circuit-remands-to-uspto-to-clarify-analysis-of-jepsonformat-and-meansplusfunction-claims-in,2024-01-26
Celltrion Launches 80 mg YUFLYMA (adalimumab-aaty) in the U.S.,https://www.goodwinlaw.com/en/insights/blogs/2024/01/celltrion-launches-80-mg-yuflyma-adalimumabaaty-in-the-us,2024-01-26
CJEU ADM Decision Casts Wide Net Over Credit Scoring Agencies,https://www.goodwinlaw.com/en/insights/blogs/2024/01/cjeu-adm-decision-casts-wide-net-over-credit-scoring-agencies,2024-01-26
Ten Considerations for Large-Cap and Upper-Middle-Market Borrowers in Early Stages of Distress,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-privateequity-ten-considerations-for-large-cap,2024-01-26
What DORA Means for Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-finance-fs-what-dora-means-for-fund-managers,2024-01-26
Year in Review: Top Regulatory Developments of 2023,https://www.goodwinlaw.com/en/insights/blogs/2024/01/year-in-review-top-regulatory-developments-of-2023,2024-01-25
"Federal Reserve Announces it Will Extend the Comment Period on its Interchange Fee Proposal Until May 12, 2024",https://www.goodwinlaw.com/en/insights/newsletters/2024/01/newsletters-finance-fs-weekly-roundup-012524,2024-01-25
"SEC Adopts New Rules Applicable to SPACs, Shell Companies and Projections",https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-lifesciences-ma-sec-adopts-new-rules-applicable-to-spacs,2024-01-25
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2024/01/newsletters-practices-df-debt-download-012524,2024-01-25
FINRA Publishes 2024 Annual Regulatory Oversight Report,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-finance-aiml-finra-publishes-2024-annual-regulatory-oversight-report,2024-01-25
FTC Reaches Settlement With Cash Advance Company,https://www.goodwinlaw.com/en/insights/blogs/2024/01/ftc-reaches-settlement-with-cash-advance-company,2024-01-24
Employment Terms – A View From Both Sides of the Pond,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-practices-emp-employment-terms-a-view-from-both-sides,2024-01-24
Updated AAA Rules and Fees Could Change the Mass Arbitration Landscape,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-updated-aaa-rules-and-fees-could-change,2024-01-24
K-Fee Provides a Warning to Life Sciences Companies – What You Say in Foreign Prosecution May Affect Your U.S. Claim Scope,https://www.goodwinlaw.com/en/insights/blogs/2024/01/kfee-provides-a-warning-to-life-sciences-companies--what-you-say-in-foreign-prosecution-may-affect-y,2024-01-23
OIG Issues Report Concerning CFPB Enforcement Investigations,https://www.goodwinlaw.com/en/insights/blogs/2024/01/oig-issues-report-concerning-cfpb-enforcement-investigations,2024-01-23
Corporate Transparency Act — Key Points,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-corporate-transparency-act-key-points,2024-01-23
CMMC 2.0: Defense Contractors Get Ready,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-dpc-cmcc-cybersecurity-maturity-model-certification,2024-01-23
2024 HSR Thresholds Announced: $119.5 million,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-2024-hsr-thresholds-announced,2024-01-23
California Department of Financial Protection Issues Consent Order Against Fintech Company,https://www.goodwinlaw.com/en/insights/blogs/2024/01/california-department-of-financial-protection-issues-consent-order-against-fintech-company,2024-01-22
PTAB Issues Final Written Decision Finding Seagen Antibody-Drug Conjugate Patent Claims to be Unpatentable,https://www.goodwinlaw.com/en/insights/blogs/2024/01/ptab-issues-final-written-decision-finding-seagen-antibodydrug-conjugate-patent-claims-to-be-unpaten,2024-01-22
Updates on Aflibercept BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/01/updates-on-aflibercept-bpcia-litigation,2024-01-22
California OHCA Publishes Final Regulations Regarding Healthcare Transaction Filing Requirements and Review Process,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-hltc-california-ohca-publishes-final-regulations,2024-01-22
New Laws Reinforce California’s Hostility to Non-Competes with Notice Obligations and Civil Penalties,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-tsemnc-new-laws-reinforce-californias-hostility-to-non-competes-with-notice,2024-01-22
Year in Review: Top Legal Developments of 2023,https://www.goodwinlaw.com/en/insights/blogs/2024/01/year-in-review-top-legal-developments-of-2023,2024-01-19
PTAB Issues Final Written Decisions Finding Claims of Aflibercept-related Patents Invalid,https://www.goodwinlaw.com/en/insights/blogs/2024/01/ptab-issues-final-written-decisions-finding-claims-of-aflibercept-related-patents-invalid,2024-01-19
CFPB and State Attorneys General File Suit Against Debt-Relief Companies,https://www.goodwinlaw.com/en/insights/blogs/2024/01/cfpb-and-state-attorneys-general-file-suit-against-debt-relief-companies,2024-01-19
CFPB Proposes Rule to Close Bank Overdraft Loophole,https://www.goodwinlaw.com/en/insights/newsletters/2024/01/newsletters-finance-fs-weekly-roundup-011924,2024-01-19
Developments in Reverse Merger Transactions: “Shell Company” Definition and New Constraints on Resales of Securities Acquired in Rule 145 Transactions,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-vc-developments-in-reverse-merger-transactions,2024-01-19
"Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024",https://www.goodwinlaw.com/en/insights/blogs/2024/01/now-available-updated-goodwins-guide-to-biosimilars-litigation-and-regulation-in-the-us-20232024,2024-01-18
"Alvotech and STADA obtain approval in Europe for ustekinumab biosimilar, UZPRUVO",https://www.goodwinlaw.com/en/insights/blogs/2024/01/alvotech-and-stada-obtain-approval-in-europe-for-ustekinumab-biosimilar-uzpruvo,2024-01-18
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2024/01/newsletters-erisa-litigation-update-q4,2024-01-18
Master(ing) Protocols for Randomized Umbrella and Platform Trials,https://www.goodwinlaw.com/en/insights/blogs/2024/01/mastering-protocols-for-randomized-umbrella-and-platform-trials,2024-01-17
Alexion Sues Samsung over Proposed Eculizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2024/01/alexion-sues-samsung-over-proposed-eculizumab-biosimilar,2024-01-17
USAO Reaches $1.9 Million Agreement with Bank to Resolve Lending Discrimination Claims,https://www.goodwinlaw.com/en/insights/blogs/2024/01/usao-reaches-19-million-agreement-with-bank-to-resolve-lending-discrimination-claims,2024-01-17
ELTIF 2.0: ESMA Provides Some Final Details,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-pif-eltif-2-0-esma-provides-some-final-details,2024-01-17
Ustekinumab Antitrust Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/01/ustekinumab-antitrust-litigation,2024-01-16
The New UK Listing Regime Takes Shape as Further Detailed Proposals are Announced by the UK Financial Conduct Authority,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-cm-the-new-uk-listing-regime-takes-shape,2024-01-16
What’s Next for AI? Six Areas to Watch in 2024,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-technology-aiml-whats-next-for-ai-six-areas,2024-01-16
Awaiting Appellate Precedent on Whether Recent New York Foreclosure Limits Are Constitutional,https://www.goodwinlaw.com/en/insights/blogs/2024/01/awaiting-appellate-precedent-on-whether-recent-new-york-foreclosure-limits-are-constitutional,2024-01-13
Merck to Buy Harpoon Therapeutics for $680 Million,https://www.goodwinlaw.com/en/insights/blogs/2024/01/merck-to-buy-harpoon-therapeutics-for-$680-million,2024-01-12
Absence of VAT on Directors’ Fees According to the CJEU,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-tax-absence-of-vat-on-directors-fees,2024-01-12
Luxembourg - Minimum Net Wealth Tax Regime Partially Unconstitutional,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-tax-luxembourg-minimum-net-wealth-tax-regime,2024-01-12
Delaware Personal Data Privacy Act: What Businesses Need to Know,https://www.goodwinlaw.com/en/insights/blogs/2024/01/delaware-personal-data-privacy-act-what-businesses-need-to-know,2024-01-11
CFPB Report Identifies Challenges Faced by Borrowers in Resumption of Student Loan Payments,https://www.goodwinlaw.com/en/insights/newsletters/2024/01/newsletters-finance-fs-weekly-roundup-011124,2024-01-11
Issue 43: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-ptab-issue-43,2024-01-11
Cybersecurity — Cracking the Code on Upcoming Disclosures,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-technology-pca-cybersecurity-upcoming-disclosures,2024-01-11
Payments Company Settles with DFPI Over Alleged Junk Fees,https://www.goodwinlaw.com/en/insights/blogs/2024/01/payments-company-settles-with-dfpi-over-alleged-junk-fees,2024-01-10
FAQs About US Bank Failure,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-faq-about-a-us-bank-failure,2024-01-10
Deadline Approaching for Reporting 2023 ISO Exercises and ESPP Transfers,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-erisa-deadline-approaching-for-reporting,2024-01-10
"CFPB and Several States Order Vocational Education Company to Pay Fines, Cancel Loans, and Cease Operations After Allegedly Deceptive Loan Practices",https://www.goodwinlaw.com/en/insights/blogs/2024/01/cfpb-and-several-states-order-vocational-education-company-to-pay-fines-cancel-loans-and-cease-opera,2024-01-09
District Court Grants Summary Judgment and Invalidates Patent in REGENXBIO v. Sarepta Litigation,https://www.goodwinlaw.com/en/insights/blogs/2024/01/district-court-grants-summary-judgment-and-invalidates-patent-in-regenxbio-v-sarepta-litigation,2024-01-09
"Regeneron’s Disputes with Celltrion, Samsung Bioepis, and Formcycon on Service and Personal Jurisdiction in Aflibercept BPCIA Litigation",https://www.goodwinlaw.com/en/insights/blogs/2024/01/regenerons-disputes-with-celltrion-samsung-bioepis-and-formcycon-on-service-and-personal-jurisdictio,2024-01-08
New IRS and FinCEN Reporting Requirements for Businesses that Accept Payments in Digital Assets,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-practices-ftec-new-irs-and-fincen-reporting-requirements,2024-01-08
A Look Ahead in Life Sciences: What We Are Tracking in Q1 2024 and Beyond,https://www.goodwinlaw.com/en/insights/blogs/2024/01/a-look-ahead-in-life-sciences-what-we-are-tracking-in-q1-2024-and-beyond,2024-01-04
Horizon Scanning — UK Employment Law Developments 2024,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-practices-emp-horizon-scanning-uk-employment-law-developments,2024-01-04
FinCEN Issues Beneficial Ownership Information Access Rule; Bank Regulators Issue Interagency Statement,https://www.goodwinlaw.com/en/insights/publications/2024/01/alerts-otherindustries-fincen-issues-final-rule-on-beneficial-ownership,2024-01-04
A Look Ahead in Life Sciences: What We Are Tracking in Q1 2024 and Beyond,https://www.goodwinlaw.com/en/insights/publications/2024/01/insights-lifesciences-a-look-ahead-in-life-sciences-q1,2024-01-04
FTC Enters Settlement with California-based Lead Generator,https://www.goodwinlaw.com/en/insights/blogs/2024/01/ftc-enters-settlement-with-california-based-lead-generator,2024-01-03
"Rushing to Chaos: The U.S. Department of Labor’s Well-Intentioned, Yet Unworkable Proposal to Redefine Fiduciary Investment Advice",https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-otherindustries-erisa-rushing-to-chaos-the-us-department-of-labors,2023-12-29
German Court Invalidates CureVac Patent in Ongoing BioNTech Lawsuit,https://www.goodwinlaw.com/en/insights/blogs/2023/12/german-court-invalidates-curevac-patent-in-ongoing-biontech-lawsuit,2023-12-28
Breaking: Judgment in Regeneron v. Mylan (aflibercept) BPCIA Case Finding Some Claims of Asserted Patents Valid and Infringed,https://www.goodwinlaw.com/en/insights/blogs/2023/12/breaking-judgment-in-regeneron-v-mylan-aflibercept-bpcia-case-finding-some-claims-of-asserted-patent,2023-12-28
Year in Review: Top Deals in 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/12/year-in-review-top-deals-in-2023,2023-12-28
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/12/newsletters-practices-df-debt-download-122823,2023-12-28
CRISPR Regulatory Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/12/crispr-regulatory-updates,2023-12-27
"Biosimilar Deals Updates: Biocon, AstraZeneca",https://www.goodwinlaw.com/en/insights/blogs/2023/12/biosimilar-deals-updates-biocon-astrazeneca,2023-12-27
Antitrust & Competition Technology Quarterly Update Q3 2023,https://www.goodwinlaw.com/en/insights/publications/2023/12/insights-technology-antc-quarterly-update-q3-2023,2023-12-27
EU Court of Justice Confirms GDPR Security Measures Can Be “Appropriate” Even If Not Foolproof,https://www.goodwinlaw.com/en/insights/blogs/2023/12/eu-court-of-justice-confirms-gdpr-security-measures-can-be-appropriate-even-if-not-foolproof,2023-12-21
Updates on Patent Challenges by Biosimilar Manufacturers at the PTAB,https://www.goodwinlaw.com/en/insights/blogs/2023/12/updates-on-patent-challenges-by-biosimilar-manufacturers-at-the-ptab,2023-12-21
CFPB and DOJ Sue Land Developer Over Allegations of Discriminatory Lending,https://www.goodwinlaw.com/en/insights/blogs/2023/12/cfpb-and-doj-sue-land-developer-over-allegations-of-discriminatory-lending,2023-12-20
"National Bank Enters into Consent Orders with CFPB and OCC, Fined $36 Million",https://www.goodwinlaw.com/en/insights/blogs/2023/12/national-bank-enters-into-consent-orders-with-cfpb-and-occ-fined-36-million,2023-12-19
CFPB Personal Financial Data Rights Proposal: What Are Your Obligations?,https://www.goodwinlaw.com/en/insights/publications/2023/12/insights-finance-ftec-cfpb-personal-financial-data-rights-proposal,2023-12-19
US Antitrust Agencies Release Final Revised Merger Guidelines,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-privateequity-ma-us-antitrust-agencies-release-final-revised-merger-guidelines,2023-12-19
CFPB Issues Consent Order Against Third-Party Debt Collector,https://www.goodwinlaw.com/en/insights/blogs/2023/12/cfpb-issues-consent-order-against-third-party-debt-collector,2023-12-15
Federal Government Releases Proposed Guidance for Exercising “March-In” Rights Under the Bayh-Dole Act: Q & A,https://www.goodwinlaw.com/en/insights/publications/2023/12/insights-lifesciences-federal-government-releases-proposed-guidance,2023-12-15
FDA Approves First Cell-Based Therapies for Treatment of Sickle Cell Disease,https://www.goodwinlaw.com/en/insights/blogs/2023/12/fda-approves-first-cell-based-therapies-for-treatment-of-sickle-cell-disease,2023-12-14
Recent Biosimilar Approvals,https://www.goodwinlaw.com/en/insights/blogs/2023/12/recent-biosimilar-approvals,2023-12-14
OCC Report Identifies Key Risks Facing Federal Banking System,https://www.goodwinlaw.com/en/insights/newsletters/2023/12/newsletters-finance-fs-weekly-roundup-121423,2023-12-14
Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/12/janssen-and-samsung-bioepis-settle-stelara-ustekinumab-litigation,2023-12-13
Denosumab Biosimilar Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/12/denosumab-biosimilar-updates,2023-12-13
October Cybersecurity Awareness Month Closes Out With Notable Changes in U.S. Regulation: New FTC Safeguards and NYDFS Cybersecurity Requirements Revealed,https://www.goodwinlaw.com/en/insights/blogs/2023/12/october-cybersecurity-awareness-month-closes-out-with-notable-changes-in-us-regulation--new-ftc-safe,2023-12-12
Providing Critical Services to the UK Financial Sector: Important Draft Rules for Fintechs,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-practices-ftec-ctp-draft-rules-for-fintechs-uk-financial-sector,2023-12-12
Federal Government Releases Proposed Guidance for Exercising “March-In” Rights Under the Bayh-Dole Act: Implications for Pharmaceutical and Medical Technology Companies,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-lifesciences-federal-government-releases-proposed-guidance,2023-12-12
Sanofi Drops Maze Licensing Deal After FTC Challenge,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-lifesciences-ma-sanofi-drops-maze-licensing-deal-after-ftc,2023-12-12
Regeneron Sues Formycon AG for Proposed Biosimilar of EYLEA in West Virginia District Court,https://www.goodwinlaw.com/en/insights/blogs/2023/12/regeneron-sues-formycon-ag-for-proposed-biosimilar-of-eylea-in-west-virginia-district-court,2023-12-11
"FCC Proposes New, Stricter TCPA Rules That Would Limit Lead Generation to One-Company Consent",https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-otherindustries-dpc-fcc-proposes-new-stricter-tcpa-rules,2023-12-11
FDA Targets April 2024 for Laboratory Developed Test (LDT) Final Rule,https://www.goodwinlaw.com/en/insights/blogs/2023/12/fda-targets-april-2024-for-laboratory-developed-test-ldt-final-rule,2023-12-08
FINRA Kicks Off the Holiday Season With a Proposal to Permit the Use of Some Projections and Targeted Returns,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-finance-fs-finra-kicks-off-holiday-season-with-proposal,2023-12-08
"OCC Issues Guidance on Risk Management of “Buy Now, Pay Later” Lending",https://www.goodwinlaw.com/en/insights/newsletters/2023/12/newsletters-finance-fs-weekly-roundup-120723,2023-12-07
How to Make AI-Powered Productivity Gains Stick,https://www.goodwinlaw.com/en/insights/publications/2023/12/insights-technology-aiml-how-to-make-ai-powered-productivity-gains-stick,2023-12-07
The FCA’s Sustainability Disclosure Requirements and Labelling Regime (SDR): A Flexible Regime for UK Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-otherindustries-pif-fca-sustainability-disclosure-requirements-labelling-regime,2023-12-05
Recent Updates in the UK Venture Fundraising Landscape,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-otherindustries-vc-recent-updates-uk-venture-fundraising-landscape,2023-12-04
Additional Disclosure Required: CMS Implements Substantial Changes to Reporting Skilled Nursing Facility Ownership Information,https://www.goodwinlaw.com/en/insights/publications/2023/12/alerts-privateequity-hltc-cms-implements-substantial-changes,2023-12-01
Unlocking AI’s Power to Multiply Manufacturing Productivity,https://www.goodwinlaw.com/en/insights/publications/2023/11/insights-technology-aiml-unlocking-ai-power-to-multiply-manufacturing,2023-11-30
FDIC Board of Directors Issues a Final Rule Pursuant to Special Assessment,https://www.goodwinlaw.com/en/insights/newsletters/2023/11/newsletters-finance-fs-weekly-roundup-113023,2023-11-30
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/11/newsletters-practices-df-debt-download-113023,2023-11-30
How To Reduce the Risk of Copyright Infringement When Using Generative AI To Write Code,https://www.goodwinlaw.com/en/insights/publications/2023/11/insights-technology-aiml-reduce-risk-copyright-infringement-gen-ai-write-code,2023-11-30
The Justice Department and Consumer Financial Protection Bureau Issue Joint Statement Focused on Antidiscrimination in Lending Practices,https://www.goodwinlaw.com/en/insights/blogs/2023/11/the-justice-department-and-consumer-financial-protection-bureau--issue-joint-statement-focused-on-an,2023-11-29
Half of private investment funds set hurdle rates at 8% but rates differ by asset class and strategy,https://www.goodwinlaw.com/en/insights/publications/2023/11/insights-otherindustries-pif-half-of-private-investment-funds-set-hurdle-rates,2023-11-29
Regeneron Sues Samsung Bioepis for Proposed Biosimilar of EYLEA in West Virginia District Court,https://www.goodwinlaw.com/en/insights/blogs/2023/11/regeneron-sues-samsung-bioepis-for-proposed-biosimilar-of-eylea-in-west-virginia-district-court,2023-11-28
CFPB Enters Into $60M Consent Order with Vehicle Lending Credit Corporation,https://www.goodwinlaw.com/en/insights/blogs/2023/11/cfpb-enters-into-$60m-consent-order-with-vehicle-lending-credit-corporation,2023-11-27
A Practical Look at OIG’s New Compliance Guidance,https://www.goodwinlaw.com/en/insights/blogs/2023/11/a-practical-look-at-oigs-new-compliance-guidance,2023-11-27
Acuitas Files Suit Against CureVac Alleging Incorrect Inventorship on COVID MRNA-LNP Vaccine Patent Family,https://www.goodwinlaw.com/en/insights/blogs/2023/11/acuitas-files-suit-against-curevac-alleging-incorrect-inventorship-on-covid-mrnalnp-vaccine-patent-f,2023-11-22
A Practical Look at OIG’s New Compliance Guidance,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-hltc-oig-new-compliance-guidance,2023-11-22
"Genentech, Roche, and Biogen Sue Dr. Reddy’s and Fresenius for a Proposed Biosimilar of Rituxan in District of New Jersey",https://www.goodwinlaw.com/en/insights/blogs/2023/11/genentech-roche-and-biogen-sue-dr-reddys-and-fresenius-for-a-proposed-biosimilar-of-rituxan-in-distr,2023-11-21
European Biologics Regulatory Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/11/european-biologics-regulatory-updates,2023-11-21
Cybersecurity Toolkit for Healthcare and Public Health Sector,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-hltc-healthcare-public-health-cybersecurity-toolkit,2023-11-21
AIFMD II (Near) Final Text Agreed: What’s New?,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-pif-aifmd-ii-near-final-text-agreed,2023-11-21
"SEC Announces an Increase in Total Enforcement Actions in FY 2023, with Close to $5 Billion in Financial Penalties, the Second Highest Amount in SEC History",https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-cldr-sec-announces-an-increase-in-total-enforcement-actions,2023-11-21
Significant 340B Drug Pricing Program Litigation May Impact 340B Scope,https://www.goodwinlaw.com/en/insights/blogs/2023/11/significant-340b-drug-pricing-program-litigation-may-impact-340b-scope,2023-11-17
Significant 340B Drug Pricing Program Litigation May Impact 340B Scope,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-lifesciences-significant-340b-drug-pricing-program-litigation,2023-11-17
UK Authorizes World-First Gene Therapy from Vertex and CRISPR Therapeutics for Blood Disorders,https://www.goodwinlaw.com/en/insights/blogs/2023/11/uk-authorizes-world-first-gene-therapy-from-vertex-and-crispr-therapeutics-for-blood-disorders,2023-11-16
FinCEN Finalizes Rule on Use of FinCEN Identifiers in Beneficial Ownership Information Reporting,https://www.goodwinlaw.com/en/insights/newsletters/2023/11/newsletters-finance-fs-weekly-roundup-111623,2023-11-16
FDIC Proposes Guidelines Establishing Standards for Corporate Governance and Risk Management for Covered Institutions with Total Assets of $10 Billion or More,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-finance-ftec-fdic-proposes-guidelines-establishing-standards-for-corporate,2023-11-15
Regeneron Sues Celltrion For Proposed Biosimilar of Eylea in West Virginia District Court,https://www.goodwinlaw.com/en/insights/blogs/2023/11/regeneron-sues-celltrion-for-proposed-biosimilar-of-eylea-in-west-virginia-district-court,2023-11-14
UK HNW and Sophisticated Investor Exemptions: More Financial Promotion Changes,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-finance-fs-uk-hnw-and-sophisticated-investor-exemptions,2023-11-14
BYOOVIZ® (Ranibizumab-Nuna) Granted Interchangeable Status,https://www.goodwinlaw.com/en/insights/blogs/2023/11/byooviz-ranibizumabnuna-granted-interchangeable-status,2023-11-10
Formycon Enjoined From Manufacturing FYB202 Biosimilar of STELARA in Germany,https://www.goodwinlaw.com/en/insights/blogs/2023/11/formycon-enjoined-from-manufacturing-fyb202-biosimilar-of-stelara-in-germany,2023-11-09
Minnesota AG Reaches Settlement with Student-Loan Debt Relief Company,https://www.goodwinlaw.com/en/insights/blogs/2023/11/minnesota-ag-reaches-settlement-with-student-loan-debt-relief-company,2023-11-09
Crypto business in (and “to”) the UK: Further light on the new regulatory regimes,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-dcb-crypto-business-in-the-uk,2023-11-09
Cross-Border Transactional Risk Insurance,https://www.goodwinlaw.com/en/insights/publications/2023/11/insights-privateequity-ma-cross-border-transaction-risk-insurance,2023-11-09
FDIC Announces Iowa Bank Failure – 5th Bank to Fail in 2023,https://www.goodwinlaw.com/en/insights/newsletters/2023/11/newsletters-finance-fs-weekly-roundup-110923,2023-11-09
“Open Banking” Promoted in New CFPB Rule,https://www.goodwinlaw.com/en/insights/blogs/2023/11/open-banking-promoted-in-new-cfpb-rule,2023-11-08
"Pursuant to Consent Order with CFPB, National Bank to Pay $25.9 Million for Alleged Discrimination Against Armenian Americans",https://www.goodwinlaw.com/en/insights/blogs/2023/11/pursuant-to-consent-order-with-cfpb-national-bank-to-pay-259-million-for-alleged-discrimination-agai,2023-11-08
Another Domino Falls: Ohio Voters Legalize Adult-Use Cannabis,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-can-ohio-voters-legalize-adult-use-cannabis,2023-11-08
"Fresenius Kabi Launches TYENNE, The First Approved Tocilizumab Biosimilar In The European Union",https://www.goodwinlaw.com/en/insights/blogs/2023/11/fresenius-kabi-launches-tyenne-the-first-approved-tocilizumab-biosimilar-in-the-european-union,2023-11-07
2023 State Drug Transparency Law Development Update,https://www.goodwinlaw.com/en/insights/blogs/2023/11/2023-state-drug-transparency-law-development-update,2023-11-07
Biosimilars Patent Challenges at the PTAB: Update and Lessons Learned,https://www.goodwinlaw.com/en/insights/blogs/2023/11/biosimilars-patent-challenges-at-the-ptab-update-and-lessons-learned,2023-11-07
Banking Agencies Finalize Community Reinvestment Act Rules,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-finance-pif-banking-agencies-finalize-community-reinvestment-act-rules,2023-11-07
2023 State Drug Transparency Law Development Update,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-lifesciences-state-drug-transparency-law-development-update,2023-11-07
"Complicit Defendants Lose, Sovereign Agency Wins in Eternal Madoff Litigation",https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-otherindustries-bcl-complicit-defendants-lose-sovereign-agency,2023-11-07
FDA Approves VABYSMO (faricimab) for Retinal Vein Occlusion,https://www.goodwinlaw.com/en/insights/blogs/2023/11/fda-approves-vabysmo-faricimab-for-retinal-vein-occlusion,2023-11-06
United States: Trends of Agency Scrutiny on Pharmaceutical Transactions Expected to Shift Amid Rise in Deal Activity (GCR),https://www.goodwinlaw.com/en/insights/blogs/2023/11/united-states-trends-of-agency-scrutiny-on-pharmaceutical-transactions-expected-to-shift-amid-rise-i,2023-11-06
FDA Approves Amgen’s WEZLANA As Biosimilar to and Interchangeable With Janssen’s STELARA (ustekinumab) – Stelara Is One of the 10 Drugs Selected by CMS for Drug Price Negotiations Under the Inflation Reduction Act,https://www.goodwinlaw.com/en/insights/blogs/2023/11/fda-approves-amgens-wezlana-as-biosimilar-to-and-interchangeable-with-janssens-stelara-ustekinumab,2023-11-06
Reviewing the Industry Groups’ Opening Brief Challenging the Private Funds Rules,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-finance-pif-reviewing-the-industry-groups-opening-brief,2023-11-06
Antitrust & Competition Healthcare Quarterly Update Q3 2023,https://www.goodwinlaw.com/en/insights/publications/2023/11/insights-otherindustries-hltc-antitrust-competition-quarterly-update-q3-2023,2023-11-06
FTC Reaches $18 Million Settlement with Personal Finance App,https://www.goodwinlaw.com/en/insights/blogs/2023/11/ftc-reaches-$18-million-settlement-with-personal-finance-app,2023-11-03
CFPB Updates Exam Manual in Light of the United States District Court for the Eastern District of Texas’s Ruling in the U.S. Chamber of Commerce Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/11/cfpb-updates-exam-manual-in-light-of-the-united-states-district-court-for-the-eastern-district-of-te,2023-11-02
Federal Reserve Requests Comment on a Proposal to Lower The Maximum Interchange Fee that a Large Debit Card Issuer Can Receive for a Debit Card Transaction,https://www.goodwinlaw.com/en/insights/newsletters/2023/11/newsletters-finance-fs-weekly-roundup-110223,2023-11-02
“Corrective construction” to achieve commercial common sense in company articles,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-finance-fs-corrective-construction-in-company-articles,2023-11-01
Biometric Data Collection: A Significant Risk for the Real Estate Industry,https://www.goodwinlaw.com/en/insights/publications/2023/11/alerts-realestate-propt-biometric-data-collection,2023-11-01
FDA Approves LOQTORZI in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma,https://www.goodwinlaw.com/en/insights/blogs/2023/10/fda-approves-loqtorzi-in-all-lines-of-treatment-for-recurrent-or-metastatic-nasopharyngeal-carcinoma,2023-10-31
Transactions in the Insurance Space: 4 Key Regulatory Issues,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-finance-ftec-transactions-in-the-insurance-space,2023-10-31
"White House Unveils Landmark Executive Order on Safe, Secure, and Trustworthy Artificial Intelligence",https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-lifesciences-hltc-white-house-unveils-landmark-executive-order,2023-10-31
Coding with AI in an Open-Source World,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-technology-aiml-coding-with-ai-in-an-open-source-world,2023-10-31
FDA to Review Vertex Pharmaceutical’s Application for CRISPR-based Gene Therapy Exa-cel,https://www.goodwinlaw.com/en/insights/blogs/2023/10/fda-to-review-vertex-pharmaceuticals-application-for-crispr-based-gene-therapy-exa-cel,2023-10-30
FTC Consent Order Results in Permanent Ban for Cash Advance Business Owner,https://www.goodwinlaw.com/en/insights/blogs/2023/10/ftc-consent-order-results-in-permanent-ban-for-cash-advance-business-owner,2023-10-30
Newly Launched: Goodwin’s Laboratory Developed Tests Resource Page,https://www.goodwinlaw.com/en/insights/blogs/2023/10/newly-launched-goodwins-laboratory-developed-tests-resource-page,2023-10-30
AI and Machine Learning in UK financial services: the public response to the FCA and PRA,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-ftec-ai-and-machine-learning-in-uk-financial-services,2023-10-30
How to Write an Effective Search Fund PPM,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-privateequity-how-to-write-an-effective-search-fund-ppm,2023-10-30
State of Play: Current Trends in APAC Private Real Estate Funds,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-realestate-pif-state-of-play,2023-10-30
UK Limited Partnership Reform Becomes Law: A Practical Guide of How Best To Get Ready To Comply,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-pif-uk-limited-partnership-reform-becomes-law,2023-10-30
Celltrion Announces FDA Approval of ZYMFENTRA (infliximab-dyyb),https://www.goodwinlaw.com/en/insights/blogs/2023/10/celltrion-announces-fda-approval-of-zymfentra-infliximabdyyb,2023-10-28
CFPB Proposes Rule to Accelerate Shift to Open Banking,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-finance-fs-weekly-roundup-102723,2023-10-27
Antitrust & Competition Life Sciences Quarterly Update Q3 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/10/antitrust--competition-life-sciences-quarterly-update-q3-2023,2023-10-26
How to Get Your SIUU Out: FDA Provides Long-Awaited Update for Industry on Communicating Off-Label Information,https://www.goodwinlaw.com/en/insights/blogs/2023/10/how-to-get-your-siuu-out-fda-provides-longawaited-update-for-industry-on-communicating-offlabel-info,2023-10-26
What’s in a Name? Why Your “Dual Class” IPO Should Be a “Dual Series” IPO Instead,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-lifesciences-cm-whats-in-a-name,2023-10-26
Genentech and Biogen File Joint Stipulation of Dismissal in BPCIA Litigation Regarding Tocilizumab,https://www.goodwinlaw.com/en/insights/blogs/2023/10/genentech-and-biogen-file-joint-stipulation-of-dismissal-in-bpcia-litigation-regarding-tocilizumab,2023-10-25
Senate Confirms Magistrate Judge Hall as District Court Judge for U.S. District Court for the District of Delaware,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-senate-confirms-magistrate-judge-hall-as-us-district-judge,2023-10-25
Pillar Two Implementation in Luxembourg,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-pillar-two-implementation-in-luxembourg,2023-10-25
SEC EXAMS Division Announces 2024 Priorities Ahead of Schedule,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-privateequity-fs-sec-exams-division-announces-2024-priorities,2023-10-25
FTC and Wisconsin AG File Complaint Against Auto Financing Company,https://www.goodwinlaw.com/en/insights/blogs/2023/10/ftc-and-wisconsin-ag-file-complaint-against-auto-financing-company,2023-10-24
The UK Announces UK-US Data Bridge,https://www.goodwinlaw.com/en/insights/blogs/2023/10/the-uk-announces-uk-us-data-bridge,2023-10-24
Crypto Regulation in Europe: ESMA Statement Clarifies process for the Transition to MiCA,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-finance-ftec-esma-mica-statement-alert,2023-10-24
Amneal Expands Oncology Offering with Two Denosumab Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2023/10/amneal-expands-oncology-offering-with-two-denosumab-biosimilars,2023-10-23
New California Law to Require Venture Capital Firms to Disclose Founder Diversity Information,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-vc-new-california-law,2023-10-23
Antitrust & Competition Life Sciences Quarterly Update Q3 2023,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-lifesciences-antc-quarterly-update-q3-2023,2023-10-23
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-practices-df-debt-download-102323,2023-10-23
Supreme Court Hears Oral Argument on the Constitutionality of the Funding of the CFPB,https://www.goodwinlaw.com/en/insights/blogs/2023/10/supreme-court-hears-oral-argument-on-the-constitutionality-of-the-funding-of-the-cfpb,2023-10-20
Some Much-Needed (Applicant-Friendly) Clarification on Priority Claims at the European Patent Office,https://www.goodwinlaw.com/en/insights/blogs/2023/10/some-muchneeded-applicantfriendly-clarification-on-priority-claims-at-the-european-patent-office,2023-10-20
Recent FDA Initiatives to Support Development of Individualized Cell and Gene Therapies and Rare Disease Therapies,https://www.goodwinlaw.com/en/insights/blogs/2023/10/recent-fda-initiatives-to-support-development-of-individualized-cell-and-gene-therapies-and-rare-dis,2023-10-19
FTC and CFPB Announce $15 Million Settlement Against Credit Reporting Agency For Alleged Inaccuracies In Tenant Screening Reports,https://www.goodwinlaw.com/en/insights/blogs/2023/10/ftc-and-cfpb-announce-15-million-settlement-against-credit-reporting-agency-for-alleged-inaccuracies,2023-10-19
CFPB Files Complaint Against Mortgage Originator For Allegedly Inaccurate HMDA Reporting,https://www.goodwinlaw.com/en/insights/blogs/2023/10/cfpb-files-complaint-against-mortgage-originator-for-allegedly-inaccurate-hmda-reporting,2023-10-19
Some Much-Needed (Applicant-Friendly) Clarification on Priority Claims at the European Patent Office,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-lifesciences-some-much-needed-applicant-friendly-clarification,2023-10-19
Celltrion Expands Access to YUFLYMA (adalimumab-aaty),https://www.goodwinlaw.com/en/insights/blogs/2023/10/celltrion-expands-access-to-yuflyma-adalimumabaaty,2023-10-18
Meitheal Announces Exclusive Commercial Licensing Agreement for Insulin Biosimilars in the US,https://www.goodwinlaw.com/en/insights/blogs/2023/10/meitheal-announces-exclusive-commercial-licensing-agreement-for-insulin-biosimilars-in-the-us,2023-10-18
FTC Reaches Consent Order with For-Profit College Resolving Allegations of Deceptive Advertising and Loan Agreements,https://www.goodwinlaw.com/en/insights/blogs/2023/10/ftc-reaches-consent-order-with-forprofit-college-resolving-allegations-of-deceptive-advertising-and,2023-10-18
"Mark Your Calendars: This Halloween, Don’t Miss FDA’s LDT Webinar",https://www.goodwinlaw.com/en/insights/blogs/2023/10/mark-your-calendars-this-halloween-dont-miss-fdas-ldt-webinar,2023-10-18
Inventing with AI,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-technology-aiml-inventing-with-ai,2023-10-18
A Closer Look at the SEC’s Cybersecurity Rules for Covered Entities and Market Entities,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-finance-ftec-a-closer-look-at-the-sec-cybersecurity-rules,2023-10-18
Internet Privacy Litigation Continues to Create Uncertainty for Websites Using Third-Party Technology while Expanding to More States,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-dpc-internet-privacy-litigation-create-uncertainty,2023-10-18
Washington Attorney General Announces Recovery in Student Debt Adjuster Investigations,https://www.goodwinlaw.com/en/insights/blogs/2023/10/washington-attorney-general-announces-recovery-in-student-debt-adjuster-investigations,2023-10-17
48 States Settle with Payment Processor Over Unauthorized Withdrawal Claims for $10 Million,https://www.goodwinlaw.com/en/insights/blogs/2023/10/48-states-settle-with-payment-processor-over-unauthorized-withdrawal-claims-for-$10-million,2023-10-17
Irreconcilable? The EU’s Article 8 and “Anti-ESG” Investor Demands,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-pif-the-eu-article-8-and-anti-esg-investor-demands,2023-10-17
Massachusetts Doubles Estate Tax Exemption as Part of $1 Billion Tax Bill,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-massachusetts-doubles-estate-tax-extemption,2023-10-16
Update on Ophthalmic Anti-VEGF Therapeutics,https://www.goodwinlaw.com/en/insights/blogs/2023/10/update-on-ophthalmic-anti-vegf-therapeutics,2023-10-13
FDA’s Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA’s Proposed Phaseout Policy – Key Considerations & Open Questions,https://www.goodwinlaw.com/en/insights/blogs/2023/10/fdas-proposed-rule-for-oversight-of-laboratory-developed-tests-part-ii-fdas-proposed-phaseout-policy,2023-10-13
Careful Review of Litigation Disclosure in Periodic Reports and Registrations Statement Required Following U.S. District Court’s Decision,https://www.goodwinlaw.com/en/insights/blogs/2023/10/careful-review-of-litigation-disclosure-in-periodic-reports-and-registrations-statement-required-fol,2023-10-13
SEC Adopts Amendments to Rules Governing Schedule 13D and Schedule 13G Beneficial Ownership Reporting,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-pca-sec-adopts-amendments-to-rules-governing,2023-10-13
Preparing for Early Stage VC Rounds: A Discussion with Female Founders,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-otherindustries-preparing-for-early-stage-vc-rounds,2023-10-13
FDIC Proposes Guidelines for Corporate Governance and Risk Management,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-finance-fs-weekly-roundup-101323,2023-10-13
FDA’s Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA’s Proposed Phaseout Policy – Key Considerations & Open Questions,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-lifesciences-fdas-proposed-rule-for-oversight-of-laboratory,2023-10-13
CFPB Issues Consent Order Against Credit Reporting Agency For Alleged Failures to Timely Place Credit Freezes And Locks On Conumser Reports,https://www.goodwinlaw.com/en/insights/blogs/2023/10/cfpb-issues-consent-order-against-credit-reporting-agency-for-alleged-failures-to-timely-place-credi,2023-10-12
SEC Disclosure Considerations Arising From the Israel-Hamas War,https://www.goodwinlaw.com/en/insights/blogs/2023/10/sec-disclosure-considerations-arising-from-the-israel-hamas-war,2023-10-12
Recent Adalimumab Biosimilar Developments,https://www.goodwinlaw.com/en/insights/blogs/2023/10/recent-adalimumab-biosimilar-developments,2023-10-11
Minnesota AG Settles with Student Loan Debt Relief Company,https://www.goodwinlaw.com/en/insights/blogs/2023/10/minnesota-ag-settles-with-student-loan-debt-relief-company,2023-10-11
Further Light on Generative AI and UK Financial Services Regulation,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-finance-ftec-generative-ai-uk-financial-services-regulation,2023-10-11
SEC’s ATS Re-proposal Doubles Down on DeFi and Digital Asset Regulation,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-technology-ftec-sec-ats-reproposal-doubles-down-on-defi,2023-10-11
Delaware ABCs (Assignments for the Benefit of Creditors): No Longer as Easy as 1-2-3,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-delaware-abc-assignments-benefit-creditors,2023-10-10
Federal Court Strikes Down Copay Accumulator Programs,https://www.goodwinlaw.com/en/insights/blogs/2023/10/federal-court-strikes-down-copay-accumulator-programs,2023-10-09
FDA’s Proposed Rule for Oversight of Laboratory Developed Tests: Part I: Underpinnings of FDA’s Proposed Rule,https://www.goodwinlaw.com/en/insights/blogs/2023/10/fdas-proposed-rule-for-oversight-of-laboratory-developed-tests-part-i-underpinnings-of-fdas-proposed,2023-10-09
Opening the Fund Finance Toolkit,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-otherindustries-pif-opening-the-fund-finance-toolkit,2023-10-09
DOJ Announces Safe Harbor Policy for M&A Self-Disclosures,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-otherindustries-doj-announces-safe-harbor-policy,2023-10-09
Big Deal: What’s New in Tech M&A?,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-technology-whats-new-in-tech-ma,2023-10-09
Goodwin REIT Alert: Trends in REIT M&A (2022-2023),https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-realestate-reit-goodwin-reit-alert-trends-in-reit,2023-10-09
In This Issue: DC Court Orders Covington to Disclose Client Names to SEC; SDNY Finds No Duty to Disclose Potential Loss of Clients in Olo Class Action,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-sslit-securities-snapshot-100423,2023-10-09
FDA’s Proposed Rule for Oversight of Laboratory Developed Tests: Part I: Underpinnings of FDA’s Proposed Rule,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-lifesciences-fda-proposed-rule-for-oversight,2023-10-06
Patent Dance Disclosures and Beyond: Recent Biosimilars Litigation at the District Court,https://www.goodwinlaw.com/en/insights/blogs/2023/10/patent-dance-disclosures-and-beyond-recent-biosimilars-litigation-at-the-district-court,2023-10-05
"Biogen Announces FDA Approval of TOFIDENCE, a Tocilizumab Biosimilar Referencing ACTEMRA",https://www.goodwinlaw.com/en/insights/blogs/2023/10/biogen-announces-fda-approval-of-tofidence-a-tocilizumab-biosimilar-referencing-actemra,2023-10-05
“Greenfield Fraught with Problems”: District of Massachusetts Holds But-For Causation Required in False Claims Act Cases Based on Kickbacks,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-lifesciences-hltc-greenfield-fraught-with-problems,2023-10-05
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-erisa-litigation-update-q3,2023-10-05
OIG: Review of the Supervision of Silvergate Bank,https://www.goodwinlaw.com/en/insights/newsletters/2023/10/newsletters-finance-fs-weekly-roundup-100523,2023-10-05
Katalin Karikó and Drew Weissman Awarded Nobel Prize in Physiology or Medicine For Discoveries Relating to mRNA Vaccines,https://www.goodwinlaw.com/en/insights/blogs/2023/10/katalin-karik-and-drew-weissman-awarded-nobel-prize-in-physiology-or-medicine-for-discoveries-relati,2023-10-03
IRA Drug Price Negotiation Program Litigation Updates – Denial of PI Motion and Motion to Dismiss in Chambers of Commerce Case and New Complaint Filed by Novo Nordisk,https://www.goodwinlaw.com/en/insights/blogs/2023/10/ira-drug-price-negotiation-program-litigation-updates--denial-of-pi-motion-and-motion-to-dismiss-in,2023-10-03
A Look Ahead in Life Sciences: What We Are Tracking in Q4 2023 and Beyond,https://www.goodwinlaw.com/en/insights/blogs/2023/10/a-look-ahead-in-life-sciences-what-we-are-tracking-in-q4-2023-and-beyond,2023-10-02
“Emerging Growth Company” Transition and Compliance After Loss of Status,https://www.goodwinlaw.com/en/insights/blogs/2023/10/emerging-growth-company-transition-and-compliance-after-loss-of-status,2023-10-02
Is It Possible to Copyright Works That Include AI-Generated Material?,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-technology-aiml-is-it-possible-to-copyright-works,2023-10-02
"Employers Are Strongly Encouraged to Revisit Whistleblower Protection Language in Agreements and Policies in Light of Recent Legal Developments, including SEC Enforcement Actions",https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-practices-emp-employers-encouraged-to-revisit-whistleblower-protection,2023-10-02
Supreme Court to Decide Scope of Potential Liability Based on MD&A in Annual Reports,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-practices-cldr-macquarie-v-moab,2023-10-02
"Horizon Scan for Private Investment Funds: Key Recent and Expected Funds, Regulatory, and Tax Developments to Look Out For",https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-finance-pif-horizon-scan-for-private-investment-funds,2023-10-02
Trends in Growth Equity Financing in an Uncertain Economy,https://www.goodwinlaw.com/en/insights/publications/2023/10/insights-privateequity-ge-trends-in-growth-equity-financing,2023-10-02
FDA Proposes Phased Approach to Regulating Laboratory Developed Tests,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-lifesciences-fda-proposes-phased-approach-to-regulating,2023-10-02
SEC Adopts Rule Enhancements to Prevent Misleading or Deceptive Investment Fund Names,https://www.goodwinlaw.com/en/insights/publications/2023/10/alerts-finance-fs-sec-adopts-rule-enhancements,2023-10-02
"Regulatory Update on Alvotech’s AVT02, a High-Concentration Interchangeable Adalimumab Biosimilar",https://www.goodwinlaw.com/en/insights/blogs/2023/09/regulatory-update-on-alvotechs-avt02-a-highconcentration-interchangeable-adalimumab-biosimilar,2023-09-29
FDA Grants Priority Review to Merck’s Application for KEYTRUDA (pembrolizumab) as Part of Treatment for Early-Stage Cervical Cancer,https://www.goodwinlaw.com/en/insights/blogs/2023/09/fda-grants-priority-review-to-mercks-application-for-keytruda-pembrolizumab-as-part-of-treatment-for,2023-09-29
FDA Proposes Phased Approach to Regulating Laboratory Developed Tests,https://www.goodwinlaw.com/en/insights/blogs/2023/09/fda-proposes-phased-approach-to-regulating-laboratory-developed-tests,2023-09-29
A Look Ahead in Life Sciences: What We Are Tracking in Q4 2023 and Beyond,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-lifesciences-a-look-ahead-in-life-sciences-what-we-are-tracking,2023-09-29
Recent Biosimilar Commercialization Developments,https://www.goodwinlaw.com/en/insights/blogs/2023/09/recent-biosimilar-commercialization-developments,2023-09-28
Bloomberg Intelligence – Arman Oruc’s Perspective on the FTC and Pharma and Biotech Industry M&A Impact,https://www.goodwinlaw.com/en/insights/blogs/2023/09/bloomberg-intelligence--arman-orucs-perspective-on-the-ftc-and-pharma-andbiotech-industry-ma-impact,2023-09-28
Commercial Leasing in Massachusetts: SJC Confirms Enforceability of Accelerated Rent as Liquidated Damages,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-realestate-commercial-leasing-in-massachusetts-sjc-confirms,2023-09-28
SEC Approves Revised Privacy Act Rule,https://www.goodwinlaw.com/en/insights/newsletters/2023/09/newsletters-finance-fs-weekly-roundup-092823,2023-09-28
Scheduling Order Issued in REGENXBIO v. Sarepta Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/09/scheduling-order-issued-in-regenxbio-v-sarepta-litigation,2023-09-27
"The FCA Consults: D&I Standards for Large Firms, Nonfinancial Misconduct Rules for All",https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-practices-pif-the-fca-consults,2023-09-27
Update on Recent International Biosimilar Approvals,https://www.goodwinlaw.com/en/insights/blogs/2023/09/update-on-recent-international-biosimilar-approvals,2023-09-26
The CFPB Proposal to Remove Medical Debt from Credit Report,https://www.goodwinlaw.com/en/insights/blogs/2023/09/the-cfpb-proposal-to-remove-medical-debt-from-credit-report,2023-09-26
FDA Releases Draft Labeling Guidance for Biosimilar Products,https://www.goodwinlaw.com/en/insights/blogs/2023/09/fda-releases-draft-labeling-guidance-for-biosimilar-products,2023-09-25
Is it Biosimilar or Interchangeable? It Won’t Be Easy to Tell Under FDA’s Latest Draft Labeling Guidance,https://www.goodwinlaw.com/en/insights/blogs/2023/09/is-it-biosimilar-or-interchangeable--it-wont-be-easy-to-tell-under-fdas-latest-draft-labeling-guidan,2023-09-25
Update on mRNA Vaccine Patent Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/09/update-on-mrna-vaccine-patent-litigation,2023-09-22
FTC Sues Private Equity Firm Welsh Carson and U.S. Anesthesia Partners Over Alleged Anesthesiology “Roll-Up Scheme” in Texas,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-privateequity-hltc-ftc-sues-private-equity-firm-welsh-carson,2023-09-22
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/09/newsletters-practices-df-debt-download-092223,2023-09-22
SEC Sends Second Message to Private-Fund Sponsors on Audit Obligations Under Custody Rule Through Enforcement Actions,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-privateequity-pif-sec-sends-second-message-to-private-fund,2023-09-21
SEC Marketing Rule Enforcement Actions Emphasize Need for Policies and Procedures Regarding the Use of Hypothetical Performance,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-otherindustries-pif-sec-marketing-rule-enforcement-actions,2023-09-21
CFPB Affirms Lenders Using AI Must Provide Accurate and Specific Reasons For Adverse Action,https://www.goodwinlaw.com/en/insights/newsletters/2023/09/newsletters-finance-fs-weekly-roundup-092123,2023-09-21
EU Cybersecurity Rules and DORA: Commission Resolves Conflict,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-ftec-eu-cybersecurity-rules-dora,2023-09-21
How Much Must Managers ‘Deploy’ From an Existing Fund Before Starting a Successor?,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-otherindustries-pif-how-much-must-managers-deploy,2023-09-21
FAQs on New Executive Incentive Compensation Clawback Rules,https://www.goodwinlaw.com/en/insights/blogs/2023/09/faqs-on-new-executive-incentive-compensation-clawback-rules,2023-09-20
Why Your Consumer Complaint Response Function Is Vital to Your Business,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-finance-ftec-consumer-complaint-response-function-is-vital-to-business,2023-09-20
FinCEN Publishes Notice and Proposed Rule Related to CTA Beneficial Ownership Information System,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-fs-fincen-publishes-notice-proposed-rule,2023-09-19
Ten Issues to Consider When Acquiring a Food Business,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-privateequity-ten-issues-to-consider-when-acquiring,2023-09-19
The Seeds for SFDR II? Two EU Commission Consultations,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-pif-the-seeds-for-sfdr-ii-two-eu-commission,2023-09-18
Blind Pool REIT IPOs: Real Estate Sponsors Are Getting Ready To Jump Back In,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-realestate-reit-blind-pool-reit-ipos,2023-09-18
The CFTC’s DeFi Trifecta: Lessons and Implications for DeFi Participants Inside and Outside the US,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-ftec-cftc-decentralized-finance-defi-lessons-implications,2023-09-18
U.S. Chamber of Commerce Wins Summary Judgment in Challenge to CFPB’s Update to Its Examination Manual,https://www.goodwinlaw.com/en/insights/blogs/2023/09/us-chamber-of-commerce-wins-summary-judgment-in-challenge-to-cfpbs-update-to-its-examination-manual,2023-09-17
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions,https://www.goodwinlaw.com/en/insights/blogs/2023/09/modernizing-the-fdas-510k-program-for-medical-devices-selection-of-predicate-devices-and-use-of-clin,2023-09-15
Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022,https://www.goodwinlaw.com/en/insights/blogs/2023/09/generic-and-biosimilar-drugs-save-$408b-for-americas-patients-and-healthcare-system-in-2022,2023-09-15
UK’s Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024,https://www.goodwinlaw.com/en/insights/blogs/2023/09/uks-medicines-regulator-announces-guidance-on-the-new-international-recognition-procedure-for-the-ap,2023-09-15
FDIC Releases Report Revising the Supervision of Former First Republic Bank,https://www.goodwinlaw.com/en/insights/newsletters/2023/09/newsletters-finance-fs-weekly-roundup-091523,2023-09-15
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-lifesciences-modernizing-fda-510k-program-for-medical-devices,2023-09-15
Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al. v. Becerra et al.,https://www.goodwinlaw.com/en/insights/blogs/2023/09/legal-challenges-to-the-inflation-reduction-act-an-update-on-pending-challenges-and-reactions-to-ora,2023-09-14
Sunset on (some) Stamp Taxes: HMRC confirms 1.5% charge on issuance and capital raising transfers to depositary receipt and clearance systems will not apply,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-otherindustries-sunset-on-stamp-taxes,2023-09-14
Government Continues to Explore Role of 340B Contract Pharmacies,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-practices-hltc-government-continues-to-explore-role-of-340b,2023-09-14
CJEU Confirms Competition Authorities’ Power to Investigate GDPR Violations and Provides Insights into Personalised Social Media Advertising and GDPR Compliance,https://www.goodwinlaw.com/en/insights/blogs/2023/09/cjeu-confirms-competition-authorities-power-to-investigate-gdpr-violations-and-provides-insights-int,2023-09-13
"Sandoz Receives FDA Approval for TYRUKO® (natalizumab-sztn), the First and Only FDA-Approved Biosimilar for Relapsing Forms of Multiple Sclerosis",https://www.goodwinlaw.com/en/insights/blogs/2023/09/sandoz-receives-fda-approval-for-tyruko-natalizumabsztn-the-first-and-only-fdaapproved-biosimilar-fo,2023-09-13
Propsci Perspectives: Breakthrough Properties,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-otherindustries-props-propsci-perspectives-breakthrough-properties,2023-09-13
SEC’s Division of Examinations Sheds Light Regarding Exam Selection and Scoping,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-practices-pif-sec-division-of-examination,2023-09-13
SEC’s Division of Corporation Finance “Sample Letter to Companies Regarding Their XBRL Disclosures”,https://www.goodwinlaw.com/en/insights/blogs/2023/09/secs-division-of-corporation-finance-sample-letter-to-companies-regarding-their-xbrl-disclosures,2023-09-12
Formycon Announces FDA Acceptance of the aBLA for Its Aflibercept Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/09/formycon-announces-fda-acceptance-of-the-abla-for-its-aflibercept-biosimilar,2023-09-11
Final Reminder: New UK Crypto Marketing Rules Less Than a Month Away,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-ftec-final-reminder-new-uk-crypto,2023-09-11
CFPB Analyzes Mobile Device Tap-To-Pay Market as Possible Precursor to New Regulation,https://www.goodwinlaw.com/en/insights/blogs/2023/09/cfpb-analyzes-mobile-device-tap-to-pay-market-as-possible-precursor-to-new-regulation,2023-09-08
Second Circuit Rules that Syndicated Loans Are Not “Securities” Under State and Federal Law,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-otherindustries-second-circuit-rules-syndicated-loans-are-not-securities,2023-09-08
So You Want To Make A Biosimilar: Top Considerations Before BLA Submission,https://www.goodwinlaw.com/en/insights/blogs/2023/09/so-you-want-to-make-a-biosimilar-top-considerations-before-bla-submission,2023-09-07
The SEC’s New Private Funds Rules on Preferential Treatment: How Do They Compare With the AIFMD?,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-pif-sec-new-private-funds-rules-on-preferential-treatment,2023-09-07
Acquiring or Investing in EU Crypto-Asset Businesses: MiCA’s Impact,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-acquiring-or-investing-in-eu-crypto-asset,2023-09-07
Does the New EU Digital Services Act Apply to Me?,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-technology-does-the-new-eu-digital-services-act-apply,2023-09-06
Issue 42: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-otherindustries-ptab-issue-42,2023-09-06
New ISSB Sustainability Standards: A Long-awaited Milestone for Harmonising ESG-Related Disclosure,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-otherindustries-new-issb-sustainability-standards,2023-09-06
Till We Meet Again: Eighth Circuit Weighs in on Appropriate Interest Rate in a Cramdown,https://www.goodwinlaw.com/en/insights/publications/2023/09/alerts-finance-bcl-eighth-circuit-cramdown-chapter-11-plan,2023-09-06
Recent SEC’s Enforcement Actions Highlight Continued Focus on Late Filing Disclosures,https://www.goodwinlaw.com/en/insights/blogs/2023/09/recent-secs-enforcement-actions-highlight-continued-focus-on-late-filing-disclosures,2023-09-05
Who Gets the Patent When AI Is the Inventor?,https://www.goodwinlaw.com/en/insights/publications/2023/09/insights-technology-aiml-who-gets-the-patent-when-ai,2023-09-05
The CFPB Faces Challenges to the Small Business Lending Rule in Texas and Kentucky,https://www.goodwinlaw.com/en/insights/blogs/2023/09/the-cfpb-faces-challenges-to-the-small-business-lending-rule-in-texas-and-kentucky,2023-09-01
PTAB Issues Final Written Decisions Finding Claims of Tocilizumab-related Patents Invalid,https://www.goodwinlaw.com/en/insights/blogs/2023/09/ptab-issues-final-written-decisions-finding-claims-of-tocilizumab-related-patents-invalid,2023-09-01
LDT Proposed Rule Remains Under OIRA Review,https://www.goodwinlaw.com/en/insights/blogs/2023/08/ldt-proposed-rule-remains-under-oira-review,2023-08-31
DOL Proposes Substantial Increases in Minimum Salary for Most Exemptions from Overtime Pay under the FLSA,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-otherindustries-cldr-dol-proposes-increase-in-minimum-salary,2023-08-31
Department of Health and Human Services Recommends that Cannabis be Rescheduled as a Schedule III Drug Under the Controlled Substances Act,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-otherindustries-can-department-of-health-and-human-services,2023-08-31
Celltrion Stelara (Ustekinumab) Settlement With J&J,https://www.goodwinlaw.com/en/insights/blogs/2023/08/celltrion-stelara-ustekinumab-settlement-with-jj,2023-08-30
SEC Announces First Fee Rate Advisory for Fiscal Year 2024,https://www.goodwinlaw.com/en/insights/blogs/2023/08/sec-announces-first-fee-rate-advisory-for-fiscal-year-2024,2023-08-30
In re Cellect: Federal Circuit Opens New Path for Double Patenting Challenges,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-otherindustries-ip-in-re-cellect-federal-circuit-opens-new-path,2023-08-30
Additional Disclosure and Interpretive Guidance from the SEC’s Division of Corporation Finance on Insider Trading Arrangements and Policies,https://www.goodwinlaw.com/en/insights/blogs/2023/08/additional-disclosure-and-interpretive-guidance-from-the-secs-division-of-corporation-finance-on-ins,2023-08-29
First Drugs Selected for Price Negotiations Under The Inflation Reduction Act,https://www.goodwinlaw.com/en/insights/blogs/2023/08/first-drugs-selected-for-price-negotiations-under-the-inflation-reduction-act,2023-08-29
BREAKING NEWS – HHS Announces the First 10 Drugs Selected for IRA Drug Price Negotiation Program,https://www.goodwinlaw.com/en/insights/blogs/2023/08/breaking-news--hhs-announces-the-first-10-drugs-selected-for-ira-drug-price-negotiation-program,2023-08-29
Biden Executive Order Puts Focus on Domestic Manufacturing of Inventions Created Using Federal Funding,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-practices-ip-biden-bayh-dole-act-executive-order,2023-08-29
The Fintech Deal Long Pole: License Change of Controls,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-finance-ftec-the-fintech-deal-long-pole,2023-08-29
CFPB Enters Settlement with Credit Repair Conglomerate for $2.7 Billion,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cfpb-enters-settlement-with-credit-repair-conglomerate-for-27-billion,2023-08-28
FDA Approves Regeneron’s 8 mg injection of EYLEA (aflibercept) and VEOPOZ (pozelimab),https://www.goodwinlaw.com/en/insights/blogs/2023/08/fda-approves-regenerons-8-mg-injection-of-eylea-aflibercept-and-veopoz-pozelimab,2023-08-28
CFPB Enters into Consent Orders with Mortgage Loan Originator and Real Estate Brokerage Firm for Illegal Kickbacks,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cfpb-enters-into-consent-orders-with-mortgage-loan-originator-and-real-estate-brokerage-firm-for-ill,2023-08-26
First Drugs Selected for Price Negotiations Under The Inflation Reduction Act To Be Announced Next Week: A Recap of What That Means – The Drug Price Negotiation Program and Pending Legal Challenges,https://www.goodwinlaw.com/en/insights/blogs/2023/08/first-drugs-selected-for-price-negotiations-under-the-inflation-reduction-act-to-be-announced-next-w,2023-08-25
"US Antitrust Regulators Continue to Crack Down on Interlocking Directorates, and the FTC Expands Scope of Clayton Act to Noncorporate Entities",https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-privateequity-ma-us-antitrust-regulators-continue-to-crack-down,2023-08-25
Biosimilars Webinar Series,https://www.goodwinlaw.com/en/insights/blogs/2023/08/biosimilars-webinar-series,2023-08-24
SEC Announces the First Enforcement Action under the New Marketing Rule,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-otherindustries-pif-sec-announces-the-first-enforcement-action-under,2023-08-24
The Art of AI: Protected by Copyright Law or Up for Grabs?,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-technology-aiml-thaler-v-copyright-register-gen-ai,2023-08-24
Antitrust & Competition Technology Quarterly Update Q2 2023,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-technology-antc-quarterly-update-q2-2023,2023-08-24
SEC Adopts Expansive (Albeit Slightly Softened) Private Funds Rules,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-finance-pif-sec-adopts-private-funds-rules,2023-08-23
Samsung Bioepis Files IPR Petition Challenging Regeneron Aflibercept Patent,https://www.goodwinlaw.com/en/insights/blogs/2023/08/samsung-bioepis-files-ipr-petition-challenging-regeneron-aflibercept-patent,2023-08-22
GSK Sues Pfizer for Patent Infringement over RSV Vaccine,https://www.goodwinlaw.com/en/insights/blogs/2023/08/gsk-sues-pfizer-for-patent-infringement-over-rsv-vaccine,2023-08-21
C.D. Cal. Issues Temporary Restraining Order Against Companies Accused of Preying on Students Seeking Debt Relief,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cd-cal-issues-temporary-restraining-order-against-companies-accused-of-preying-on-students-seeking-d,2023-08-21
Sixth Circuit Does Not Permit Third-Party Releases in Equity Receiverships,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-lifesciences-lit-sixth-circuit-does-not-permit-third-party,2023-08-21
A Vital Decision on Social Media Ownership,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-lifesciences-a-vital-decision-on-social-media-ownership,2023-08-18
AI’s Data Governance Challenge: Where to Start,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-technology-aiml-ai-data-governance-challenge,2023-08-18
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/08/newsletters-practices-df-debt-download-081823,2023-08-18
EU Sustainable Finance Legislative Impact on Private Funds: Overview Guide,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-finance-pif-eu-sustainable-finance-legislative-impact-on-private-funds,2023-08-18
Sarepta and Catalent File Answers in REGENXBIO v. Sarepta Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/08/sarepta-and-catalent-file-answers-in-regenxbio-v-sarepta-litigation,2023-08-17
CFPB Takes Enforcement Action Against Mortgage Lender and Real Estate Brokerage for RESPA Violations,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cfpb-takes-enforcement-action-against-mortgage-lender-and-real-estate-brokerage-for-respa-violations,2023-08-17
Loan Purchase Activities: Legal Lending Limit Guidance From the OCC,https://www.goodwinlaw.com/en/insights/newsletters/2023/08/newsletters-finance-fs-weekly-roundup-081723,2023-08-17
FDA Issues Draft Guidance on Formal Meetings between the FDA and Sponsors or Applicants of BsUFA Products and Classification Categories for Certain Supplements under BsUFA III,https://www.goodwinlaw.com/en/insights/blogs/2023/08/fda-issues-draft-guidance-on-formal-meetings-between-the-fda-and-sponsors-or-applicants-of-bsufa-pro,2023-08-16
Can Generative AI Already Do Basic Legal Tasks as Well as Lawyers?,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-technology-aiml-can-generative-ai-do-basic-legal-tasks,2023-08-16
Private Funds Rules Set to Be Adopted—What to Watch For,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-technology-private-funds-rules-set-to-be-adopted,2023-08-16
Spotlight on Life Sciences Collaboration and License Agreements,https://www.goodwinlaw.com/en/insights/blogs/2023/08/spotlight-on-life-sciences-collaboration-and-license-agreements,2023-08-15
Investors Should Seize the Renewables Opportunity in Real Estate,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-realestate-esg-investors-renewables-opportunity,2023-08-15
"Charlie Brown Finally Kicks the Football: US Outbound Investment Program Will Target China’s Semiconductor, Quantum Computing, and AI Industries",https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-technology-aiml-outbound-investment-program-target-china,2023-08-15
Regeneron Moves to Terminate Celltrion IPR on Aflibercept Patent After Regeneron Files Statutory Disclaimer,https://www.goodwinlaw.com/en/insights/blogs/2023/08/regeneron-moves-to-terminate-celltrion-ipr-on-aflibercept-patent-after-regeneron-files-statutory-dis,2023-08-14
CFPB Reports Troubling Trends in Auto Loan Servicing,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cfpb-reports-troubling-trends-in-auto-loan-servicing,2023-08-11
Antitrust & Competition Life Sciences Quarterly Update Q2 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/08/antitrust--competition-life-sciences-quarterly-update-q2-2023,2023-08-11
Acuitas Seeks Declaratory Judgment of Non-Infringement and Invalidity Against Arbutus and Genevant in New Jersey Court Challenging mRNA-Delivery Specific Patents,https://www.goodwinlaw.com/en/insights/blogs/2023/08/acuitas-seeks-declaratory-judgment-of-noninfringement-and-invalidity-against-arbutus-and-genevant-in,2023-08-11
Antitrust & Competition Life Sciences Quarterly Update Q2 2023,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-lifesciences-antc-quarterly-update-q2-2023,2023-08-11
Antitrust & Competition Healthcare Quarterly Update Q2 2023,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-otherindustries-hltc-antitrust-competition-quarterly-update-q2-2023,2023-08-11
HHS OCR Proposes Changes to HIPAA to Support Reproductive Health Care Privacy,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-otherindustries-hltc-hipaa-support-reproductive-healthcare-privacy,2023-08-10
Primer on the EU AI Act: An Emerging Global Standard for Artificial Intelligence,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-technology-aiml-eu-ai-act-global-standard-artificial-intelligence,2023-08-09
First Reminder: Two Months Until New UK Crypto Marketing Rules Take Effect,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-finance-ftec-two-months-until-new-uk-crypto-marketing-rules,2023-08-08
Use of EBITDA in Earnouts Increased 22% in Two Years,https://www.goodwinlaw.com/en/insights/publications/2023/08/insights-otherindustries-use-of-ebitda-in-earnouts-increased,2023-08-07
Website Operators Should Take Steps to Mitigate Risk of Session Replay and Chatbot Technology Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/08/website-operators-should-take-steps-to-mitigate-risk-of-session-replay-and-chatbot-technology-litiga,2023-08-04
Federal Banking Agencies Propose Basel III Endgame Capital Rules,https://www.goodwinlaw.com/en/insights/newsletters/2023/08/newsletters-finance-fs-weekly-roundup-080423,2023-08-04
CFPB Files Complaint Against Auto Loan Servicer,https://www.goodwinlaw.com/en/insights/blogs/2023/08/cfpb-files-complaint-against-auto-loan-servicer,2023-08-03
Federal Banking Agencies Propose Basel III Endgame Capital Rules,https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-finance-fs-federal-banking-agencies-propose,2023-08-03
"Redemption Rights, Minus the Redemption",https://www.goodwinlaw.com/en/insights/publications/2023/08/alerts-privateequity-redemption-rights-minus-the-redemption,2023-08-02
Public Company Stockholder Meeting Adjournment Proposals,https://www.goodwinlaw.com/en/insights/blogs/2023/08/public-company-stockholder-meeting-adjournment-proposals,2023-08-01
Update: Post-Trial Briefing in Regeneron v. Mylan Aflibercept BPCIA Case Now Complete,https://www.goodwinlaw.com/en/insights/blogs/2023/08/update-posttrial-briefing-in-regeneron-v-mylan-aflibercept-bpcia-case-now-complete,2023-08-01
Bristol-Myers Squibb and AstraZeneca Settle Anti-PD-L1 Antibody Product Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/08/bristol-myers-squibb-and-astrazeneca-settle-anti-pd-l1-antibody-product-litigation,2023-08-01
CFPB and Justice and Consumer Protection of the European Commission Announce Plans for an “Informal Dialogue”,https://www.goodwinlaw.com/en/insights/blogs/2023/07/cfpb-and-justice-and-consumer-protection-of-the-european-commission-announce-plans-for-an-informal-d,2023-07-31
CFPB Issues New Supervisory Highlights Report,https://www.goodwinlaw.com/en/insights/blogs/2023/07/cfpb-issues-new-supervisory-highlights-report,2023-07-30
Aflibercept IPR Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/07/aflibercept-ipr-updates,2023-07-28
Federal Reserve’s New Instant Payment System FedNow® Service Goes Live,https://www.goodwinlaw.com/en/insights/newsletters/2023/07/newsletters-finance-fs-weekly-roundup-072823,2023-07-28
"Although Scaled Back, the SEC’s Newly Adopted Cybersecurity Disclosure Rule Will Require Significant Effort by Public Companies to Comply",https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-finance-dpc-although-scaled-back-the-secs-newly-adopted-cybersecurity,2023-07-28
Sandoz Invests in New Biosimilar Manufacturing Facility,https://www.goodwinlaw.com/en/insights/blogs/2023/07/sandoz-invests-in-new-biosimilar-manufacturing-facility,2023-07-27
Generative AI and Financial Services: A Recent View From the UK Regulator,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-finance-ftec-generative-ai-financial-services,2023-07-27
DHS Ends Temporary Suspension of Form I-9 Physical Examination Requirements and Announces Alternative Verification Procedure and Revised Form I-9,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-practices-emp-dhs-announces-revised-i9-form,2023-07-27
Be Mindful of Phantom Equity,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-privateequity-be-mindful-of-phantom-equity,2023-07-27
Massachusetts Proposes Sweeping Requirements for Processing Mobile Device Location Data,https://www.goodwinlaw.com/en/insights/blogs/2023/07/massachusetts-proposes-sweeping-requirements-for-processing-mobile-device-location-data,2023-07-26
FCA Publishes Feedback Statement on Potential Competition Impacts of Big Tech Entry and Expansion in Retail Financial Services,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-finance-ftec-fca-publishes-feedback-statement,2023-07-26
Phantom Equity to the Rescue,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-privateequity-phantom-equity-to-the-rescue,2023-07-26
Teva and Alvotech Expand Strategic Biosimilars Partnership,https://www.goodwinlaw.com/en/insights/blogs/2023/07/teva-and-alvotech-expand-strategic-biosimilars-partnership,2023-07-25
Bureau Sues Lease-to-Own Company for its Financing Options to Asset Limited Consumers,https://www.goodwinlaw.com/en/insights/blogs/2023/07/bureau-sues-snap-finance-for-its-financing-options-to-asset-limited-consumers,2023-07-24
Navigating the SEC's Focus on Private Fund Fees: Understanding the Trends and Mitigating Risk,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-privateequity-cm-navigating-the-secs-focus,2023-07-24
Why Hotels Are Turning to C-PACE Financing to Drive Sustainable Development,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-otherindustries-hospitality-leisure-hotels-cpace-financing-development,2023-07-24
CFPB and States Launch Enforcement Action Related to Student Loans,https://www.goodwinlaw.com/en/insights/blogs/2023/07/cfpb-and-states-launch-enforcement-action-related-to-student-loans,2023-07-22
EMA Accepts MAA for Dong-A ST’s Ustekinumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/07/ema-accepts-maa-for-dong-a-sts-ustekinumab-biosimilar,2023-07-21
FDA Accepts BLA for Dr. Reddy’s Rituximab Biosimilar for Review,https://www.goodwinlaw.com/en/insights/blogs/2023/07/fda-accepts-bla-for-dr-reddys-rituximab-biosimilar-for-review,2023-07-21
Mansion House Reforms Continue the UK’s Quest to Be a Leading Destination for Growth Company Investment,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-technology-mansion-house-reforms-continue,2023-07-21
Financial Institution Diversity Voluntary Self-Assessments: Due September 30,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-finance-banking-weekly-roundup-072023,2023-07-21
US Antitrust Agencies Release Revised Draft Merger Guidelines,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-us-antitrust-agencies-release-revised,2023-07-20
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/07/newsletters-practices-df-debt-download-072023,2023-07-20
SEC Adopts Reforms for Money Market Funds,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-sec-adopts-reforms,2023-07-19
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2023/07/insights-finance-erisalit-erisa-litigation-update-0723,2023-07-19
How Much Do Fund Managers Have to Contribute to Their Own Funds?,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-otherindustries-how-much-do-fund-managers,2023-07-19
Form 10-Q Risk Factor Updates: Better Practices for Companies that Restate Risk Factors,https://www.goodwinlaw.com/en/insights/blogs/2023/07/form-10-q-risk-factor-updates-better-practices-for-companies-that-restate-risk-factors,2023-07-18
New Guidance & Ongoing Litigation: Summer 2023 Updates on the Inflation Reduction Act’s Medicare Drug Pricing Negotiation Program,https://www.goodwinlaw.com/en/insights/blogs/2023/07/new-guidance--ongoing-litigation-summer-2023-updates-on-the-inflation-reduction-acts-medicare-drug-p,2023-07-18
Regulation A+ SEC Developments — Recent SEC Enforcement Proceedings and SEC Comment Letter Trends,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-pca-regulation-a-sec-developments,2023-07-18
CFPB Files Opening Brief in its Appeal of District Court Ruling that ECOA Applies Only to Applicants,https://www.goodwinlaw.com/en/insights/blogs/2023/07/cfpb-files-opening-brief-in-its-appeal-of-district-court-ruling-that-ecoa-applies-only-to-applicants,2023-07-17
Trading Venues in the UK: Regulatory Clarity for Fintech Providers; Implications for Crypto-Trading and DeFi?,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-finance-ftec-trading-venues-in-the-uk,2023-07-17
Far Beyond Real Estate: The Real Impact of Florida’s SB 264,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-realestate-far-beyond-real-estate,2023-07-17
Sens. Tillis and Coons Propose New Legislation Regarding Patentability Under § 101,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-ip-sens-tillis-and-coons-propose-new-legislation,2023-07-17
What Companies Need to Know About the New EU-US Data Privacy Framework for Cross-Border Data Transfers,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-dpc-what-companies-need-to-know,2023-07-17
Supreme Court Delivers Key Defense Victory by Limiting Section 11 Claims in Direct Listings — and Again Calling for a Rigid Application of the Tracing Requirement,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-sslit-securities-snapshot-071723,2023-07-17
"CFPB, U.S. Department of Health and Human Services, and U.S. Department of Treasury Initiate Public Inquiry into Financial Products Targeted at Healthcare Costs",https://www.goodwinlaw.com/en/insights/blogs/2023/07/cfpb-us-department-of-health-and-human-services-and-us-department-of-treasury-initiate-public-inquir,2023-07-15
Genentech Files BPCIA Complaint Against Biogen Regarding Tocilizumab,https://www.goodwinlaw.com/en/insights/blogs/2023/07/genentech-files-bpcia-complaint-against-biogen-regarding-tocilizumab,2023-07-14
Post-Trial Briefing in Regeneron v. Mylan Aflibercept BPCIA Case,https://www.goodwinlaw.com/en/insights/blogs/2023/07/posttrial-briefing-in-regeneron-v-mylan-aflibercept-bpcia-case,2023-07-14
Think You Don’t Need to Worry About Patents Before Commercializing Your Gene or Cell Therapy Product? Think Again! The Safe Harbor and Lessons Learned from REGENXBIO v. Sarepta.,https://www.goodwinlaw.com/en/insights/blogs/2023/07/think-you-dont-need-to-worry-about-patents-before-commercializing-your-gene-or-cell-therapy-product,2023-07-13
What Employers Need to Know About Use of Generative AI at Work,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-technology-aiml-employers-generative-ai-at-work,2023-07-13
CFTC Announces Two New Task Forces,https://www.goodwinlaw.com/en/insights/publications/2023/07/insights-finance-banking-weekly-roundup,2023-07-13
Missouri Becomes Second State To Enact Law Regulating Earned Wage Access Services,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-finance-ftec-missouri-becomes-second-state-to-enact,2023-07-12
Model 10b-1 Plan Disclosure to Comply with Item 408(a) of Regulation S-K,https://www.goodwinlaw.com/en/insights/blogs/2023/07/model-10b1-plan-disclosure-to-comply-with-item-408a-of-regulation-sk,2023-07-11
Common FDA Bioresearch Monitoring Violations: Updates from FY 2022 to Now,https://www.goodwinlaw.com/en/insights/blogs/2023/07/common-fda-bioresearch-monitoring-violations-updates-from-fy-2022-to-now,2023-07-11
Comprehensive Modernisation for Luxembourg Funds and Their Managers,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-pif-comprehensive-modernisation-for-luxembourg,2023-07-11
A Look Ahead in Life Sciences: What We Are Tracking in Q3 2023 and Beyond,https://www.goodwinlaw.com/en/insights/blogs/2023/07/a-look-ahead-in-life-sciences-what-we-are-tracking-in-q3-2023-and-beyond,2023-07-10
New York Courts Split on the Constitutionality of the Foreclosure Abuse Prevention Act,https://www.goodwinlaw.com/en/insights/blogs/2023/07/new-york-courts-split-on-the-constitutionality-of-the-foreclosure-abuse-prevention-act,2023-07-07
Biocon Completes Integration of Viatris Biosimilars Business,https://www.goodwinlaw.com/en/insights/blogs/2023/07/biocon-completes-integration-of-viatris-biosimilars-business,2023-07-07
FTC Permanently Bans Extended Warranty Provider Over Deceptive Marketing Practices,https://www.goodwinlaw.com/en/insights/blogs/2023/07/ftc-permanently-bans-extended-warranty-provider-over-deceptive-marketing-practices,2023-07-06
HUMIRA (adalimumab) Biosimilar Launches,https://www.goodwinlaw.com/en/insights/blogs/2023/07/humira-adalimumab-biosimilar-launches,2023-07-06
New Guidance on Los Angeles Measure ULA (Mansion Tax) Exemptions,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-realestate-new-guidance-on-los-angeles-measure-ula,2023-07-06
Regeneron Received FDA Complete Response Letter For Its Higher Dose Aflibercept Injection BLA,https://www.goodwinlaw.com/en/insights/blogs/2023/07/regeneron-received-fda-complete-response-letter-for-its-higher-dose-aflibercept-injection-bla,2023-07-05
Supreme Court Establishes a New Standard for Assessing Proposed Religious Accommodations in the Workplace,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-emp-supreme-court-establishes,2023-07-05
The FCA’s Final Rules For LTAFs: Distribution To Mass Market Retail Investors,https://www.goodwinlaw.com/en/insights/publications/2023/07/alerts-otherindustries-pif-the-fcas-final-rules-for-ltafs,2023-07-03
NJ AG Enters into Consent Order with Mortgage Servicer,https://www.goodwinlaw.com/en/insights/blogs/2023/07/nj-ag-enters-into-consent-order-with-mortgage-servicer,2023-07-01
CYLTEZO® to Launch on July 1 as the First Interchangeable HUMIRA® Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/06/cyltezo-to-launch-on-july-1-as-the-first-interchangeable-humira-biosimilar,2023-06-30
Formycon and Celltrion Announce FDA Submission of aBLAs Seeking Approval to Market Aflibercept Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2023/06/formycon-and-celltrion-announce-fda-submission-of-ablas-seeking-approval-to-market-aflibercept-biosi,2023-06-30
Notice of Proposed Rulemaking for Quality Control Standards for Automated Valuation Models (AVMs) Published,https://www.goodwinlaw.com/en/insights/blogs/2023/06/notice-of-proposed-rulemaking-for-quality-control-standards-for-automated-valuation-models-avms-publ,2023-06-30
SEC Regulatory Agenda Showcases Important Rules by Fall 2023,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-lifesciences-pca-sec-regulatory-agenda-showcases,2023-06-30
Bank Regulators Issue Guidance for Third-Party Risk Management,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-fs-bank-regulators-issue-guidance,2023-06-30
"Doing Crypto Business in Europe: MiCAR, the EU’s New Uniform Crypto Code – Part 2",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-ftec-doing-crypto-business-in-europe,2023-06-30
The South Korean K-Chips Act and Its Impact on International Companies and Investors,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-privateequity-the-south-korean-k-chips-act,2023-06-30
REGENXBIO Sues Sarepta Therapeutics for Patent Infringement on Gene Therapy Product,https://www.goodwinlaw.com/en/insights/blogs/2023/06/regenxbio-sues-sarepta-therapeutics-for-patent-infringement-on-gene-therapy-product,2023-06-29
Court Denies Motion for Preliminary Injunction in Biogen v. Sandoz Natalizumab BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/06/court-denies-motion-for-preliminary-injunction-in-biogen-v-sandoz-natalizumab-bpcia-litigation,2023-06-29
Conducting Privacy Impact Assessments State-By-State,https://www.goodwinlaw.com/en/insights/blogs/2023/06/conducting-privacy-impact-assessments-state-by-state,2023-06-29
FDIC Refines Supervisory Strategy Concerning Multiple Re-Presentment NSF Fees Guidance,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-finance-banking-weekly-roundup-0629,2023-06-29
A Look Ahead in Life Sciences: What We Are Tracking in Q3 2023 and Beyond,https://www.goodwinlaw.com/en/insights/publications/2023/06/insight-lifescience-a-look-ahead-in-life-sciences-what-we-are-tracking,2023-06-29
FDA Accepts Xbrane’s sBLA for LUCENTIS® (Ranibizumab) Biosimilar Candidate,https://www.goodwinlaw.com/en/insights/blogs/2023/06/fda-accepts-xbranes-sbla-for-lucentis-ranibizumab-biosimilar-candidate,2023-06-28
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years: Orphan Medicines,https://www.goodwinlaw.com/en/insights/blogs/2023/06/the-european-commission-proposes-first-major-overhaul-of-the-eu-medicines-regulatory-framework-in-20,2023-06-28
FTC and DOJ Propose Major Changes to HSR Form and Disclosure,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-ftc-and-doj-propose-major-changes,2023-06-28
Colorado Opts Out of Federal Interest Exportation for Consumer Credit: 3 Things Credit Card and Lending Programs Need to Know,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-finance-ftec-colorado-opts-out-of-federal-interest,2023-06-28
MetaBirkins Post-Trial Ruling Clarifies Line Between Trademark Infringement and Free Expression and Grants Broad Injunctive Relief,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-ip-metabirkins-post-trial-ruling-clarifies-line,2023-06-28
Hospitality in the Metaverse,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-technology-meta-hospitality-in-the-metaverse,2023-06-28
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years: Orphan Medicines,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-lifesciences-hltc-european-commission-orphan-medicines,2023-06-28
You May Have Already Agreed to Be Sued in Pennsylvania and Georgia: The Supreme Court Makes Jurisdiction Easier For State-Court Plaintiffs But Hints at a New Defense,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-fs-you-may-have-already-agreed-to-be-sued,2023-06-28
The EU Retail Investment Strategy and Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-pif-the-eu-retail-investment-strategy,2023-06-27
Coherus and AbbVie File Dueling Motions for Injunctive Relief Relating to Coherus’s HUMIRA Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/06/coherus-and-abbvie-file-dueling-motions-for-injunctive-relief-relating-to-coheruss-humira-biosimilar,2023-06-26
Eleventh Circuit Reprimands CFPB for Discovery Abuses During Rule 30(b)(6) Depositions,https://www.goodwinlaw.com/en/insights/blogs/2023/06/eleventh-circuit-reprimands-cfpb-for-discovery-abuses-during-rule-30b6-depositions,2023-06-23
Samsung Bioepis Files Four IPR Petitions on Alexion Eculizumab Patents and One IPR Petition on a Janssen Ustekinumab Patent,https://www.goodwinlaw.com/en/insights/blogs/2023/06/samsung-bioepis-files-four-ipr-petitions-on-alexion-eculizumab-patents-and-one-ipr-petition-on-a-jan,2023-06-23
Natasha Daughtrey to Speak at ACI’s 14th Annual Summit on Biosimilars & Innovator Biologics,https://www.goodwinlaw.com/en/insights/blogs/2023/06/natasha-daughtrey-to-speak-at-acis-14th-annual-summit-on-biosimilars--innovator-biologics,2023-06-22
Coherus to Acquire Surface Oncology,https://www.goodwinlaw.com/en/insights/blogs/2023/06/coherus-to-acquire-surface-oncology,2023-06-22
Addressing Generative AI’s Privacy Challenge,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-technology-aiml-privacy-regulations-use-generative-ai-tool,2023-06-22
"Florida Amends Mini-TCPA, Clarifies Confusion",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-dpc-florida-amends-mini-tcpa,2023-06-22
Celltrion and Rani Therapeutics to Jointly Develop Oral Formulation of Adalimumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/06/celltrion-and-rani-therapeutics-to-jointly-develop-oral-formulation-of-adalimumab-biosimilar,2023-06-21
"Starting in April 2024, California Joins Growing Trend of Implementing Advance Review Processes for Healthcare Transactions",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-lifesciences-hltc-starting-in-april-2024-california,2023-06-21
Employee Incentive Compensation Plan or Plan Amendment Filed as Exhibit to Form 8-K After Shareholder Approval,https://www.goodwinlaw.com/en/insights/blogs/2023/06/employee-incentive-compensation-plan-or-plan-amendment-filed-as-exhibit-to-form-8k-after-shareholder,2023-06-20
The EU Sustainable Finance Package: key points for private fund managers,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-pif-the-eu-sustainable-finance-package,2023-06-20
Nevada Enacts First-Of-Its-Kind Licensing Law For Earned Wage Access Services,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-ftec-nevada-enacts-first-of-its-kind,2023-06-16
Second Circuit Upholds Dismissal of AstraZeneca Investor Suit,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-sslit-securities-snapshot-061623,2023-06-16
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/06/newsletters-practices-df-debt-download-061623,2023-06-15
Federal Agencies Propose Interagency Guidance on Reconsiderations of Value for Residential Real Estate Valuations,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-finance-banking-weekly-roundup-0615,2023-06-15
SEC Announces Focus Areas for Next Stage of Marketing Rule Exams,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-pif-sec-announces-focus-areas,2023-06-14
Antitrust & Competition Technology Quarterly Update Q1 2023,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-technology-antc-quarterly-update-q1-2023,2023-06-14
Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J,https://www.goodwinlaw.com/en/insights/blogs/2023/06/alvotech-and-teva-reach-ustekinumab-stelara-settlement-with-jj,2023-06-13
SEC Sues Binance and Coinbase: What Are the Allegations and What Is Next?,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-ftec-sec-sues-binance-and-coinbase,2023-06-13
"Marketing Crypto-Assets in and Into Europe: MiCAR, the EU’s New Uniform Crypto Code",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-dcb-marketing-crypto-assets,2023-06-13
What Does the Irish DPC’s 1.2 Billion Euro Data Transfer Fine Mean For EU-US Transfers?,https://www.goodwinlaw.com/en/insights/blogs/2023/06/what-does-the-irish-dpcs-12-billion-euro-data-transfer-fine-mean-for-euus-transfers,2023-06-12
SEC Approves December 1st Deadline for NYSE and Nasdaq Clawback Policies: Preparations Companies Should Consider Undertaking Now,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-pca-sec-approves-december-first-deadline,2023-06-12
CFPB Highlights Risks Arising from Chatbot Usage in Banking Industry,https://www.goodwinlaw.com/en/insights/blogs/2023/06/cfpb-highlights-risks-arising-from-chatbot-usage-in-banking-industry,2023-06-09
Regeneron v. Mylan – Update on Aflibercept BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/06/regeneron-v-mylan--update-on-aflibercept-bpcia-litigation,2023-06-09
Supreme Court Limits Expression-Based Defenses to Trademark Claims,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-ip-supreme-court-limits-expression-based,2023-06-09
Blueprint of the Advisers Act-Related SPAC Enforcement Actions So Far,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-pif-blueprint-of-the-advisers-act-related,2023-06-09
Marketing Cryptoassets and Services In and Into The UK: A Near-Final Regulatory Regime,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-ftec-marketing-cryptoassets-uk,2023-06-09
California Invasion of Privacy Act (CIPA) Decisions Continue to Create Uncertainty for Websites Using Third-Party Technology,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-technology-california-invasion-of-privacy-act,2023-06-08
Agencies Issue Final Guidance on Third-Party Risk Management,https://www.goodwinlaw.com/en/insights/publications/2023/06/insights-finance-banking-weekly-roundup-0608,2023-06-08
Updates on Recent Foreign Approvals and Launches,https://www.goodwinlaw.com/en/insights/blogs/2023/06/updates-on-recent-foreign-approvals-and-launches,2023-06-06
Disclosure Considerations – Second Quarter 2023 Form 10-Q Reports,https://www.goodwinlaw.com/en/insights/blogs/2023/06/disclosure-considerations--second-quarter-2023-form-10-q-reports,2023-06-06
Too Important to Fail - Part 2: The Coming Regulation of Providers of Critical Technology Services to UK Financial Institutions,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-fs-too-important-to-fail-part-2,2023-06-06
"The Supreme Court Holds that the False Claims Act’s Scienter Element Turns on Defendant’s Subjective Beliefs, Rejecting Seventh Circuit’s Objective Standard",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-hltc-the-supreme-court-holds,2023-06-05
"The Digital Markets, Competition, and Consumers Bill",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-technology-the-digital-markets-competition-and-consumers-bill,2023-06-05
FTC Approves Consent Order with Payment Card Network Operator for EFTA Violations,https://www.goodwinlaw.com/en/insights/blogs/2023/06/ftc-approves-consent-order-with-payment-card-network-operator-for-efta-violations,2023-06-02
CFPB Reaches $20 Million Consent Order with Lender Over Optional Add-On Products,https://www.goodwinlaw.com/en/insights/blogs/2023/06/cfpb-reaches-$20-million-consent-order-with-lender-over-optional-add-on-products,2023-06-02
DOJ Reaches Settlement Over Bank’s Alleged Redlining,https://www.goodwinlaw.com/en/insights/blogs/2023/06/doj-reaches-settlement-over-banks-alleged-redlining,2023-06-02
Telehealth HIPAA Compliance Flexibilities Extended as the Public Health Emergency Ends,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-hltc-telehealth-hipaa-compliance-flexibilities,2023-06-02
"Current Issues for Qualified Small Business Stock — How New R&E Expensing Rules Could Hurt Your QSBS Status, and Why Cash Management Changes Likely Won’t",https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-technology-tax-current-issues-for-qualified,2023-06-02
Alnylam Files New COVID-19 Vaccine Infringement Lawsuits Against Pfizer and Moderna,https://www.goodwinlaw.com/en/insights/blogs/2023/06/alnylam-files-new-covid-19-vaccine-infringement-lawsuits-against-pfizer-and-moderna,2023-06-01
ELTIF Regulation regulatory technical standards (RTS): Important detail in the ESMA consultation,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-otherindustries-pif-eltif-regulation,2023-06-01
Too Important To Fail? Further Light on When EU and Non-EU Technology Providers Will Become Subject To DORA,https://www.goodwinlaw.com/en/insights/publications/2023/06/alerts-finance-fs-too-important-to-fail,2023-06-01
Webinar: 2022-2023 Key Trends and Updates: Securities Litigation Against Life Sciences Companies,https://www.goodwinlaw.com/en/insights/blogs/2023/05/webinar-2022-2023-key-trends-and-updates-securities-litigation-against-life-sciences-companies,2023-05-31
Psychedelics & Drug Development — Key Considerations for Healthcare Industry and Life Sciences Companies as Congress Seeks to Tap Into Psychedelics’ Therapeutic Potential,https://www.goodwinlaw.com/en/insights/blogs/2023/05/psychedelics--drug-development--key-considerations-for-healthcare-industry-and-life-sciences-compani,2023-05-31
Seven Things to Know About the SRC Public Float Measurement Date and SRC Qualification,https://www.goodwinlaw.com/en/insights/blogs/2023/05/seven-things-to-know-about-the-src-public-float-measurement-date-and-src-qualification,2023-05-31
Alvotech and Advanz Pharma Extend Partnership to Commercialize Five Proposed Biosimilars in Europe,https://www.goodwinlaw.com/en/insights/blogs/2023/05/alvotech-and-advanz-pharma-extend-partnership-to-commercialize-five-proposed-biosimilars-in-europe,2023-05-31
Psychedelics & Drug Development — Key Considerations for Healthcare Industry and Life Sciences Companies as Congress Seeks to Tap Into Psychedelics’ Therapeutic Potential,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-lifesciences-psychedelics-drug-development,2023-05-31
FINRA Asks How to Improve Capital Formation Rules; Public Companies and Fund Managers May Have Ideas,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-technology-ftec-finra-asks-how-to-improve-capital-formation,2023-05-31
“Regulation by Enforcement” in the Digital Asset Industry: A Lagging Response to Stale Facts,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-otherindustries-dcb-regulation-by-enforcement,2023-05-31
Most Noncompete Agreements with Covered Employees Violate the National Labor Relations Act According to Recent Guidance,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-emp-most-noncompete-agreements,2023-05-31
ILPA Publishes Guidance on Continuation Funds,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-pif-ilpa-publishes-guidance,2023-05-30
A Mini-Green Wave? Two More States Legalize Adult-Use Cannabis,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-cannabis-a-mini-green-wave,2023-05-30
Amgen Intervenes in Regeneron v. Mylan BPCIA Aflibercept Litigation to Seek Public Access to Sealed Documents,https://www.goodwinlaw.com/en/insights/blogs/2023/05/amgen-intervenes-in-regeneron-v-mylan-bpcia-aflibercept-litigation-to-seek-public-access-to-sealed-d,2023-05-25
Seven Tips for Healthcare & Life Sciences Companies Engaging Independent Monitors and Compliance Experts,https://www.goodwinlaw.com/en/insights/blogs/2023/05/seven-tips-for-healthcare--life-sciences-companies-engaging-independent-monitors-and-compliance-expe,2023-05-25
"FDA Approves Celltrion’s YUFLYMA (adalimumab-aaty), a Biosimilar to HUMIRA",https://www.goodwinlaw.com/en/insights/blogs/2023/05/fda-approves-celltrions-yuflyma-adalimumabaaty-a-biosimilar-to-humira,2023-05-25
FinCEN and the U.S. Department of Commerce’s BIS Issues Supplemental Alert Urging Continued Vigilance for Potential Russian Export Control Evasion Attempts,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-banking-weekly-roundup-0525,2023-05-25
Court Dismisses Post-SPAC Class Action for Lack of Standing,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-sslit-securities-snapshot-052523,2023-05-25
New Patents Listed in the Purple Book for Regeneron’s EYLEA,https://www.goodwinlaw.com/en/insights/blogs/2023/05/new-patents-listed-in-the-purple-book-for-regenerons-eylea,2023-05-24
Our Comments on the SEC’s Proposed Safeguarding Rule,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-pif-sec-proposed-safeguarding,2023-05-24
"Top IP, FDA, and Compliance Issues for Medtech Companies Transitioning to Data-Enabled Product Solutions",https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-lifesciences-ip-top-ip-fda-and-compliance,2023-05-24
Seven Tips for Healthcare & Life Sciences Companies Engaging Independent Monitors and Compliance Experts,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-lifesciences-seven-tips-for-healthcare,2023-05-24
"FDA Approves the Cyltezo Pen, an Autoinjector Option for Adalimumab",https://www.goodwinlaw.com/en/insights/blogs/2023/05/fda-approves-the-cyltezo-pen-an-autoinjector-option-for-adalimumab,2023-05-23
Form 8-K Report on Say-on-Frequency Vote,https://www.goodwinlaw.com/en/insights/blogs/2023/05/form-8-k-report-on-say-on-frequency-vote,2023-05-23
Janssen and Amgen Settle STELARA (Ustekinumab) BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/05/janssen-and-amgen-settle-stelara-ustekinumab-bpcia-litigation,2023-05-23
Antitrust & Competition Life Sciences Quarterly Update Q1 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/05/antitrust--competition-life-sciences-quarterly-update-q1-2023,2023-05-23
Supreme Court Affirms Amgen Patents’ Invalidity in Closely Watched Enablement Case,https://www.goodwinlaw.com/en/insights/blogs/2023/05/supreme-court-affirms-amgen-patents-invalidity-in-closely-watched-enablement-case,2023-05-23
EU AI Act: Foundation Models and Almost at the Finish Line,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-technology-aiml-eu-ai-act,2023-05-23
Massachusetts Division of Banks Enters into Consent Order with Mortgage Lender,https://www.goodwinlaw.com/en/insights/blogs/2023/05/massachusetts-division-of-banks-enters-into-consent-order-with-mortgage-lender,2023-05-22
Amneal Launches FYLNETRA (pegfilgrastim-pbbk) in the United States,https://www.goodwinlaw.com/en/insights/blogs/2023/05/amneal-launches-fylnetra-pegfilgrastimpbbk-in-the-united-states,2023-05-22
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years: Regulatory Data Protection,https://www.goodwinlaw.com/en/insights/blogs/2023/05/the-european-commission-proposes-first-major-overhaul-of-the-eu-medicines-regulatory-framework-in-20,2023-05-22
Antitrust & Competition Healthcare Quarterly Update Q1 2023,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-healthcare-antc-quarterly-update-q1-2023,2023-05-22
Six Steps Companies Can Take to Manage the Risk of Using Generative AI,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-technology-aiml-manage-risk-generative-ai,2023-05-22
Antitrust & Competition Life Sciences Quarterly Update Q1 2023,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-lifesciences-antc-quarterly-update-q1-2023,2023-05-22
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years: Regulatory Data Protection,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-lifesciences-the-european-commission-proposes-first,2023-05-22
UDAAP: You’re at Risk — 10 Essential Tips for Protecting Your Business,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-finance-ftec-udaap-youre-at-risk,2023-05-22
Supreme Court Affirms Amgen Patents’ Invalidity in Closely Watched Enablement Case,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-lifesciences-ip-supreme-court-affirms-amgen,2023-05-22
Durations in M&A Exclusivity Periods Increased Significantly Since 2021,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-privateequity-ma-durations-exclusivity-periods,2023-05-22
CFPB Warns Banks that Unilaterally Opening Closed Bank Accounts Could Be a Federal Law Violation,https://www.goodwinlaw.com/en/insights/blogs/2023/05/cfpb-warns-banks-that-unilaterally-opening-closed-bank-accounts-could-be-a-federal-law-violation,2023-05-19
Biosimilar Clinical Trial Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/05/biosimilar-clinical-trial-updates,2023-05-19
DEA Publishes Temporary Rule on the Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances,https://www.goodwinlaw.com/en/insights/blogs/2023/05/dea-publishes-temporary-rule-on-the-extension-of-covid19-telemedicine-flexibilities-for-prescription,2023-05-19
Mandatory Executive Compensation Clawback Policies: The Time Is . . . Soon,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-pca-mandatory-executive-compensation,2023-05-19
Supreme Court Clarifies Copyright Fair Use Defense in Andy Warhol Foundation v. Goldsmith,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-technology-ip-supreme-court-clarifies,2023-05-19
Proposed USPTO Fee Changes Could Impact PGR and IPR Filing Strategies Used by Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2023/05/proposed-uspto-fee-changes-could-impact-pgr-and-ipr-filing-strategies-used-by-biosimilars,2023-05-18
Pennsylvania Attorney General Settles $11 Million Dollar Lawsuit with Lender,https://www.goodwinlaw.com/en/insights/blogs/2023/05/pennsylvania-attorney-general-settles-$11-million-dollar-lawsuit-with-lender,2023-05-18
Finding Fellowship and Forging Pathways,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-otherindustries-dei-finding-fellowship-forging-pathways,2023-05-18
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/05/newsletters-practices-df-debt-download-051823,2023-05-18
FDIC Issues a Proposed Rule on Special Assessment Pursuant to Systemic Risk Determination,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-finance-banking-weekly-roundup-0518,2023-05-18
Proposed USPTO Fee Changes Will Make It Much More Expensive to Patent and to Challenge Patents on Therapeutics. You Have an Opportunity to Comment…,https://www.goodwinlaw.com/en/insights/blogs/2023/05/proposed-uspto-fee-changes-will-make-it-much-more-expensive-to-patent-and-to-challenge-patents-on-th,2023-05-17
New York Enacts Requirement for Healthcare Entities to Provide Notice of “Material Transactions”,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-hltc-new-york-enacts-requirement-for-healthcare-entities,2023-05-17
Overhaul of the UK Listing Regime Continues – A Consideration of the FCA’s Most Recent Proposals Which Are Most Relevant to Growth Companies and How They Compare With the Requirements of AIM and NASDAQ,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-overhaul-of-the-uk-listing,2023-05-17
Washington’s Biometric Data Regime Advances Privacy Regulation,https://www.goodwinlaw.com/en/insights/blogs/2023/05/washingtons-biometric-data-regime-advances-privacy-regulation,2023-05-16
"Horizon Scan for Private Investment Funds: Key Recent and Expected Funds, Regulatory and Tax Developments to Look Out For",https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-finance-pif-horizon-scan-private-investment-funds,2023-05-16
Proposed USPTO Fee Changes Will Make It Much More Expensive to Patent and to Challenge Patents on Therapeutics. You Have an Opportunity to Comment...,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-lifesciences-proposed-uspto-fee-changes,2023-05-16
New York Releases Significant Changes to Adult-Use Cannabis Regulations,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-can-new-york-releases-significant-changes,2023-05-16
New York CRPTO Bill Would Prohibit Many Digital Asset Activities and Impose Sweeping Market Structure Changes,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-finance-ftec-new-york-crpto-bill,2023-05-16
"To Manage Generative AI Risk, Understand the Terms of Use",https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-technology-aiml-generative-ai-risk-terms-of-use,2023-05-15
CFPB Issues Report Highlighting Risks of Medical Financing,https://www.goodwinlaw.com/en/insights/blogs/2023/05/cfpb-issues-report-highlighting-risks-of-medical-financing,2023-05-12
European Court Finds Pseudonymized Data is Not Personal Data in the Hands of Recipient That Can’t Re-identify It,https://www.goodwinlaw.com/en/insights/blogs/2023/05/european-court-finds-pseudonymized-data-is-not-personal-data-in-the-hands-of-recipient-that-cant-rei,2023-05-11
States Race After Utah on Minors’ Privacy Despite Legal Threats,https://www.goodwinlaw.com/en/insights/blogs/2023/05/states-race-after-utah-on-minors-privacy-despite-legal-threats,2023-05-11
Issue 41: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-ptab-issue-41,2023-05-11
CFPB Affirms Banks Risk UDAAP for Unilaterally Re-Opening Consumer Accounts After Account Closure,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-finance-banking-weekly-roundup-0511,2023-05-11
Amgen Files BPCIA Complaint Against Sandoz Regarding Denosumab,https://www.goodwinlaw.com/en/insights/blogs/2023/05/amgen-files-bpcia-complaint-against-sandoz-regarding-denosumab,2023-05-10
Takeaways from Washington’s Sweeping Health Privacy Bill,https://www.goodwinlaw.com/en/insights/blogs/2023/05/takeaways-from-washingtons-sweeping-health-privacy-bill,2023-05-10
Biogen Seeks Preliminary Injunction in Natilizumab BPCIA Litigation – Hearing Scheduled for May 17,https://www.goodwinlaw.com/en/insights/blogs/2023/05/biogen-seeks-preliminary-injunction-in-natilizumab-bpcia-litigation--hearing-scheduled-for-may-17,2023-05-10
The ABCs of DCTs: New FDA Guidance Provides Recommendations for the Conduct of Decentralized Clinical Trials,https://www.goodwinlaw.com/en/insights/blogs/2023/05/the-abcs-of-dcts-new-fda-guidance-provides-recommendations-for-the-conduct-of-decentralized-clinical,2023-05-10
SEC Files First Enforcement Complaint Under Liquidity Rule,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-imlit-sec-files-first,2023-05-10
DEA Announces Temporary Extension of COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications,https://www.goodwinlaw.com/en/insights/blogs/2023/05/dea-announces-temporary-extension-of-covid19-telehealth-flexibilities-for-prescription-of-controlled,2023-05-09
DEA Announces Temporary Extension of COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-hltc-dea-announces-temporary-extension,2023-05-09
FTC Brings Action Against Two Companies Involved in Illegal Student Loan Relief Schemes,https://www.goodwinlaw.com/en/insights/blogs/2023/05/ftc-brings-action-against-two-companies-involved-in-illegal-student-loan-relief-schemes,2023-05-08
Amplifying Operational Real Estate with Proptech,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-realestate-propt-amplifying-operational-real-estate-with-proptech,2023-05-08
SEC Adopts Final Disclosure Rules for Company Share Repurchases,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-practices-pca-sec-adopts-final-disclosure-rules,2023-05-08
CFPB Sends Approximately $22 Million in Refund Checks to Victims of Credit Card Debt Relief Scams,https://www.goodwinlaw.com/en/insights/blogs/2023/05/cfpb-sends-approximately-$22-million-in-refund-checks-to-victims-of-credit-card-debt-relief-scams,2023-05-05
Tougher Standards for Certain Home Improvement Loans,https://www.goodwinlaw.com/en/insights/blogs/2023/05/tougher-standards-for-certain-home-improvement-loans,2023-05-05
New EDPB Guidelines on Designation of a Lead Supervisory Authority,https://www.goodwinlaw.com/en/insights/blogs/2023/05/new-edpb-guidelines-on-designation-of-a-lead-supervisory-authority,2023-05-05
Samsung Files IPR Petition on Regeneron’s Aflibercept Patent,https://www.goodwinlaw.com/en/insights/blogs/2023/05/samsung-files-ipr-petition-on-regenerons-aflibercept-patent,2023-05-04
New Form PF Current and Quarterly Event Reporting and Expanded Large Private Equity Fund Adviser Reporting Adopted By SEC,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-pif-new-form-pf,2023-05-04
Maine Proposes Regulatory Approval Scheme for “Material Change Transactions” Involving “Health Care Entities”,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-otherindustries-hltc-maine-proposes-regulatory-approval-scheme,2023-05-04
Federal Reserve Announces Results From the Review of the Supervision and Regulation of SVB,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-banking-weekly-roundup,2023-05-04
Landmark Decision Regarding California Property Taxes: What Owners of California Hospitality Assets Should Know,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-realestate-landmark-decision-regarding-california-property,2023-05-03
The MHRA Proposes to Extend the Period of Acceptance of CE Marked Medical Devices in Great Britain Beyond 30 June 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/05/the-mhra-proposes-to-extend-the-period-of-acceptance-of-ce-marked-medical-devices-in-great-britain-b,2023-05-02
Structuring Hybrid Hospitality Projects for Success,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-realestate-structuring-hybrid-hospitality,2023-05-02
Bristol-Myers Squibb Files Patent Infringement Complaint Against AstraZeneca Regarding Anti-PD-L1 Antibody Product,https://www.goodwinlaw.com/en/insights/blogs/2023/05/bristolmyers-squibb-files-patent-infringement-complaint-against-astrazeneca-regarding-antipdl1-antib,2023-05-01
First Republic Bank FAQ,https://www.goodwinlaw.com/en/insights/publications/2023/05/alerts-finance-first-republic-bank-faq,2023-05-01
Three Steps to Manage Copyright Risk When Using Generative AI to Write Code,https://www.goodwinlaw.com/en/insights/publications/2023/05/insights-technology-aiml-three-steps-to-manage-copyright-risk,2023-05-01
Regeneron v. Mylan BPCIA Aflibercept Litigation Update: Claim Construction Order and Stipulation to Narrow the Case for June 2023 Trial,https://www.goodwinlaw.com/en/insights/blogs/2023/04/regeneron-v-mylan-bpcia-aflibercept-litigation-update-claim-construction-order-and-stipulation-to-na,2023-04-28
Goodwin’s Digital Currency and Blockchain Team at Consensus 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/04/goodwins-digital-currency-and-blockchain-team-at-consensus-2023,2023-04-28
House Financial Committee Introduces CFPB Reform Bill In Response To Recent Court Decisions,https://www.goodwinlaw.com/en/insights/blogs/2023/04/house-financial-committee-introduces-cfpb-reform-bill-in-response-to-recent-court-decisions,2023-04-28
FAQ About Recent Bank Failures in the US,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_13-faq-about-recent-bank-failures-in-the-us,2023-04-28
Doing Fintech Business in the UK: Regulatory Q&A for US and Other Non-UK Businesses,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_26-doing-fintech-business-in-the-uk,2023-04-28
Silicon Valley Bank FAQ,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_28-silicon-valley-bank-faq,2023-04-28
FDIC Pass-Through Coverage,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_28-fdic-pass-through-coverage,2023-04-28
Five Things You Need to Know About Launching Fintech Products in the US,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_26-five-things-you-need-to-know-about-launching,2023-04-28
Purple Book Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/04/purple-book-updates,2023-04-27
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years,https://www.goodwinlaw.com/en/insights/blogs/2023/04/the-european-commission-proposes-first-major-overhaul-of-the-eu-medicines-regulatory-framework-in-20,2023-04-27
FDA’s Final Q&A Guidance on Risk-Based Monitoring of Clinical Trials Provides Additional Recommendations for Sponsors,https://www.goodwinlaw.com/en/insights/blogs/2023/04/fdas-final-qa-guidance-on-riskbased-monitoring-of-clinical-trials-provides-additional-recommendation,2023-04-27
CFPB Deems Merchant Cash Advances to Be “Credit” Under ECOA,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_27-cfpb-deems-merchant-cash-advances,2023-04-27
The European Commission Proposes First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_27-proposal-overhaul-eu-medicines-regulatory-framework,2023-04-27
Overdraft Protection Programs: Risk Management Practices,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_27-weekly-roundup,2023-04-27
The Impact of New Patent Litigation Assignments Rules in the Western District of Texas,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_26-the-impact-of-new-patent-litigation-assignments,2023-04-26
CFPB Appeals District Court’s Dismissal of Nonbank Redlining Action,https://www.goodwinlaw.com/en/insights/blogs/2023/04/cfpb-appeals-district-courts-dismissal-of-nonbank-redlining-action,2023-04-25
Why Film and TV Studios Could Be a Blockbuster Alternative Asset Class,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_25-why-film-and-tv,2023-04-25
How Do Intellectual Property Rights Apply to Generative AI Outputs?,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_25-how-do-intellectual-property-rights-apply-to-generative-ai-outputs,2023-04-25
FDA Guidance on Continuous Manufacturing of Drug Substances and Drug Products,https://www.goodwinlaw.com/en/insights/blogs/2023/04/fda-guidance-on-continuous-manufacturing-of-drug-substances-and-drug-products,2023-04-24
"SEC Brings Suit Against Owner of BitTorrent, Inc., and Settles Claims With Celebrity Endorsers of Certain Crypto Tokens",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_24-securities-snapshot,2023-04-24
Remarks by Governor Bowman on the Consequences of Fewer Banks in the U.S. Banking System,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_21-remarks-by-governor-bowman-on-the-consequences,2023-04-21
Mabwell Announces Approval of Denosumab Biosimilar MAILISHU in China,https://www.goodwinlaw.com/en/insights/blogs/2023/04/mabwell-announces-approval-of-denosumab-biosimilar-mailishu-in-china,2023-04-20
Celltrion Launches VEGZELMA in the United States,https://www.goodwinlaw.com/en/insights/blogs/2023/04/celltrion-launches-vegzelma-in-the-united-states,2023-04-20
A Step Towards Guidance Instead of Regulation by Litigation in the ESOP Space,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_19-a-step-towards-guidance-instead-of-regulation,2023-04-19
Change to UK Insider Dealing Laws: A Step Towards Coherence,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_19-change-to-uk-insider-dealing-laws,2023-04-19
Third Circuit Upholds Dismissal of TILA Claim Based on Failure to Itemize Annual Credit Card Renewal Notice Fees,https://www.goodwinlaw.com/en/insights/blogs/2023/04/third-circuit-upholds-dismissal-of-tila-claim-based-on-failure-to-itemize-annual-credit-card-renewal,2023-04-18
Regeneron v. Mylan – Update on Aflibercept BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/04/regeneron-v-mylan--update-on-aflibercept-bpcia-litigation,2023-04-18
The FCA’s Chief Executive Updates UK Market on Continued UK Listing Regime Reforms: A Consideration of Which Reforms Will Most Impact Growth Companies,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_18-the-fcas-chief-executive-updates,2023-04-18
Celltrion Confirms Bioequivalence for CT-P39 Against Xolair in Interim Results of Phase 3 Study,https://www.goodwinlaw.com/en/insights/blogs/2023/04/celltrion-confirms-bioequivalence-for-ct-p39-against-xolair-in-interim-results-of-phase-3-study,2023-04-17
The Long (Un)Winding Road Part 2: FDA’s Final Transition Guidances for COVID-19 Devices,https://www.goodwinlaw.com/en/insights/blogs/2023/04/the-long-unwinding-road-part-2-fdas-final-transition-guidances-for-covid19-devices,2023-04-14
Accord BioPharma Announces the Acceptance of BLA for HLX02 (a proposed trastuzumab biosimilar) by FDA,https://www.goodwinlaw.com/en/insights/blogs/2023/04/accord-biopharma-announces-the-acceptance-of-bla-for-hlx02-a-proposed-trastuzumab-biosimilar-by-fda,2023-04-14
"The Long (Un)Winding Road, Part 2: The FDA’s Final Transition Guidances for COVID-19 Devices",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_14-the-long-unwinding-road,2023-04-14
ESAs propose adjustments to the EU SFDR rules,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_14-esas-propose-adjustments-to-the-eu-sfdr-rules,2023-04-14
FDIC Publishes Consumer Compliance Supervisory Highlights,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_14-weekly-roundup,2023-04-14
"SEC to Impose Significant New Privacy and Cybersecurity Rules for BDs, RIAs, TAs, and Mutual Funds",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_13-sec-to-impose,2023-04-13
REMICADE Antitrust Settlement Receives Final Approval,https://www.goodwinlaw.com/en/insights/blogs/2023/04/remicade-antitrust-settlement-receives-final-approval,2023-04-12
Update on Arbutus mRNA Vaccine Patent Litigations,https://www.goodwinlaw.com/en/insights/blogs/2023/04/update-on-arbutus-mrna-vaccine-patent-litigations,2023-04-12
US Artificial Intelligence Regulations: Watch List for 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/04/us-artificial-intelligence-regulations-watch-list-for-2023,2023-04-12
US Artificial Intelligence Regulations: Watch List for 2023,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_12-us-artificial-intelligence-regulations,2023-04-12
"RECM 2023 | Featured Speaker, Roger Morales",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_07-recm-featured-speaker-roger-morales,2023-04-12
Will AI Replace Your Lawyer? What AI Means for the Legal Profession,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_12-will-ai-replace-your-lawyer,2023-04-12
Form 10-Q Form Check Table,https://www.goodwinlaw.com/en/insights/blogs/2023/04/form-10-q-form-check-table,2023-04-11
Five Takeaways on the Future of Real Estate,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_11-recm-five-takeaways-on-the-future-of-real,2023-04-11
"A Tale of Two Lawsuits: Federal Court in Texas Suspends FDA Approval of Medication Abortion Drug Mifepristone Nationwide, While Federal Court in Washington Orders FDA to Not Alter Availability of Mifepristone in 17 States and D.C.",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_11-a-tale-of-two-lawsuits,2023-04-11
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2023/04/04_12-erisa-litigation-update,2023-04-11
An Emerging Credit Crisis Could Reshape Real Estate,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_11-recm-an-emerging-credit-crisis-could-reshape-real-estate,2023-04-11
Stock Buybacks: Recent Developments and Hot Topics for Issuers,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_10-stock-buybacks,2023-04-10
Court Holds All DAO Governance Token Holders Can Be Held Responsible for the Actions and Inactions of the DAO,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_10-court-holds-all-dao,2023-04-10
FINRA Re-Proposes Work-From-Home Supervisory Locations,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_10-finra-re-proposes,2023-04-10
The Growing Importance of Earnouts in Midmarket Dealmaking,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_10-the-growing-importance-of-earnouts,2023-04-10
CFPB Issues Guidance on Abusive Conduct Under CFPA,https://www.goodwinlaw.com/en/insights/blogs/2023/04/cfpb-issues-guidance-on-abusive-conduct-under-cfpa,2023-04-07
RECM 2023 | The Evolving Landscape of Banking with Christopher J. Mayer and Eric Rosengren,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_07-recm-the-evolving-landscape-of-banking-credit-real-estate-panel,2023-04-07
RECM 2023 | Integrating Climate Risk with Real Estate Investment with Jacques Gordon and Ahmad Wani,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_07-recm-integrating-climate-risk-with-real-estate-investment-panel,2023-04-07
Bank Officer and Director Enforcement Exposures In the Wake of Silicon Valley Bank,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_07-bank-officer-and-director-enforcement-exposures-in-the-wake-of-silicon-valley-bank,2023-04-07
"RECM 2023 | Keynote Speaker, Scott Rechler",https://www.goodwinlaw.com/en/insights/publications/2023/04/04_07-recm-scott-rechler-keynote,2023-04-07
The Inflation Reduction Act & Medicare Pricing for Drugs and Biologics,https://www.goodwinlaw.com/en/insights/blogs/2023/04/the-inflation-reduction-act--medicare-pricing-for-drugs-and-biologics,2023-04-06
CMS Issues Guidance and Solicits Comment on the 2026 Inflation Reduction Act Part D Negotiation Process,https://www.goodwinlaw.com/en/insights/blogs/2023/04/cms-issues-guidance-and-solicits-comment-on-the-2026-inflation-reduction-act-part-d-negotiation-proc,2023-04-06
CFPB Finalizes Small Business Lending Data Rule,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_06-cfpb-finalizes-small-business,2023-04-06
Overview of the UK Government’s AI White Paper,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_06-overview-of-the-uk-governments-ai-white-paper,2023-04-06
Celltrion Announces Phase III Results for Aflibercept Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/04/celltrion-announces-phase-iii-results-for-aflibercept-biosimilar,2023-04-05
CMS Issues Guidance and Solicits Comment on the 2026 Inflation Reduction Act Part D Negotiation Process,https://www.goodwinlaw.com/en/insights/publications/2023/04/04_05-cms-issues-guidance,2023-04-05
"Second Circuit Rules CFPB Constitutionally Funded, Creates Circuit Split",https://www.goodwinlaw.com/en/insights/blogs/2023/04/second-circuit-rules-cfpb-constitutionally-funded-creates-circuit-split,2023-04-03
FDIC Issues Cease and Desist Demand Against Neobank,https://www.goodwinlaw.com/en/insights/blogs/2023/04/fdic-issues-cease-and-desist-demand-against-neobank,2023-04-03
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/04/newsletters-practices-df-debt-download-040323,2023-04-03
FDA Issues Guidance Document on Animal Studies for the Evaluation of Medical Devices,https://www.goodwinlaw.com/en/insights/blogs/2023/03/fda-issues-guidance-document-on-animal-studies-for-the-evaluation-of-medical-devices,2023-03-31
White House Announces “Bold Goals” for Biotech,https://www.goodwinlaw.com/en/insights/blogs/2023/03/white-house-announces-bold-goals-for-biotech,2023-03-30
FinCEN Issues Initial Beneficial Ownership Information Reporting Guidance,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_30-weekly-roundup,2023-03-30
Issue 40: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_30-issue-40-of-the-ptab-trial-tracker,2023-03-30
Notable Differences Between US and UK M&A Deal Terms,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_28-notable-differences-between,2023-03-29
New York Legislature Considers Proposal to Require Burdensome Regulatory Approval Process for “Material Transactions” Involving Medical Practices,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_28-new-york-legislature-considers-proposal,2023-03-29
Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies,https://www.goodwinlaw.com/en/insights/blogs/2023/03/celltrion-and-genuv-partner-to-develop-novel-therapeutic-antibodies,2023-03-28
Capturing the Operational Upside in Real Estate Investing,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_28-capturing-the-operational-upside-in-real-estate-investing,2023-03-28
Fintech-Bank Lending Partnerships: 8 Key Issues,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_28-fintech-bank-lending-partnerships-8-key-issues,2023-03-28
"Court Denies Dapper Labs’ Motion to Dismiss, Finding That NFTs May Be Securities",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_28-securities-snapshot,2023-03-28
Coya Announces Agreement with Dr. Reddy’s Laboratories for Treatment of Neurodegenerative Diseases,https://www.goodwinlaw.com/en/insights/blogs/2023/03/coya-announces-agreement-with-dr-reddys-laboratories-for-treatment-of-neurodegenerative-diseases,2023-03-27
NIH Again Refuses to Exercise March-In Rights to Control Drug Price,https://www.goodwinlaw.com/en/insights/blogs/2023/03/nih-again-refuses-to-exercise-march-in-rights-to-control-drug-price,2023-03-27
US Enforcement Agencies are Turning Up the Heat on Crypto-Related Crime (Cointelegraph Magazine),https://www.goodwinlaw.com/en/insights/blogs/2023/03/us-enforcement-agencies-are-turning-up-the-heat-on-cryptorelated-crime-cointelegraph-magazine,2023-03-24
HUD Announces Final Rule Restoring 2013 Discriminatory Effects Standard,https://www.goodwinlaw.com/en/insights/blogs/2023/03/hud-announces-final-rule-restoring-2013-discriminatory-effects-standard,2023-03-24
"FINRA Extends the “Maintaining Qualifications Program” Enrollment Window for Brokerage Reps U5’d Before March 15, 2022",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_24-finra-extends-the-maintaining-qualifications-program,2023-03-24
Sandoz Announces Approval for Biosimilar Hyrimoz® (adalimumab-adaz),https://www.goodwinlaw.com/en/insights/blogs/2023/03/sandoz-announces-approval-for-biosimilar-hyrimoz-adalimumabadaz,2023-03-23
French Privacy Regulator Fines Apple 8 Million Euros for Ad Targeting Violations,https://www.goodwinlaw.com/en/insights/blogs/2023/03/french-privacy-regulator-fines-apple-8-million-euros-for-ad-targeting-violations,2023-03-23
"Delaware District Court Adopts Magistrate Judge’s Report and Recommendation Denying Amgen’s Motion to Dismiss Regeneron’s Antitrust Claims, Overruling Amgen’s Objections",https://www.goodwinlaw.com/en/insights/blogs/2023/03/delaware-district-court-adopts-magistrate-judges-report-and-recommendation-denying-amgens-motion-to,2023-03-23
USPTO Director Issues Precedential Review Decision Regarding Multiple Dependent Claims,https://www.goodwinlaw.com/en/insights/blogs/2023/03/uspto-director-issues-precedential-review-decision-regarding-multiple-dependent-claims,2023-03-23
Clinical Trial Diversity Plans and Rare Diseases,https://www.goodwinlaw.com/en/insights/blogs/2023/03/clinical-trial-diversity-plans-and-rare-diseases,2023-03-23
"DEA Proposes Rules to Allow Prescribing Controlled Substances via Telemedicine, Subject to Significant Limitations",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_23-dea-proposes-rules-to-allow-prescribing,2023-03-23
SEC Proposes Changes to Reg S-P to Enhance Protection of Customer Information,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_23-weekly-roundup,2023-03-23
Insulin Updates: March 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/03/insulin-updates-march-2023,2023-03-22
Janssen Files Redacted Public Version of Its Opening Brief in Support of Its Motion for Preliminary Injunction Against Amgen in BPCIA Ustekinumab Case,https://www.goodwinlaw.com/en/insights/blogs/2023/03/janssen-files-redacted-public-version-of-its-opening-brief-in-support-of-its-motion-for-preliminary,2023-03-22
Reactions to Amgen v. Sanofi and the Future of Patent Law’s Enablement Requirement,https://www.goodwinlaw.com/en/insights/blogs/2023/03/reactions-to-amgen-v-sanofi-and-the-future-of-patent-laws-enablement-requirement,2023-03-22
What Semiconductor Companies Need to Know: CHIPS Act and Eligibility Requirements,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_22-what-semiconductor-companies-need-to-know,2023-03-22
R&W Insurance Coverage for Healthcare Services Transactions,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_17-r-and-w-insurance-coverage-for-healthcare-services-transactions,2023-03-21
Two Major Bank Failures Require Government Regulators to Step In,https://www.goodwinlaw.com/en/insights/blogs/2023/03/two-major-bank-failures-require-government-regulators-to-step-in,2023-03-17
States Look to Strengthen Protections for Consumer Health Data Post-Dobbs,https://www.goodwinlaw.com/en/insights/blogs/2023/03/states-look-to-strengthen-protections-for-consumer-health-data-post-dobbs,2023-03-17
National Futures Association to Expand Compliance Rulebook to Address Member Activities in Spot Digital Asset Commodities,https://www.goodwinlaw.com/en/insights/blogs/2023/03/national-futures-association-to-expand-compliance-rulebook-to-address-member-activities-in-spot-digi,2023-03-17
UK Spring Budget 2023: Implications and Insights for Real Estate Funds,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_17-uk-spring-budget-2023,2023-03-17
Founders Alert: Climate Tech Funding Outlook for 2023,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_09-climate-tech-funding-outlook-for-2023,2023-03-17
The U.S. Government Takes Action on the Silicon Valley Bank and Signature Bank Failures,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_17-weekly-roundup,2023-03-17
Turbulent Banking Sector Renews Interest in Cash Management and Investment Policies,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_16-interest-in-cash-management-investment-policy,2023-03-16
The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies,https://www.goodwinlaw.com/en/insights/blogs/2023/03/the-long-unwinding-road-fda-maps-out-how-the-end-of-the-public-health-emergency-will-impact-its-covi,2023-03-15
Aflibercept IPRs Update,https://www.goodwinlaw.com/en/insights/blogs/2023/03/aflibercept-iprs-update,2023-03-15
"HHS to Create New Potential Medicare Pricing Models for Cell and Gene Therapy, Drugs Subject to Accelerated FDA Approval, and “High-Value” Generics",https://www.goodwinlaw.com/en/insights/blogs/2023/03/hhs-to-create-new-potential-medicare-pricing-models-for-cell-and-gene-therapy-drugs-subject-to-accel,2023-03-15
Private Fund Managers and Retail Investment in the UK and EU: Comparing the UK’s Long Term Asset Fund,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_14-private-fund-managers-and-retail-investment-in-the-uk-and-eu,2023-03-15
The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_15-the-long-unwinding-road,2023-03-15
The Sequel – Data Protection and Digital Information (No. 2) Bill – Further Divergence?,https://www.goodwinlaw.com/en/insights/blogs/2023/03/the-sequel--data-protection-and-digital-information-no-2-bill--further-divergence,2023-03-14
Coherus Biosciences Announces Approval of a Pegfilgrastim Autoinjector,https://www.goodwinlaw.com/en/insights/blogs/2023/03/coherus-biosciences-announces-approval-of-a-pegfilgrastim-autoinjector,2023-03-14
"HHS to Create New Potential Medicare Pricing Models for Cell and Gene Therapy, Drugs Subject to Accelerated FDA Approval, and “High-Value” Generics",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_14-hhs-to-create-new-potential-medicare-pricing-models,2023-03-14
Protecting Against Wire Fraud Scams,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_13-protecting-against-wire-fraud-scams,2023-03-13
How should I be thinking about my cash management options in light of recent events?,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_13-how-should-i-be-thinking-about-my-cash-management,2023-03-13
Silicon Valley Bank Webinar (Video),https://www.goodwinlaw.com/en/insights/publications/2023/03/03_12-silicon-valley-bank-webinar,2023-03-12
UK Model Form Bridge Financing Documents,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_12-uk-model-form-bridge-financing-documents,2023-03-12
US Model Form Bridge Financing Documents,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_12-model-form-bridge-financing-documents,2023-03-12
Some Key Issues Under State Wage Payment Laws for Employers in Light of the Silicon Valley Bank Closure,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_12-key-issues-under-state-wage-laws-svb-closure,2023-03-12
The Silicon Valley Bank UK insolvency: FAQ for those doing business with the Bank,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_11-the-silicon-valley-bank-uk-insolvency,2023-03-11
FAQ About the Silicon Valley Bank Situation in the US,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_11-faq-about-the-silicon-valley,2023-03-11
"CFPB Issues New Report On Buy Now, Pay Later Products",https://www.goodwinlaw.com/en/insights/blogs/2023/03/cfpb-issues-new-report-on-buy-now-pay-later-products,2023-03-10
Biogen Launches BYOOVIZ (ranibizumab) in Canada,https://www.goodwinlaw.com/en/insights/blogs/2023/03/biogen-launches-byooviz-ranibizumab-in-canada,2023-03-10
The Growth of Operational Real Estate: An Overview,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_10-the-growth-of-operational-real-estate,2023-03-10
Silicon Valley Bank Update (Video),https://www.goodwinlaw.com/en/insights/publications/2023/03/03_10-silicon-valley-bank-update-video,2023-03-10
Jury Acquits Tesla and Musk of Securities Fraud for 2018 Tweets Regarding Going Private,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_10-securities-snapshot,2023-03-10
Women’s History Month Spotlight: Brigitte Askonas,https://www.goodwinlaw.com/en/insights/blogs/2023/03/womens-history-month-spotlight-brigitte-askonas,2023-03-09
"FINRA Provides Update on Social Media Influencers, Customer Acquisition and Related Information Protection",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_09-weekly-roundup,2023-03-09
Janssen Seeks a Preliminary Injunction in BPCIA Ustekinumab Case Against Amgen,https://www.goodwinlaw.com/en/insights/blogs/2023/03/janssen-seeks-a-preliminary-injunction-in-bpcia-ustekinumab-case-against-amgen,2023-03-08
DOJ Revises Corporate Compliance Guidance to Take on Compensation Incentives and Communications Preservation — With a Continued Emphasis on Individual Accountability,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_07-doj-revises-corporate-compliance-guidance,2023-03-08
Transfer-on-Death Designations: A Word of Warning,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_08-transfer-on-death-designations-a-word-of-warning,2023-03-08
Bridging the Gap: How Deals Are Getting Done in a Difficult Debt Market,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_08-bridging-the-gap-how-deals-are-getting-done,2023-03-08
Bankrupt in the Metaverse,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_06-bankrupt-in-the-metaverse,2023-03-07
Marketing Cryptoassets and Services in and Into the UK: Shifting Regulatory Sands,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_07-marketing-cryptoassets-and-services-in-and-into-the-uk,2023-03-07
McDonald’s Part Two: Delaware Court of Chancery Dismisses Caremark Claims Against Directors Arising From Sexual Harassment Issues,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_07-mcdonalds-part-two-delaware-court-of-chancery,2023-03-07
Goodwin Shares 2022 Year in Review: Digital Currency and Blockchain Litigation and Enforcement Developments,https://www.goodwinlaw.com/en/insights/blogs/2023/03/goodwin-shares-2022-year-in-review-digital-currency-and-blockchain-litigation-and-enforcement-develo,2023-03-06
"Marking One Year of War, US Broadens Sanctions and Export Controls Against Russia and Other Actors",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_06-marking-one-year-of-war,2023-03-06
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar in India,https://www.goodwinlaw.com/en/insights/blogs/2023/03/alkem-subsidiary-enzene-launches-adalimumab-biosimilar-in-india,2023-03-03
Genentech Files Lawsuits Against Biogen and Millennium for Past Royalties on the Cabilly Patents,https://www.goodwinlaw.com/en/insights/blogs/2023/03/genentech-files-lawsuits-against-biogen-and-millennium-for-past-royalties-on-the-cabilly-patents,2023-03-03
FCC Proposes Rules To Block Illegal Text Messages and Close the “Lead Generator Loophole”,https://www.goodwinlaw.com/en/insights/blogs/2023/03/fcc-proposes-rules-to-block-illegal-text-messages-and-close-the-lead-generator-loophole,2023-03-03
Part III: What Primary Mitigation Strategies Exist for Companies with Double-Vest RSUs That May Be Expiring?,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_02-part-iii-what-primary-mitigation-strategies,2023-03-03
SEC Proposes New Regulation Best Execution — Brokers Must Achieve “Most Favorable Price” for Customers; Heightened Obligations for Conflicted Retail Transactions,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_01-sec-proposes-new-regulation-best-execution,2023-03-03
1x1 with Michael Greeley at Flare Capital,https://www.goodwinlaw.com/en/insights/case-studies/1x1-with-michael-greeley-at-flare-capital,2023-03-03
A Recap of Resilience: Goodwin’s Life Sciences Practice,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_28-a-recap-of-resilience-goodwin-life-sciences,2023-03-02
"SEC and FINRA to Securities Influencers: Disclose the Truth of Your Compensation, or Else!",https://www.goodwinlaw.com/en/insights/publications/2023/03/03_02-sec-and-finra-to-securities-influencers,2023-03-02
Texas Sues to Challenge Federal Guidance Asserting that Refusal to Fill Prescriptions for Certain Drugs Used to Manage Reproductive Health and Other Conditions May Violate Anti-Discrimination Laws,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_02-texas-challenge-anti-discrimination-guidance,2023-03-02
New Decision on Lease Rejection Damages,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_02-new-decision-on-lease-rejection-damages,2023-03-02
Agencies Issue Joint Statement on Liquidity Risks Resulting from Crypto-Asset Market Vulnerabilities,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_02-weekly-roundup,2023-03-02
USPTO Extends Deadline for Comments on USPTO-FDA Collaboration Initiatives,https://www.goodwinlaw.com/en/insights/blogs/2023/03/uspto-extends-deadline-for-comments-on-uspto-fda-collaboration-initiatives,2023-03-01
Goodwin to Host a Conversation on March 1 with Rare Disease Community Leaders,https://www.goodwinlaw.com/en/insights/blogs/2023/03/goodwin-to-host-a-conversation-on-march-1-with-rare-disease-community-leaders,2023-03-01
UK REIT Reorganisations for Real Estate Funds — Six Key Factors for Success,https://www.goodwinlaw.com/en/insights/publications/2023/03/03_01-uk-reit-reorganisations-for-real-estate,2023-03-02
EMA Adopts Positive Opinion for Amgen’s Eculizumab Biosimilar Candidate BEKEMV®,https://www.goodwinlaw.com/en/insights/blogs/2023/02/ema-adopts-positive-opinion-for-amgens-eculizumab-biosimilar-candidate-bekemv,2023-02-28
Proxy Statement Voting Standards Disclosure,https://www.goodwinlaw.com/en/insights/blogs/2023/02/proxy-statement-voting-standards-disclosure,2023-02-28
DOJ Announces Nationwide Voluntary Corporate Self-Disclosure Policy in Effort to Standardize and Incentivize Timely Self-Reporting,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_28-doj-announces-nationwide-voluntary-corporate,2023-02-28
Mini-TCPA Laws You Should Know and That May Be Coming Soon in 2023,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_28-mini-tcpa-laws-you-should-know,2023-02-28
Digital Asset Custody and the SEC’s Proposed Safeguarding Rule: Significant Potential Implications and Unanswered Questions,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_28-digital-asset-custody,2023-02-28
Alteogen and Sandoz Enter a Biosimilars Agreement Relating to Subcutaneous Products,https://www.goodwinlaw.com/en/insights/blogs/2023/02/alteogen-and-sandoz-enter-a-biosimilars-agreement-relating-to-subcutaneous-products,2023-02-27
Sandoz Denosumab BLA Accepted by FDA,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sandoz-denosumab-bla-accepted-by-us-fda,2023-02-27
CFPB Enters Into $15 Million Settlement with Auto Lender,https://www.goodwinlaw.com/en/insights/blogs/2023/02/cfpb-enters-into-$15-million-settlement-with-auto-lender,2023-02-27
Celltrion and Samsung File IPR Petitions on Aflibercept Patents,https://www.goodwinlaw.com/en/insights/blogs/2023/02/celltrion-and-samsung-file-ipr-petitions-on-aflibercept-patents,2023-02-27
NLRB Concludes that Separation Agreement Provisions Prohibiting Disparagement and Requiring Confidentiality of Agreement Terms Violate Employee Rights,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_27-nlrb-concludes-that-separation-agreement-provisions-prohibiting-disparagement,2023-02-27
Fresenius Kabi Launches STIMUFEND (pegfilgrastim-fpgk) in the United States,https://www.goodwinlaw.com/en/insights/blogs/2023/02/fresenius-kabi-launches-stimufend-pegfilgrastimfpgk-in-the-united-states,2023-02-24
Court Denies Amgen’s Motion to Dismiss and Motion to Stay Regeneron’s Antitrust Case,https://www.goodwinlaw.com/en/insights/blogs/2023/02/court-denies-amgens-motion-to-dismiss-and-motion-to-stay-regenerons-antitrust-case,2023-02-23
Antitrust & Competition Life Sciences 2022 Year In Review,https://www.goodwinlaw.com/en/insights/blogs/2023/02/antitrust--competition-life-sciences-2022-year-in-review,2023-02-23
Leveraging Investigator-Initiated Trials in Rare Disease Drug Development,https://www.goodwinlaw.com/en/insights/blogs/2023/02/leveraging-investigator-initiated-trials-in-rare-disease-drug-development,2023-02-23
Part II: Why Do Private Companies Shift From Stock Options to Double-Vest RSUs?,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_23-part-ii-why-do-private-companies,2023-02-23
ELTIF Reform: A Milestone in the Development of an EU Private Fund Structure for Accessing Wholesale Markets,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_23-eltif-reform-a-milestone-in-the-development,2023-02-23
Goodwin Invites You to a Conversation with Rare Disease Community Leaders,https://www.goodwinlaw.com/en/insights/blogs/2023/02/goodwin-invites-you-to-a-conversation-with-rare-disease-community-leaders,2023-02-22
CMS Issues Proposed Guidance on Inflation Rebates Under Medicare Part D,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_21-cms-issues-proposed-guidance-part-d,2023-02-22
CMS Issues Proposed Guidance on Inflation Rebates Under Medicare Part B,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_21-cms-issues-proposed-guidance-part-b,2023-02-22
Goodwin Year-In-Review Confirms 2022 Was a Regulatory Harbinger of What is in Store for The Consumer Finance Industry In 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/02/goodwin-yearinreview-confirms-2022-was-a-regulatory-harbinger-of-what-is-in-store-for-the-consumer-f,2023-02-21
Antitrust & Competition Healthcare Quarterly Update Q4 2022,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_21-antitrust-and-competition-healthcare-quarterly,2023-02-21
Antitrust & Competition Technology 2022 Year in Review,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_21-antitrust-and-competition-technology,2023-02-21
Innovations in Private Equity Fund Liquidity Solutions,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_07-innovations-private-fund-liquidity-solutions,2023-02-21
Antitrust & Competition Life Sciences 2022 Year In Review,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_21-antitrust-and-competition-life-sciences-2022,2023-02-21
Court Dismisses Class Action Against Coinbase Alleging Sale of Unregistered Securities,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_22-securities-snapshot,2023-02-21
Genentech BPCIA Trastuzumab Case Against Tanvex Dismissed After Settlement,https://www.goodwinlaw.com/en/insights/blogs/2023/02/genentech-bpcia-trastuzumab-case-against-tanvez-dismissed-after-settlement,2023-02-20
CFPB Proposes Rule To Amend Regulation Z Credit Card Late Fees,https://www.goodwinlaw.com/en/insights/blogs/2023/02/cfpb-proposes-rule-to-amend-regulation-z-credit-card-late-fees,2023-02-17
SEC Requires T+1 Settlement Cycle,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_17-sec-requires-t1-settlement-cycle,2023-02-17
Federal Reserve and OCC Release 2023 Bank Stress Test Scenarios,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_16-weekly-roundup,2023-02-16
Part I: What are “Double-Vest” RSUs and Why Are They Making Headlines?,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_16-what-are-doublevest-rsus,2023-02-16
SEC Proposes Radical Transformation of Custody Rule Into New Safeguarding Rule,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_16-sec-proposes-radical-transformation-of-custody-rule-into-new-safeguarding-rule,2023-02-16
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/02/newsletters-practices-df-debt-download-021623,2023-02-16
SEC to Enhance Its Regulation of Security-Based Swaps,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-to-enhance-its-regulation-of-security-based-swaps,2023-02-15
Navigating Loss of WKSI Status,https://www.goodwinlaw.com/en/insights/blogs/2023/02/navigating-loss-of-wksi-status,2023-02-15
CFPB Advisory Opinion Details RESPA Implications for Mortgage Comparison Websites,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_15-cfpb-advisory-opinion-details-respa-implications,2023-02-15
FDA Approves EYLEA® (Aflibercept) for Treatment of Retinopathy of Prematurity,https://www.goodwinlaw.com/en/insights/blogs/2023/02/fda-approves-eylea-aflibercept-for-treatment-of-retinopathy-of-prematurity,2023-02-14
Biosimilar Clinical Trial Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/02/biosimilar-clinical-trial-updates,2023-02-14
"Minnesota Attorney General Enters Into $20,000 Settlement with Student-Loan Debt Relief Company",https://www.goodwinlaw.com/en/insights/blogs/2023/02/minnesota-attorney-general-enters-into-20000-settlement-with-studentloan-debt-relief-company,2023-02-14
340B Drug Pricing Program Reform Considerations,https://www.goodwinlaw.com/en/insights/blogs/2023/02/340b-drug-pricing-program-reform-considerations,2023-02-14
DC Circuit Holds CFPB Did Not Exceed Statutory Authority with the Prepaid Rule,https://www.goodwinlaw.com/en/insights/blogs/2023/02/dc-circuit-holds-cfpb-did-not-exceed-statutory-authority-with-the-prepaid-rule,2023-02-14
New York Finalizes Commercial Financing Disclosure Regulations,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_14-new-york-finalizes-commercial-financing,2023-02-14
A Better Liquidity Feature for Non-Traded REITs: Share Repurchase Plans and the Next Frontier,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_13-a-better-liquidity-feature-for-nontraded,2023-02-13
2022 Year in Review: Digital Currency and Blockchain Litigation and Enforcement Developments,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_13-2022-year-in-review-digital-currency-and-blockchain,2023-02-13
SEC to Enhance Its Regulation of Security-Based Swaps,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_10-sec-to-enhance-its-regulation-of-security-based-swaps,2023-02-13
CFPB Advises Manipulating Search Results on Comparison-Shopping Platforms May Violate RESPA,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_10-weekly-roundup,2023-02-10
Court Dismisses CFPB’s ECOA Action Alleging Discrimination Against Prospective Applicants Against Nonbank Lender,https://www.goodwinlaw.com/en/insights/blogs/2023/02/court-dismisses-cfpbs-ecoa-action-alleging-discrimination-against-prospective-applicants-against-non,2023-02-09
Understanding Data Monitoring Committee Conflict of Interest Limitations,https://www.goodwinlaw.com/en/insights/blogs/2023/02/understanding-data-monitoring-committee-conflict-of-interest-limitations,2023-02-09
Peer-to-Peer Lender Agrees to Pay $18 Million to Settle FTC Suit,https://www.goodwinlaw.com/en/insights/blogs/2023/02/peer-to-peer-lender-agrees-to-pay-$18-million-to-settle-ftc-suit,2023-02-09
SEC Examinations Division Publishes 2023 Priorities Letter,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-examinations-division-publishes-2023-priorities-letter,2023-02-09
SEC Examinations Division Publishes 2023 Priorities Letter,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_09-sec-examinations-division-publishes-2023-priorities-letter,2023-02-09
SEC EXAMS Division Publishes Reg. BI Risk Alert,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-exams-division-publishes-reg-bi-risk-alert,2023-02-08
FINRA 2023 Examination and Risk Monitoring Report Highlights Numerous Risk Areas for Brokers,https://www.goodwinlaw.com/en/insights/blogs/2023/02/finra-2023-examination-and-risk-monitoring-report-highlights-numerous-risk-areas-for-brokers,2023-02-08
"Broker-Dealer Compliance With Revamped Recordkeeping Requirements Begins May 3, 2023; FINRA Publishes Chart of “Most Significant Changes”",https://www.goodwinlaw.com/en/insights/blogs/2023/02/brokerdealer-compliance-with-revamped-recordkeeping-requirements-begins-may-3-2023-finra-publishes-c,2023-02-08
"FINRA Reminds Firms of Trusted Contact Person Requirement, Benefits, and Related Effective Practices",https://www.goodwinlaw.com/en/insights/blogs/2023/02/finra-reminds-firms-of-trusted-contact-person-requirement-benefits-and-related-effective-practices,2023-02-08
"SEC “Gift” to the Industry: Four Market Structure Proposals, 3-2 Votes (In Part), but No Partridge in a Pear Tree",https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-gift-to-the-industry-four-market-structure-proposals-32-votes-in-part-but-no-partridge-in-a-pear,2023-02-08
SEC EXAMS Division Issues Reg. S-ID Risk Alert,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-exams-division-issues-reg-sid-risk-alert,2023-02-08
Massachusetts AG Enters Into $7.6 Million Settlement With Auto Dealer,https://www.goodwinlaw.com/en/insights/blogs/2023/02/massachusetts-ag-enters-into-76-million-settlement-with-auto-dealer,2023-02-08
Private Fund Sponsors Remain in Spotlight of the SEC’s Examination Priorities,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_08-private-fund-sponsors-remain-in-spotlight,2023-02-08
The UK Consumer Duty: The FCA’s Reminder for Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_08-the-uk-consumer-duty,2023-02-08
New Federal M&A Broker Exemption is a Big Deal!,https://www.goodwinlaw.com/en/insights/blogs/2023/02/new-federal-ma-broker-exemption-is-a-big-deal,2023-02-07
SEC Regulatory Agenda Showcases 52 Proposed and Final Rules by Spring 2023,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-regulatory-agenda-showcases-52-proposed-and-final-rules-by-spring-2023,2023-02-07
SEC Staff Risk Alert Criticizes Broker-Dealer Reports on Best Execution and Payment for Order Flow,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-staff-risk-alert-criticizes-broker-dealer-reports-on-best-execution-and-payment-for-order-flow,2023-02-07
FINRA Provides Update on Options Account Opening and Trading Sweep Exam Findings,https://www.goodwinlaw.com/en/insights/blogs/2023/02/finra-provides-update-on-options-account-opening-and-trading-sweep-exam-findings,2023-02-07
FINRA Exam Targets Broker Crypto Asset Communications,https://www.goodwinlaw.com/en/insights/blogs/2023/02/finra-exam-targets-broker-crypto-asset-communications,2023-02-07
FINRA Sheds Light on Path to Digital Asset Security Broker Registration,https://www.goodwinlaw.com/en/insights/blogs/2023/02/finra-sheds-light-on-path-to-digital-asset-security-broker-registration,2023-02-07
SEC Announces Record-Breaking Penalties and a 9% increase in total number of Enforcement Actions in FY 2022,https://www.goodwinlaw.com/en/insights/blogs/2023/02/sec-announces-recordbreaking-penalties-and-a-9-increase-in-total-number-of-enforcement-actions-in-fy,2023-02-07
European Biosimilar Regulatory Updates,https://www.goodwinlaw.com/en/insights/blogs/2023/02/european-biosimilar-regulatory-updates,2023-02-06
"In the Metaverse, Existing Healthcare Rules Apply",https://www.goodwinlaw.com/en/insights/publications/2023/02/02_06-in-the-metaverse-existing-healthcare-rules-apply,2023-02-06
Telehealth Issues to Watch in 2023,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_06-telehealth-issues-to-watch-in-2023,2023-02-06
EU Technology Regulation: Watch List for 2023 and Beyond,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_06-eu-technology-regulation-watch-list-for-2023,2023-02-06
"ISDA Publishes New Digital Asset Definitions, White Paper on Navigating Bankruptcy in Digital Asset Markets",https://www.goodwinlaw.com/en/insights/blogs/2023/02/isda-publishes-new-digital-asset-definitions-white-paper-on-navigating-bankruptcy-in-digital-asset-m,2023-02-03
"ISDA Publishes New Digital Asset Definitions, White Paper on Navigating Bankruptcy in Digital Asset Markets",https://www.goodwinlaw.com/en/insights/publications/2023/02/02_03-isda-publishes-new-digital-asset-definitions,2023-02-03
Regulators Align in Their Focus on Digital Advertising,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_03-regulators-align-in-their-focus-on-digital-advertising,2023-02-03
SEC EXAMS Division Publishes Reg. BI Risk Alert,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_02-sec-exams-division-publishes-reg-bi-risk-alert,2023-02-02
Federal Reserve Issues Policy Statement on Section 9(13) of the Federal Reserve Act,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_03-weekly-roundup,2023-02-02
Celltrion’s Anticancer Biosimilar Debuts in Japan,https://www.goodwinlaw.com/en/insights/blogs/2023/02/celltrions-anticancer-biosimilar-debuts-in-japan,2023-02-01
Amgen Launches AMJEVITA—First Biosimilar to HUMIRA in the United States,https://www.goodwinlaw.com/en/insights/blogs/2023/02/amgen-launches-amjevitafirst-biosimilar-to-humira-in-the-united-states,2023-02-01
Federal Court of Appeals Rejects HHS Stance on Section 340B Contract Pharmacies,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_01-federal-court-of-appeals-rejects-hhs-stance,2023-02-01
FINRA 2023 Examination and Risk Monitoring Report Highlights Numerous Risk Areas for Brokers,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_01-finra-2023-examination-and-risk-monitoring,2023-02-01
Delaware Court of Chancery Clarifies That Fiduciary ‘Duty of Oversight’ Applies to Officers and Extends Fiduciary Duty Claims to Include Sexual Harassment,https://www.goodwinlaw.com/en/insights/publications/2023/02/02_01-securities-snapshot,2023-02-01
AIFMD II Gathers Momentum: The European Parliament Finalises Its Proposed Text,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_31-aifmd-ii-gathers-momentum,2023-01-31
CFPB Seeks Dismissal of Complaint Filed by the U.S. Chamber of Commerce Challenging the CFPB’s Update to the UDAAP Section of Its Examination Manual,https://www.goodwinlaw.com/en/insights/blogs/2023/01/cfpb-seeks-dismissal-of-complaint-filed-by-the-us-chamber-of-commerce-challenging-the-cfpbs-update-t,2023-01-30
California Attorney General Announces Focus on Mobile Apps,https://www.goodwinlaw.com/en/insights/blogs/2023/01/california-attorney-general-announces-focus-on-mobile-apps,2023-01-30
FDA Commissioner Delivers Remarks at FDA-U.S. Patent and Trademark Office Public Workshop,https://www.goodwinlaw.com/en/insights/blogs/2023/01/fda-commissioner-delivers-remarks-at-fdaus-patent-and-trademark-office-public-workshop,2023-01-30
"Delaware Court of Chancery Finds for the First Time That Officers’ Fiduciary Duties Include Caremark Duty of Oversight, and That Sexual Harassment Is a Breach of the Duty of Loyalty",https://www.goodwinlaw.com/en/insights/publications/2023/01/01_30-delaware-court-of-chancery-finds,2023-01-30
Celltrion Files IPR Petition on Aflibercept Patent,https://www.goodwinlaw.com/en/insights/blogs/2023/01/celltrion-files-ipr-petition-on-aflibercept-patent,2023-01-27
Cannabis Marketing Proposed Regulations in New York & Neighboring States (Bloomberg Law),https://www.goodwinlaw.com/en/news-and-events/news/2023/01/01_27-cannabis-marketing-proposed-regulations-in-new-york,2023-01-27
Top 5 Compliance Issues for Medtech Firms Transitioning To Data-Enabled Solutions (MedCity News),https://www.goodwinlaw.com/en/news-and-events/news/2023/01/01_27-top-5-compliance-issues-for-medtech-firms,2023-01-27
New Federal M&A Broker Exemption is a Big Deal!,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_27-new-federal-ma-broker-exemption,2023-01-27
FinCEN Proposes Form of Report to Collect Beneficial Ownership Information and Application to Obtain FinCEN Identifiers,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_26-weekly-roundup,2023-01-26
"CMS Issues First Request for Public Comments on the Medicare Drug Price Negotiation Program “Small Biotech” Exception – Due March 27, 2023",https://www.goodwinlaw.com/en/insights/publications/2023/01/01_26-cms-issues-first-request-for-public-comments,2023-01-26
Exempt Reporting Advisers Faced Significantly More SEC Enforcements in 2022,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_25-exempt-reporting-advisers-sec-enforcements,2023-01-26
"An Interview with Rachel Goode, Ph.D, about Biological Patent Thickets",https://www.goodwinlaw.com/en/insights/blogs/2023/01/an-interview-with-rachel-goode-phd-about-biological-patent-thickets,2023-01-25
"European Top Court Confirms Companies Need to Name “Recipients” of Personal Data When Responding to Access Requests, Not Just Categories",https://www.goodwinlaw.com/en/insights/blogs/2023/01/european-top-court-confirms-companies-need-to-name-recipients-of-personal-data-when-responding-to-ac,2023-01-25
Alvotech and Bioventure Announce Approval of ADALIMUMAB Biosimilar in Saudi Arabia,https://www.goodwinlaw.com/en/insights/blogs/2023/01/alvotech-and-bioventure-announce-approval-of-adalimumab-biosimilar-in-saudi-arabia,2023-01-25
2023 HSR Thresholds Announced: $111.4 million,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_23-2023-hsr-thresholds-announced,2023-01-24
"Broker-Dealer Compliance With Revamped Recordkeeping Requirements Begins May 3, 2023; FINRA Publishes Chart of “Most Significant Changes”",https://www.goodwinlaw.com/en/insights/publications/2023/01/01_23-broker-dealer-compliance-with-revamped,2023-01-23
"6 Predictions, 6 Attorneys – Goodwin’s 2023 Data, Privacy & Cybersecurity Outlook",https://www.goodwinlaw.com/en/insights/blogs/2023/01/6-predictions-6-attorneys--goodwins-2023-data-privacy--cybersecurity-outlook,2023-01-20
Genentech and Tanvex Reach Settlement in Principle in Trastuzumab BPCIA Litigation,https://www.goodwinlaw.com/en/insights/blogs/2023/01/genentech-and-tanvex-reach-settlement-in-principle-in-trastuzumab-bpcia-litigation,2023-01-20
Transfer-on-Death Designations: Potential Pitfalls,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_20-transfer-on-death-designations-potential,2023-01-20
Implications of Abortion Laws for Fertility Services,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_20-implications-of-abortion-laws-for-fertility-services,2023-01-20
Chinese Market Biosimilar Update,https://www.goodwinlaw.com/en/insights/blogs/2023/01/chinese-market-biosimilar-update,2023-01-19
SEC Regulatory Agenda Showcases 52 Proposed and Final Rules by Spring 2023,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_19-sec-regulatory-agenda-showcases-52-proposed,2023-01-19
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2023/01/newsletters-practices-df-debt-download-011923,2023-01-19
USPTO Launches the Cancer Moonshot Expedited Examination Pilot Program,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_18-uspto-launches-the-cancer-moonshot,2023-01-18
CFPB Proposes Rule That Nonbanks Must Publicly Register with CFPB When They Use Certain Terms and Conditions in Form Contracts,https://www.goodwinlaw.com/en/insights/blogs/2023/01/cfpb-proposes-rule-that-nonbanks-must-publicly-register-with-cfpb-when-they-use-certain-terms-and-co,2023-01-17
France enacts the Finance Law for 2023,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_13-finance-law-for-2023,2023-01-17
"Goodwin Wins Dismissal of Putative Securities Class Action for Citrix Systems, Inc.",https://www.goodwinlaw.com/en/insights/publications/2023/01/01_17--securities-snapshot,2023-01-17
Celltrion Obtains Canadian Approval To Sell Bevacizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/01/celltrion-obtains-canadian-approval-to-sell-bevacizumab-biosimilar,2023-01-13
PTAB Institutes Mylan’s Two EYLEA (aflibercept) IPRs,https://www.goodwinlaw.com/en/insights/blogs/2023/01/ptab-institutes-mylans-two-eylea-aflibercept-iprs,2023-01-13
"Alvotech and Teva Announce Acceptance of BLA for AVT04, a Proposed Biosimilar to STELARA (ustekinumab)",https://www.goodwinlaw.com/en/insights/blogs/2023/01/alvotech-and-teva-announce-acceptance-of-bla-for-avt04-a-proposed-biosimilar-to-stelara-ustekinumab,2023-01-13
Alvotech Initiates Study of Biosimilar of J&J’s Rheumatoid Arthritis Drug SIMPONI,https://www.goodwinlaw.com/en/insights/blogs/2023/01/alvotech-initiates-study-of-biosimilar-of-jjs-rheumatoid-arthritis-drug-simponi,2023-01-13
Coherus Agrees to Acquire a Biosimilar EYLEA Candidate from Klinge Biopharma,https://www.goodwinlaw.com/en/insights/blogs/2023/01/coherus-agrees-to-acquire-a-biosimilar-eylea-candidate-from-klinge-biopharma,2023-01-13
CFPB Reaches Proposed Settlement With Financial Service Company for Allegedly Offering Fake High-Yield Bank Accounts,https://www.goodwinlaw.com/en/insights/blogs/2023/01/cfpb-reaches-proposed-settlement-with-financial-service-company-for-allegedly-offering-fake-highyiel,2023-01-12
SEC Staff Issues Important New Guidance on Presentation of Investment-Level Performance Under the Marketing Rule,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_12-sec-staff-issues-important-new-guidance,2023-01-12
FinCEN Issues NPRM Regarding Access to Beneficial Ownership Information and Related Safeguards,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_12-weekly-roundup,2023-01-12
Celltrion and Rani Therapeutics to Jointly Develop Oral Formulation of Ustekinumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2023/01/celltrion-and-rani-therapeutics-to-jointly-develop-oral-formulation-of-ustekinumab-biosimilar,2023-01-10
Deadline Approaching for Reporting 2022 ISO Exercises and ESPP Transfers,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_10-deadline-approaching-for-reporting-2022,2023-01-10
"New Swiss Data Protection Law Will Become Effective September 1st, 2023 – What You Need to Know",https://www.goodwinlaw.com/en/insights/blogs/2023/01/new-swiss-data-protection-law-will-become-effective-september-1st-2023--what-you-need-to-know,2023-01-09
Year in Review: Top Deals in 2022,https://www.goodwinlaw.com/en/insights/blogs/2023/01/year-in-review-top-deals-in-2022,2023-01-09
The European Commission Proposes to Extend the Transition Deadline in the EU Medical Device Regulation,https://www.goodwinlaw.com/en/insights/blogs/2023/01/the-european-commission-proposes-to-extend-the-transition-deadline-in-the-eu-medical-device-regulati,2023-01-09
"Crystal Ball Privacy in 2023: US States, Kids and AI",https://www.goodwinlaw.com/en/insights/blogs/2023/01/crystal-ball-privacy-in-2023-us-states-kids-and-ai,2023-01-06
Year in Review: Top Legal Developments of 2022,https://www.goodwinlaw.com/en/insights/blogs/2023/01/year-in-review-top-legal-developments-of-2022,2023-01-06
"Samsung Bioepis Announces Approval of Citrate-Free, High-Concentration Adalimumab Biosimilar in Canada",https://www.goodwinlaw.com/en/insights/blogs/2023/01/samsung-bioepis-announces-approval-of-citratefree-highconcentration-adalimumab-biosimilar-in-canada,2023-01-06
Who Owns Digital Assets When a Cryptocurrency Platform Files Bankruptcy? The Terms of Use Answer the Question,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_06-who-owns-digital-assets-when-a-cryptocurrency,2023-01-06
FTC Proposes a Sweeping Rule That Would Ban Nearly All US Noncompete Agreements,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_06-ftc-proposes-rule-ban-most-noncompete-agreements,2023-01-06
"FINRA Reminds Firms of Trusted Contact Person Requirement, Benefits, and Related Effective Practices",https://www.goodwinlaw.com/en/insights/publications/2023/01/01_05-finra-reminds-firms-of-trusted-contact-requirement,2023-01-05
The Remaining New Financial Promotion Rules for UK Private Fund Managers: Less Than a Month Away,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_04-the-remaining-new-financial-promotion-rules,2023-01-05
Insurtech Innovation in the Metaverse,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_03-insurtech-innovation-in-the-metaverse,2023-01-05
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2023/01/01_05-erisa-litigation-update,2023-01-05
Goodwin Presents on Hot Topics in 2023 and Beyond in the Healthcare Regulatory Environment at JP Morgan Healthcare Conference,https://www.goodwinlaw.com/en/insights/blogs/2023/01/goodwin-presents-on-hot-topics-in-2023-and-beyond-in-the-healthcare-regulatory-environment-at-jp-mor,2023-01-04
CFPB and New York AG Announce Joint Enforcement Action Against Auto Lender,https://www.goodwinlaw.com/en/insights/blogs/2023/01/cfpb-and-new-york-ag-announce-joint-enforcement-action-against-auto-lender,2023-01-04
New Appropriations Bill Reforms Antitrust Laws and Modifies HSR Fees,https://www.goodwinlaw.com/en/insights/publications/2023/01/01_04-new-appropriations-bill-reforms-antitrust-laws,2023-01-04
Banking on an Exemption: Do Universities Qualify as Financial Institutions Exempt from the Illinois Biometric Information Privacy Act?,https://www.goodwinlaw.com/en/insights/blogs/2023/01/banking-on-an-exemption-do-universities-qualify-as-financial-institutions-exempt-from-the-illinois-b,2023-01-03
Department of Labor Finalizes Amendments to Investment Duties Regulation,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_30-department-of-labor-finalizes,2023-01-03
Year in Review: Top Biosimilars-Related Regulatory Developments of 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/12/year-in-review--top-biosimilars-related-regulatory-developments-of-2022,2022-12-31
"Congress Expands Pathway for Drug & Device Manufacturers’ Pre-Approval Communication of Health Care Economic Information to Payors, Formularies, & Similar Entities",https://www.goodwinlaw.com/en/insights/blogs/2022/12/congress-expands-pathway-for-drug--device-manufacturers-preapproval-communication-of-health-care-eco,2022-12-29
"Congress Expands Pathway for Drug & Device Manufacturers’ Pre-Approval Communication of Health Care Economic Information to Payors, Formularies, & Similar Entities",https://www.goodwinlaw.com/en/insights/publications/2022/12/12_28-congress-expands-pathway,2022-12-28
Celltrion USA Announces Submission of BLA for Subcutaneous Infliximab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/12/celltrion-usa-announces-submission-of-bla-for-subcutaneous-infliximab-biosimilar,2022-12-24
"CFPB Enters Into $700,000 Consent Order With Remittance Company for Alleged EFTA and Reg E Violations",https://www.goodwinlaw.com/en/insights/blogs/2022/12/cfpb-enters-into-700000-consent-order-with-remittance-company-for-alleged-efta-and-reg-e-violations,2022-12-22
"Massachusetts AG Settles with Mortgage Servicer for $975,000",https://www.goodwinlaw.com/en/insights/blogs/2022/12/massachusetts-ag-settles-with-mortgage-servicer-for-975000,2022-12-22
Findings from the Final Evaluation Report on the Operation of the Permanent Measures in the UK Corporate Insolvency and Government Act,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_22-findings-from-the-final-evaluation-report,2022-12-22
REITs Should Review Disclosure of Non-GAAP Financial Measures Based on New SEC Staff Guidance,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_22-reits-should-review-disclosure,2022-12-22
BTI v. Sequana – What’s new for directors in the zone of insolvency?,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_22-bti-v-sequana-whats-new-for-directors,2022-12-22
CFPB Proposes Rule That Nonbanks Subject to Certain Public Orders Must Publicly Register with CFPB As a Means of Detecting “Repeat Offenders”,https://www.goodwinlaw.com/en/insights/blogs/2022/12/cfpb-proposes-rule-that-nonbanks-subject-to-certain-public-orders-must-publicly-register-with-cfpb-a,2022-12-21
CFPB Files Certiorari Petition With the U.S. Supreme Court Seeking Review of the Fifth Circuit’s Decision in Community Fin. Services,https://www.goodwinlaw.com/en/insights/blogs/2022/12/cfpb-files-certiorari-petition-with-the-us-supreme-court-seeking-review-of-the-fifth-circuits-decisi,2022-12-20
BPCIA Aflibercept Litigation:  Regeneron Files 12(c) Motion to Dismiss Mylan’s Counterclaim for Inequitable Conduct,https://www.goodwinlaw.com/en/insights/blogs/2022/12/bpcia-aflibercept-litigation-regeneron-files-12c-motion-to-dismiss-mylans-counterclaim-for-inequitab,2022-12-20
"Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2022-2023",https://www.goodwinlaw.com/en/insights/blogs/2022/12/now-available-updated-goodwins-guide-to-biosimilars-litigation-and-regulation-in-the-us-20222023,2022-12-20
Lessons from the First Universal Proxy Contest,https://www.goodwinlaw.com/en/insights/blogs/2022/12/lessons-from-the-first-universal-proxy-contest,2022-12-20
CFPB Reaches $3.7 Billion Settlement With National Bank to Resolve Alleged UDAAP Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/12/cfpb-reaches-37-billion-settlement-with-national-bank-to-resolve-alleged-udaap-violations,2022-12-20
Proxy Statement Form Check,https://www.goodwinlaw.com/en/insights/blogs/2022/12/proxy-statement-form-check,2022-12-20
FCC Confirms “Ringless Voicemails” Are Subject to the TCPA,https://www.goodwinlaw.com/en/insights/blogs/2022/12/fcc-confirms-ringless-voicemails-are-subject-to-the-tcpa,2022-12-20
Key Compensation Considerations for Public Companies in a Market Downturn,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_19-key-compensation-considerations,2022-12-20
SEC Publishes New Non-GAAP Financial Measures Guidance as 2022 Year-End Reporting Season Approaches,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_20-sec-new-non-gaap-financial-measures-guidance,2022-12-20
New Corporate Reporting Requirements on Trusts and Other Estate Planning Vehicles,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_20-new-corporate-reporting-requirements,2022-12-20
Goodwin Wins Appeal of Certification of Nationwide Class in ERISA Lawsuit,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_20-securities-snapshot,2022-12-20
FDA Accepts Biogen’s aBLA for Tocilizumab,https://www.goodwinlaw.com/en/insights/blogs/2022/12/fda-accepts-biogens-abla-for-tocilizumab,2022-12-17
Decision Time: The Unified Patent Court Begins in 2023,https://www.goodwinlaw.com/en/insights/blogs/2022/12/decision-time-the-unified-patent-court-begins-in-2023,2022-12-16
SEC Adopts Amendments to Rules Governing Rule 10b5-1 Trading Plans,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_16-sec-adopts-amendments-to-rules,2022-12-16
USPTO Announces Cancer Moonshot Expedited Examination Program,https://www.goodwinlaw.com/en/insights/blogs/2022/12/uspto-announces-cancer-moonshot-expedited-examination-program,2022-12-15
EU Commission Publishes Draft Adequacy Decision on Privacy Shield 2.0,https://www.goodwinlaw.com/en/insights/blogs/2022/12/eu-commission-publishes-draft-adequacy-decision-on-privacy-shield-20,2022-12-15
OCC Reports on Key Risks Facing Federal Banking System,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_15-weekly-roundup,2022-12-15
Decision Time: The Unified Patent Court Begins in 2023,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_15-decision-time-the-unified-patent-court,2022-12-15
"SEC ""Gift"" to the Industry: Four Market Structure Proposals, 3-2 Votes (In Part), but No Partridge in a Pear Tree",https://www.goodwinlaw.com/en/insights/publications/2022/12/12_15-sec-gift-to-the-industry,2022-12-15
Commercial Leasing in Massachusetts: Commercial Landlord Cannot Collect Accelerated Rent as Liquidated Damages and Rent From New Tenant,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_15-commercial-leasing-in-massachusetts,2022-12-15
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2022/12/newsletters-practices-df-debt-download-121522,2022-12-15
Fresenius Kabi Announces FDA Approval of Adalimumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/12/fresenius-kabi-announces-fda-approval-of-adalimumab-biosimilar,2022-12-14
Colorado Attorney General Reaches Settlement with Affiliated Lender and Debt Management Company,https://www.goodwinlaw.com/en/insights/blogs/2023/01/colorado-attorney-general-reaches-settlement-with-affiliated-lender-and-debt-management-company,2022-12-14
SEC EXAMS Division Issues Reg. S-ID Risk Alert,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_13-sec-exams-division-issues,2022-12-14
BPCIA Aflibercept Litigation: Mylan Seeks Leave to Add a Declaratory Judgment Counterclaim of No Lost Profits or Injunctive Relief,https://www.goodwinlaw.com/en/insights/blogs/2022/12/bpcia-aflibercept-litigation--mylan-seeks-leave-to-add-a-declaratory-judgment-counterclaim-of-no-los,2022-12-13
SEC Staff Risk Alert Criticizes Broker-Dealer Reports on Best Execution and Payment for Order Flow,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_13-sec-staff-risk-alert-criticizes-broker,2022-12-13
Regeneron Files Expedited Motion Challenging Mylan’s Designation of Entire aBLA Production as Outside Counsel’s Eyes Only,https://www.goodwinlaw.com/en/insights/blogs/2022/12/regeneron-files-expedited-motion-challenging-mylans-designation-of-entire-abla-production-as-outside,2022-12-12
LA Measure ULA: A New Real Estate Transfer Tax on Residential and Commercial Properties Over $5 Million,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_09-la-measure-ula,2022-12-09
Alvotech Broadens Access to HUMIRA (adalimumab) Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2022/12/alvotech-broadens-access-to-humira-adalimumab-biosimilars,2022-12-08
Federal Reserve Invites Public Comment on Proposed Principles for Large Banking Organizations to Manage Climate-Related Financial Risks,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_08-weekly-roundup,2022-12-08
FINRA Provides Update on Options Account Opening and Trading Sweep Exam Findings,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_08-finra-provides-update-on-options,2022-12-08
Updated Pay for Performance FAQs,https://www.goodwinlaw.com/en/insights/blogs/2022/12/updated-pay-for-performance-faqs,2022-12-07
Second Circuit Vacates Certification of Nationwide Class in ERISA Lawsuit,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_07-second-circuit-vacates-certification,2022-12-07
Issue 39: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_07-issue-39-ptab-trial-tracker,2022-12-07
"EU Standard Contractual Clauses Need Replacing by December 27, 2022",https://www.goodwinlaw.com/en/insights/blogs/2022/12/eu-standard-contractual-clauses-need-replacing-by-december-27-2022,2022-12-06
ISS and Glass Lewis Issue 2023 Policy Updates,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_06-iss-and-glass-lewis-issue,2022-12-06
"EU Standard Contractual Clauses Need Replacing by December 27, 2022",https://www.goodwinlaw.com/en/insights/publications/2022/12/12_06-eu-standard-contractual-clauses,2022-12-06
"FINRA, Nasdaq, and NYSE Warn Firms of Pump-and-Dump Schemes Following IPOs of Small-Cap Issuers",https://www.goodwinlaw.com/en/insights/publications/2022/12/12_05-finra-nasdaq-and-nyse-warn-firms,2022-12-05
Biocon Biologics Confirms Completion of Multi-Billion Dollar Acquisition of Viatris’ Global Biosimilars Business,https://www.goodwinlaw.com/en/insights/blogs/2022/12/biocon-biologics-confirms-completion-of-multibillion-dollar-acquisition-of-viatris-global-biosimilar,2022-12-02
Update on Celltrion’s Infliximab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/12/update-on-celltrions-infliximab-biosimilar,2022-12-02
DOL Finalizes Rule Opening Door to ESG Investing in Retirement Plans,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_01-weekly-roundup,2022-12-01
Frequently Asked Questions: Pay Versus Performance Final Rules,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_15-pay-versus-performance-final-rules,2022-12-01
“Good Faith” in Shareholders’ Agreements: What Does it Mean?,https://www.goodwinlaw.com/en/insights/publications/2022/12/12_01-good-faith-in-shareholders-agreements,2022-12-01
Janssen Files BPCIA Complaint Against Amgen Regarding Ustekinumab,https://www.goodwinlaw.com/en/insights/blogs/2022/11/janssen-files-bpcia-complaint-against-amgen-regarding-ustekinumab,2022-11-30
Form 10-K Form Check,https://www.goodwinlaw.com/en/insights/blogs/2022/11/form-10-k-form-check,2022-11-29
Amneal Launches RELEUKO (filgrastim-ayow) in the United States,https://www.goodwinlaw.com/en/insights/blogs/2022/11/amneal-launches-releuko-filgrastimayow-in-the-united-states,2022-11-23
USPTO and FDA Continue to Focus on Patent Quality in the Pharmaceutical Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/11/uspto-and-fda-continue-to-focus-on-patent-quality-in-the-pharmaceutical-industry,2022-11-23
SEC Adopts Amendments to Shareholder Reports and Advertising Rules,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_23-sec-adopts-amendments,2022-11-23
Avoiding Misbranding: Words Matter When Describing the Regulatory Status of 510(k) Cleared Devices and Registered Device Establishments,https://www.goodwinlaw.com/en/insights/blogs/2022/11/avoiding-misbranding-words-matter-when-describing-the-regulatory-status-of-510k-cleared-devices-and,2022-11-22
FDA Approves Eli Lilly’s REZVOGLAR As the Second Interchangeable Insulin Glargine,https://www.goodwinlaw.com/en/insights/blogs/2022/11/fda-approves-eli-lillys-rezvoglar-as-the-second-interchangeable-insulin-glargine,2022-11-22
FINRA Exam Targets Broker Crypto Asset Communications,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_22-finra-exam-targets-brokers-crypto,2022-11-22
London’s Efforts to Facilitate Secondary Capital Raisings Continue: UK Pre-emption Group Issues Updated Statement of Principles,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_22-londons-efforts-to-facilitate-secondary,2022-11-22
Pennsylvania AG Sues Lead Generators For Deceptive Ads,https://www.goodwinlaw.com/en/insights/blogs/2022/11/pennsylvania-ag-sues-lead-generators-for-deceptive-ads,2022-11-21
FINRA Sheds Light on Path to Digital Asset Security Broker Registration,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_21-finra-sheds-light-on-path-to-digital-asset,2022-11-21
NYDFS Escalates and Expands Cybersecurity Enforcement,https://www.goodwinlaw.com/en/insights/blogs/2022/11/nydfs-escalates-and-expands-cybersecurity-enforcement,2022-11-18
CFPB Enters into $5.25 Million Consent Order with California Mortgage Servicer,https://www.goodwinlaw.com/en/insights/blogs/2022/11/cfpb-enters-into-525-million-consent-order-with-california-mortgage-servicer,2022-11-18
SEC Announces Record-Breaking Penalties and a 9% increase in total number of Enforcement Actions in FY 2022,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_18-sec-announces-record-breaking-penalties,2022-11-18
SEC Rulemaking & Corporate Governance Developments,https://www.goodwinlaw.com/en/insights/blogs/2022/11/sec-rulemaking--corporate-governance-developments,2022-11-17
The UK’s MHRA Updates its Guidance on Licensing of Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2022/11/the-uks-mhra-updates-its-guidance-on-licensing-of-biosimilars,2022-11-17
Five Key Regulatory Considerations for Virtual Ketamine Clinics,https://www.goodwinlaw.com/en/insights/blogs/2022/11/five-key-regulatory-considerations-for-virtual-ketamine-clinics,2022-11-17
New Costs For Landlords Due To Carbon Dioxide Cost Allocation Act,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_17-new-costs-for-landlords,2022-11-17
Debt Download,https://www.goodwinlaw.com/en/insights/newsletters/2022/11/newsletters-practices-df-debt-download-111722,2022-11-17
CFPB Issues Guidance on Investigation Practices by Consumer Reporting Agencies,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_17-weekly-roundup,2022-11-17
International Biosimilar Market Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/11/international-biosimilar-market-updates,2022-11-16
Five Key Regulatory Considerations for Virtual Ketamine Clinics,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_16-five-key-regulatory-considerations,2022-11-16
Pro Bono Prose: Tina Zakhary,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_16-pro-bono-prose-tina-zakhary,2022-11-16
Delaware Court of Chancery Holds Buzzfeed Not Bound by Pre-SPAC Merger Employment Agreements,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_16-securities-snapshot,2022-11-16
Organon Launches HERCEPTIN and AVASTIN Biosimilars in Canada,https://www.goodwinlaw.com/en/insights/blogs/2022/11/organon-launches-herceptin-and-avastin-biosimilars-in-canada,2022-11-15
FINRA Urges Firms to Focus on Succession Planning,https://www.goodwinlaw.com/en/insights/blogs/2022/11/finra-urges-firms-to-focus-on-succession-planning,2022-11-15
SEC Revamps Broker-Dealer Recordkeeping Requirements; “Audit Trail” Alternative Replaces “WORM” Format,https://www.goodwinlaw.com/en/insights/blogs/2022/11/sec-revamps-brokerdealer-recordkeeping-requirements-audit-trail-alternative-replaces-worm-format,2022-11-15
FINRA Focused on Registered Reps Named as Beneficiaries and Trustees for Customer Accounts,https://www.goodwinlaw.com/en/insights/blogs/2022/11/finra-focused-on-registered-reps-named-as-beneficiaries-and-trustees-for-customer-accounts,2022-11-15
FINRA on Reg. BI Compliance: There is “No One-Size Fits All” Approach,https://www.goodwinlaw.com/en/insights/blogs/2022/11/finra-on-reg-bi-compliance-there-is-no-onesize-fits-all-approach,2022-11-15
SEC and CFTC Send Powerful Message with $2 Billion in Fines Related to Social Media and Text Recordkeeping Lapses,https://www.goodwinlaw.com/en/insights/blogs/2022/11/sec-and-cftc-send-powerful-message-with-2-billion-in-fines-related-to-social-media-and-text-recordke,2022-11-15
Employee Benefits Post-Dobbs Considerations for Year-End Planning,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_15-employee-benefits-post-dobbs,2022-11-15
FINRA Urges Firms to Focus on Succession Planning,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_15-finra-urges-firms-to-focus-on,2022-11-15
New Risk Warning Rules for UK Private Fund Managers: Action Required,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_15-new-risk-warning-rules,2022-11-15
Goodwin REIT Alert: REIT Disclosure Requirements When Acquiring or Disposing of Real Estate Operations,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_15-goodwin-reit-alert,2022-11-15
China Approves World’s First Denosumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/11/china-approves-worlds-first-denosumab-biosimilar,2022-11-14
A Long-Awaited Privacy Measure Finally Becomes Law in Indonesia,https://www.goodwinlaw.com/en/insights/blogs/2022/11/a-long-awaited-privacy-measure-finally-becomes-law-in-indonesia,2022-11-14
STADA and Xbrane Announce Approval of Ranibizumab Biosimilar in Europe,https://www.goodwinlaw.com/en/insights/blogs/2022/11/stada-and-xbrane-announce-approval-of-ranibizumab-biosimilar-in-europe,2022-11-13
PTAB Issues Final Written Decisions Finding Claims of Regeneron’s Aflibercept Patents Invalid,https://www.goodwinlaw.com/en/insights/blogs/2022/11/ptab-issues-final-written-decisions-finding-claims-of-regenerons-aflibercept-patents-invalid,2022-11-11
Federal Trade Commission Issues Expansive New Policy Statement Regarding Enforcement Powers Under Section 5 of the FTC Act,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_11-federal-trade-commission-issues-expansive,2022-11-11
SEC Adopts Proxy Reporting Rule and Form Amendments,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_11-sec-adopts-proxy-reporting,2022-11-11
Antitrust & Competition Life Sciences Quarterly Update Q3 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/11/antitrust--competition-life-sciences-quarterly-update-q3-2022,2022-11-10
PTAB Grants Petitioner Celltrion’s Motion To Submit Supplemental Information in Tocilizumab IPR,https://www.goodwinlaw.com/en/insights/blogs/2022/11/ptab-grants-petitioner-celltrions-motion-to-submit-supplemental-information-in-tocilizumab-ipr,2022-11-10
California Expands Pay Data Reporting Obligations for Large Employers,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_10-california-expands-pay-data,2022-11-10
Federal Reserve Invites Public Comment on Proposal to Publish Periodic List of Depository Institutions That Have Access to Federal Reserve Accounts,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_10-federal-reserve-invites-public-comment-on,2022-11-10
Antitrust & Competition Healthcare Quarterly Update Q3 2022,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_10-antitrust-competition-healthcare,2022-11-10
FDA Announces Total Product Life Cycle Advisory Program (TAP) Pilot,https://www.goodwinlaw.com/en/insights/blogs/2022/11/fda-announces-total-product-life-cycle-advisory-program-tap-pilot,2022-11-09
Request for Comments on USPTO-FDA Collaboration Initiatives to Promote Generic Drug and Biosimilar Competition,https://www.goodwinlaw.com/en/insights/blogs/2022/11/request-for-comments-on-usptofda-collaboration-initiatives-to-promote-generic-drug-and-biosimilar-co,2022-11-09
"No Green Wave This Time, But Two More States Legalize Adult-Use Cannabis",https://www.goodwinlaw.com/en/insights/publications/2022/11/11_09-no-green-wave-this-time,2022-11-09
Antitrust & Competition Life Sciences Quarterly Update Q3 2022,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_09-antitrust-competition-life-sciences,2022-11-09
Antitrust & Competition Technology Quarterly Update Q3 2022,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_10-antitrust-competition-technology-quarterly,2022-11-09
FDA Announces Total Product Life Cycle Advisory Program (TAP) Pilot,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_08-fda-announces-total-product-life-cycle,2022-11-08
Similis Bio and Blau Farmaceutica Enter into Development and License Agreement for Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2022/11/similis-bio-and-blau-farmaceutica-enter-into-development-and-license-agreement-for-biosimilars,2022-11-07
SEC Proposes Regulatory Changes to Open-End Fund Liquidity Requirements,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_07-sec-proposes-regulatory-changes,2022-11-07
Mylan Files IPR on Regeneron Aflibercept Patent,https://www.goodwinlaw.com/en/insights/blogs/2022/11/mylan-files-ipr-on-regeneron-aflibercept-patent,2022-11-04
Supreme Court Grants Cert to Address Enablement in Amgen Case,https://www.goodwinlaw.com/en/insights/blogs/2022/11/supreme-court-grants-cert-to-address-enablement-in-amgen-case,2022-11-04
Breach of Contract and Implied Covenant of Good Faith Claims Survive Motion to Dismiss in Boardriders Uptier Exchange Dispute,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_04-breach-of-contract-and-implied-covenant,2022-11-04
AbbVie’s Q322 Earnings Call Highlights Oncoming Adalimumab Biosimilar Competition,https://www.goodwinlaw.com/en/insights/blogs/2022/11/abbvies-q322-earnings-call-highlights-oncoming-adalimumab-biosimilar-competition,2022-11-03
Fifth Circuit Issues Decision Holding that the Funding Mechanism for the Consumer Financial Protection Bureau Is Unconstitutional,https://www.goodwinlaw.com/en/insights/blogs/2022/11/fifth-circuit-issues-decision-holding-that-the-funding-mechanism-for-the-consumer-financial-protecti,2022-11-03
SEC Proposes New Rule Addressing Outsourcing by Investment Advisers,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_03-weekly-roundup,2022-11-03
New California Pay Transparency Law Expands Requirement to Disclose Pay Ranges,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_03-new-california-pay-transparency-law,2022-11-03
"SEC Revamps Broker-Dealer Recordkeeping Requirements; ""Audit Trail"" Alternative Replaces ""WORM"" Format",https://www.goodwinlaw.com/en/insights/publications/2022/11/11_03-sec-revamps-broker-deal-recordkeeping,2022-11-03
Top 10 Commercial & IP Tips for Start-Ups,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_03-top-10-commercial-ip-tips-for-startups,2022-11-03
FDA Accepts Outlook Therapeutics’ BLA for Ophthalmic Bevacizumab,https://www.goodwinlaw.com/en/insights/blogs/2022/11/fda-accepts-outlook-therapeutics-bla-for-ophthalmic-bevacizumab,2022-11-02
FINRA Focused on Registered Reps Named as Beneficiaries and Trustees for Customer Accounts,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_02-finra-focused-on-registered-reps,2022-11-02
Goodwin Wins Dismissal of Shareholder Derivative Suit for Failure to Allege Demand Was Excused,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_02-securities-snapshot,2022-11-02
Ninth Circuit Issues Two Significant TCPA Decisions Concerning Mixed-Use Cellphones and Statutory Damages Awards,https://www.goodwinlaw.com/en/insights/blogs/2022/11/ninth-circuit-issues-two-significant-tcpa-decisions-concerning-mixeduse-cellphones-and-statutory-dam,2022-11-01
Sweeping New US Export Controls Target China’s Semiconductor Industry,https://www.goodwinlaw.com/en/insights/publications/2022/11/11_01-sweeping-new-us-export-controls,2022-11-01
Regeneron Identifies Six Patents for Expedited Trial in BPCIA Aflibercept Case Against Mylan,https://www.goodwinlaw.com/en/insights/blogs/2022/10/regeneron-identifies-six-patents-for-expedited-trial-in-bpcia-aflibercept-case-against-mylan,2022-10-31
The Sustainability Disclosure Requirements and Investment Labels Rules: Tougher ESG Standards for UK Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_31-the-sustainability-disclosure-requirements,2022-10-31
DOL Proposes Rule Regarding Independent Contractor Status,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_31-dol-proposes-rule-regarding-independent,2022-10-31
SEC Adopts Final Rules Requiring Disclosure and Recovery of Erroneously Awarded Incentive-Based Compensation,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_31-sec-adopts-final-rules-requiring-disclosure,2022-10-31
CFPB Releases Supervisory Highlights Regarding Practices of Student Loan Servicers and University-Owned Lenders,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cfpb-releases-supervisory-highlights-regarding-practices-of-student-loan-servicers-and-universityown,2022-10-28
Expedited Trial Ordered in Regeneron Aflibercept BPCIA Case Against Mylan,https://www.goodwinlaw.com/en/insights/blogs/2022/10/expedited-trial-ordered-in-regeneron-aflibercept-bpcia-case-against-mylan,2022-10-28
Biogen Seeks a Preliminary Injunction in Natalizumab BPCIA Case Against Sandoz,https://www.goodwinlaw.com/en/insights/blogs/2022/10/biogen-seeks-a-preliminary-injunction-in-natalizumab-bpcia-case-against-sandoz,2022-10-27
Genentech Voluntarily Recalls SUSVIMO (ranibizumab),https://www.goodwinlaw.com/en/insights/blogs/2022/10/genentech-voluntarily-recalls-susvimo-ranibizumab,2022-10-27
United States: FTC Looks Set To Open Up New Enforcement Front (Global Competition Review),https://www.goodwinlaw.com/en/insights/blogs/2022/10/united-states-ftc-looks-set-to-open-up-new-enforcement-front-global-competition-review,2022-10-27
Pre-revenue Specialist Technology Companies May Soon List in Hong Kong,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_27-pre-revenue-specialist-technology,2022-10-27
FINRA Requests Comment on Its Machine-Readable Rulebook Initiative,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_27-weekly-roundup,2022-10-27
Clayton Act Questions for D&O Questionnaires,https://www.goodwinlaw.com/en/insights/blogs/2022/10/clayton-act-questions-for-do-questionnaires,2022-10-26
Earnings Release Checklist & Guide,https://www.goodwinlaw.com/en/insights/blogs/2022/10/earnings-release-checklist--guide,2022-10-26
Luxembourg Draft Budget Law 2023: The Most Awaited Reverse Hybrid Clarification,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_26-luxembourg-draft-budget-law-2023,2022-10-26
Request for Comments on USPTO Initiatives To Promote Generic Drug and Biosimilar Competition,https://www.goodwinlaw.com/en/insights/blogs/2022/10/request-for-comments-on-uspto-initiatives-to-promote-generic-drug-and-biosimilar-competition,2022-10-25
California Lawmakers Pass The Transformative Age Appropriate Design Code Act,https://www.goodwinlaw.com/en/insights/blogs/2022/10/california-lawmakers-pass-the-transformative-age-appropriate-design-code-act,2022-10-24
Biosimilars Licensing Agreement Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/10/biosimilars-licensing-agreement-updates,2022-10-21
FDA Issues Final Clinical Decision Support Software Guidance,https://www.goodwinlaw.com/en/insights/blogs/2022/10/fda-issues-final-clinical-decision-support-software-guidance,2022-10-20
Healthcare in a Post-Roe World,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_20-healthcare-in-a-post-roe-world,2022-10-20
Federal Reserve and FDIC Solicit Public Comments on Proposed Rulemaking Addressing Large Banks’ Financial Stability,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_20-weekly-roundup,2022-10-20
USPTO Doubles Down Calling Out Pharmaceutical Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/10/uspto-doubles-down-calling-out-pharmaceutical-industry,2022-10-19
Protecting Data in the Metaverse: Do Avatars Dream of Privacy?,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_19-protecting-data-in-the-metaverse,2022-10-19
Goodwin Secures Dismissal of Putative Securities Class Action for Plug Power Inc.,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_19-securities-snapshot,2022-10-19
"Crypto Lawyer Karen Ubell on Crypto Regulation, the SEC, and DAOs (Stronghold SpeakBold Fireside Chat)",https://www.goodwinlaw.com/en/insights/blogs/2022/10/crypto-lawyer-karen-ubell-on-crypto-regulation-the-sec-and-daos-stronghold-speakbold-fireside-chat,2022-10-18
FCA ESG Rules: The Next Deadline for U.K. Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_18-fca-esg-rules-the-next-deadline-for-uk,2022-10-18
Ten Action Items for Employers When Planning Layoffs,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_18-ten-action-items-for-employers,2022-10-18
FDA Issues Final Clinical Decision Support Software Guidance,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_17-fda-issues-final-clinical-decision,2022-10-17
Amgen Releases 2022 Biosimilar Trends Report,https://www.goodwinlaw.com/en/insights/blogs/2022/10/amgen-releases-2022-biosimilar-trends-report,2022-10-14
Extra Time in the Supreme Court,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_14-extra-time-in-the-supreme-court,2022-10-14
Goodwin Partner Mitzi Chang Featured on Hsu Untied Podcast,https://www.goodwinlaw.com/en/insights/blogs/2022/10/goodwin-partner-mitzi-chang-featured-on-hsu-untied-podcast,2022-10-13
FINRA on Reg. BI Compliance: There is “No One-Size Fits All” Approach,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_13-finra-on-reg-bi-compliance-there-is,2022-10-13
FinCEN Finalizes Rule Implementing Beneficial Ownership Reporting Requirements Under the CTA,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_13-weekly-roundup,2022-10-13
Recent and Proposed Legislation Affecting Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2022/10/recent-and-proposed-legislation-affecting-biosimilars,2022-10-12
FDA Releases Biosimilar User Fee Act Rates for Fiscal Year 2023,https://www.goodwinlaw.com/en/insights/blogs/2022/10/fda-releases-biosimilar-user-fee-act-rates-for-fiscal-year-2023,2022-10-11
North Carolina AG Enters Into $23 Million Settlement with Debt Collector,https://www.goodwinlaw.com/en/insights/blogs/2022/10/north-carolina-ag-enters-into-$23-million-settlement-with-debt-collector,2022-10-11
CFPB Issues Consent Order Against Money Transfer Company for Remittance Failures,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cfpb-issues-consent-order-against-money-transfer-company-for-remittance-failures,2022-10-11
Earnings Releases,https://www.goodwinlaw.com/en/insights/blogs/2022/10/earnings-releases,2022-10-11
Biogen Announces EMA Acceptance of Tocilizumab Biosimilar Application,https://www.goodwinlaw.com/en/insights/blogs/2022/10/biogen-announces-ema-acceptance-of-tocilizumab-biosimilar-application,2022-10-11
DOJ Intensifies Investigations Into Overlapping Board Membership and Senior Officers Between Competitors,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_11-doj-intensifies-investigations,2022-10-11
Issue 38: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_11-issue-38-ptab-trial-tracker,2022-10-11
Benefit Plan Considerations for Employers in a Market Downturn,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_11-benefit-plan-considerations-for-employers,2022-10-11
FinCEN Finalizes Rule Implementing Beneficial Ownership Reporting Requirements Under the Corporate Transparency Act,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_11-fincen-finalizes-rule,2022-10-11
UK Limited Partnership Legislative Reform Package Introduced in the Economic Crime and Corporate Transparency Bill,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_11-uk-limited-partnership-legislative-reform,2022-10-11
Do Directors Have a Duty to Consider the Interests of Creditors Prior to Insolvency?,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_10-do-directors-have-a-duty-to-consider,2022-10-10
"President Biden Announces a Three-Step Approach to Cannabis Reform: Federal Pardons, an Appeal to the States, and a Review of Cannabis Classification Under the Controlled Substances Act",https://www.goodwinlaw.com/en/insights/publications/2022/10/10_10-president-biden-announces,2022-10-10
President Biden Signs “Privacy Shield” Executive Order to Address European Concerns Over Surveillance Practices in the United States,https://www.goodwinlaw.com/en/insights/blogs/2022/10/president-biden-signs-privacy-shield-executive-ord,2022-10-07
"Goodwin Secures Dismissal of Putative Securities Class Action for Bellus Health, Inc.",https://www.goodwinlaw.com/en/insights/publications/2022/10/10_07-securities-snapshot,2022-10-07
President Biden Signs “Privacy Shield” Executive Order to Address European Concerns Over Surveillance Practices in the United States,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_07-president-biden-signs-privacy-shield,2022-10-07
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2022/10/10_06-erisa-litigation-update,2022-10-06
SEC and CFTC Send Powerful Message With $2 Billion in Fines Related to Social Media and Text Recordkeeping Lapses,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_06-sec-and-cftc-send-powerful-message,2022-10-06
Financial Stability Oversight Council Releases Report on Digital Asset Financial Stability Risks and Regulation,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_06-weekly-roundup,2022-10-06
CFTC Attempts To Extend Liability To DAO Participants,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cftc-attempts-to-extend-liability-to-dao-participa,2022-10-05
"U.S. Crypto Regulation: Less Conversation, More Action (International Financial Law Review)",https://www.goodwinlaw.com/en/insights/blogs/2022/10/us-crypto-regulation-less-conversation-more-action,2022-10-05
‘Our Rules Have To Evolve’: The Crypto Industry Is Trapped In Regulatory Purgatory (Fortune),https://www.goodwinlaw.com/en/insights/blogs/2022/10/our-rules-have-to-evolve-the-crypto-industry-is-tr,2022-10-05
CFTC Attempts to Extend Liability to DAO Participants,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_05-cftc-attempts-to-extend-liability,2022-10-05
The UK Consumer Duty: Next Steps For Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/10/10_05-the-uk-consumer-duty,2022-10-05
White House Crypto Framework Should Inform SEC Approach (Law360),https://www.goodwinlaw.com/en/insights/blogs/2022/10/white-house-crypto-framework-should-inform-sec-app,2022-10-04
Amneal Launches Bevacizumab Biosimilar in the United States,https://www.goodwinlaw.com/en/insights/blogs/2022/10/amneal-launches-bevacizumab-biosimilar-in-the-unit,2022-10-04
"CFPB Enters Into $950,000 Consent Order With Non-Bank Remittance Transfer Provider",https://www.goodwinlaw.com/en/insights/blogs/2022/10/cfpb-enters-into-950000-consent-order-with-nonbank-remittance-transfer-provider,2022-10-04
Buying A U.K. Crypto Business: The New Regulatory Hurdles,https://www.goodwinlaw.com/en/insights/blogs/2022/10/buying-a-uk-crypto-business-the-new-regulatory-hur,2022-10-04
Goodwin Expands Private Investment Funds Practice with Regulatory Partner in London,https://www.goodwinlaw.com/en/insights/blogs/2022/10/goodwin-expands-private-investment-funds-practice,2022-10-04
CFPB Issues Circular Confirming that Financial Companies May Violate Consumer Financial Protection Law by Failing to Protect Consumer Data,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cfpb-issues-circular-confirming-that-financial-companies-may-violate-consumer-financial-protection-l,2022-10-03
CFPB Issues Circular Confirming that Financial Companies May Violate Consumer Financial Protection Law by Failing to Protect Consumer Data,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cfpb-issues-circular-confirming-that-financial-com,2022-10-03
BD and IA Conflicts of Interest: SEC Staff Says Don’t Set It (Them) and Forget It (Them),https://www.goodwinlaw.com/en/insights/blogs/2022/10/bd-and-ia-conflicts-of-interest-sec-staff-says-don,2022-10-03
"NASAA (State Securities, Not Outer Space) Cautions Investors Exploring Opportunities in the Metaverse",https://www.goodwinlaw.com/en/insights/blogs/2022/10/nasaa-state-securities-not-outer-space-cautions-in,2022-10-03
CFTC Commissioner Romero Calls on Agency to Bring the “HEAT” in Enforcement Actions,https://www.goodwinlaw.com/en/insights/blogs/2022/10/cftc-commissioner-romero-calls-on-agency-to-bring,2022-10-03
New SEC “Marketing Rule” for Investment Advisers: Effect on Private Fund Placement Agents,https://www.goodwinlaw.com/en/insights/blogs/2022/10/new-sec-marketing-rule-for-investment-advisers-eff,2022-10-03
CFPB Launches Lawsuit Against Online Lender Alleging Violations of the Military Lending Act,https://www.goodwinlaw.com/en/insights/blogs/2022/09/cfpb-launches-lawsuit-against-online-lender-alleging-violations-of-the-military-lending-act,2022-09-30
Celltrion’s Bevacizumab Biosimilar Approved by FDA,https://www.goodwinlaw.com/en/insights/blogs/2022/09/celltrions-bevacizumab-biosimilar-approved-by-fda,2022-09-30
DOJ Cracking Down on Private Equity Interlocking Directorates Between Competing Portfolio Companies,https://www.goodwinlaw.com/en/insights/publications/2022/09/test-doj-cracking-down-on-private-equity,2022-09-30
SEC Enforcement Against Cheetah Mobile Execs Reflects Heightened Scrutiny of 10b5-1 Plans,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_29-sec-enforcement-against-cheetah-mobile-execs,2022-09-29
Federal Reserve Seeks Feedback on Proposed Updates to FMUs Risk Management Requirements,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_29-weekly-roundup,2022-09-29
SEC Sanctions Broker for Failure to Register as Municipal Advisor and for Inadequate Procedures to Ensure Registration: A Reminder for Brokers and Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_29-sec-sanctions-broker-for-failure-to-register,2022-09-29
EMA Adopts Positive Opinion for STADA and Xbrane’s Ranibuzumab Biosimilar Candidate XIMLUCI®,https://www.goodwinlaw.com/en/insights/blogs/2022/09/ema-adopts-positive-opinion-for-stada-and-xbranes,2022-09-28
CFPB Requires Bank to Pay Over $190 Million for Overdraft Fees,https://www.goodwinlaw.com/en/insights/blogs/2022/09/cfpb-requires-bank-to-pay-over-$190-million-for-overdraft-fees,2022-09-28
Public Companies: Time to Consider Repricing Underwater Stock Options?,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_28-public-companies-time-to-consider-repricing,2022-09-28
Lupin Announces Approval of ENBREL Biosimilar in Canada,https://www.goodwinlaw.com/en/insights/blogs/2022/09/lupin-announces-approval-of-enbrel-biosimilar-in-c,2022-09-27
Form 10-Q Form Check Table,https://www.goodwinlaw.com/en/insights/blogs/2022/09/form-10q-form-check-table,2022-09-27
Practical Guide to the Application of the Marketing Rule to Private Fund Placement Agents,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_28-practical-guide-to-the-application,2022-09-27
CFTC Commissioner Romero Calls on Agency to Bring the “HEAT” in Enforcement Actions,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_23-cftc-commissioner-romero-calls-on-agency,2022-09-26
Executive Order for Advancing Biotechnology and Biomanufacturing Innovation Signed by President Biden,https://www.goodwinlaw.com/en/insights/blogs/2022/09/executive-order-for-advancing-biotechnology-and-bi,2022-09-24
Formycon Announces Details for Pembrolizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/09/formycon-announces-details-for-pembrolizumab-biosi,2022-09-23
White House Crypto Framework Should Inform SEC Approach,https://www.goodwinlaw.com/en/insights/blogs/2022/09/white-house-crypto-framework-should-inform-sec-app,2022-09-23
"NASAA (State Securities, not Outer Space) Cautions Investors Exploring Opportunities in the Metaverse",https://www.goodwinlaw.com/en/insights/publications/2022/09/09_23-nasaa-cautions-investors,2022-09-23
UK Consultation on Sovereign Immunity from UK Direct Tax — Implications for Real Estate Investments,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_23-uk-consultation-on-sovereign-immunity,2022-09-23
SEC Proposes Rules to Improve Risk Management in Clearance and Settlement and to Facilitate Additional Central Clearing for the U.S. Treasury Market,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_22-weekly-roundup,2022-09-22
DOJ Cracking Down on Private Equity Interlocking Directorates Between Competing Portfolio Companies,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_22-doj-cracking-down-on-private-equity,2022-09-22
Back to Business: The FCA's 2022-23 Priorities for Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_21-fca-2022-23-priorities-private-fund-test,2022-09-21
SEC Sues and Settles Claim Against Investment Adviser Representative For “Cherry-Picking Scheme” After Entry of Cease and Desist Order Against the Investment Adviser,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_21-securities-snapshot,2022-09-21
Back to Business: the FCA's 2022-23 Priorities for Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_21-maryanntest-back-to-business,2022-09-21
DOJ Reaches $1.3 Million Settlement with Mortgage Lender for Allegedly Discriminatory Pricing Practices,https://www.goodwinlaw.com/en/insights/blogs/2022/09/doj-reaches-13-million-settlement-with-mortgage-lender-for-allegedly-discriminatory-pricing-practice,2022-09-20
European Regulatory Heads Make Biosimilars Interchangeable,https://www.goodwinlaw.com/en/insights/blogs/2022/09/european-regulatory-heads-make-biosimilars-interch,2022-09-20
3 Reasons Beauty Cos. Should Consider Pursuing Patents,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_20-3-reasons-beauty-cos,2022-09-20
Buying a UK Crypto Business: The New Regulatory Hurdles,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_20-buying-a-uk-crypto-business,2022-09-20
Private Companies: Time to Consider Repricing Underwater Stock Options?,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_19-whats-next-a-path-forward-in-uncertain-times,2022-09-19
Pay for Performance FAQs,https://www.goodwinlaw.com/en/insights/blogs/2022/09/pay-for-performance-faqs,2022-09-17
Genentech and Samsung Bioepis Settle Bevacizumab Biosimilar Patent Dispute,https://www.goodwinlaw.com/en/insights/blogs/2022/09/genentech-and-samsung-bioepis-settle-bevacizumab-b,2022-09-15
The 15-Minute Founder's Guide: Series A Financing Documents,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_14-the-15-minute-founders-guide,2022-09-15
OCC Releases Strategic Plan for Fiscal Years 2023-2027,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_15-weekly-roundup,2022-09-15
Apotex Files IPR Petition on Aflibercept Patent,https://www.goodwinlaw.com/en/insights/blogs/2022/09/apotex-files-ipr-petition-on-aflibercept-patent,2022-09-14
"Federal District Court Ruling May Jeopardize Insurance Coverage of More Than 50 Recommended Procedures, Screenings, and Treatments",https://www.goodwinlaw.com/en/insights/publications/2022/09/09_14-federal-district-court-ruling-may-jeopardize,2022-09-14
Regeneron Seeks Expedited Trial in BPCIA Case Against Mylan Regarding Aflibercept Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/09/regeneron-seeks-expedited-trial-in-bpcia-case-agai,2022-09-13
U.S. Attorney’s Office Settles False Claims Act Allegations with Paycheck Protection Program Lender,https://www.goodwinlaw.com/en/insights/blogs/2022/09/us-attorneys-office-settles-false-claims-act-allegations-with-paycheck-protection-program-lender,2022-09-13
SEC Sends Message to Private Fund Sponsors on Audit Obligations Under Custody Rule Through Enforcement Actions,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_13-sec-sends-message-to-private-fund-sponsors,2022-09-13
Biogen Files Sealed Complaint Against Sandoz and Polpharma Biologics Regarding Natalizumab,https://www.goodwinlaw.com/en/insights/blogs/2022/09/biogen-files-sealed-complaint-against-sandoz-and-p,2022-09-12
Restructuring and Insolvency in the Life Sciences Sector: Q&A,https://www.goodwinlaw.com/en/insights/blogs/2022/09/restructuring-and-insolvency-in-the-life-sciences,2022-09-12
Structuring for Success: Growth Equity Investors Adapt to Adjusting Valuations and a Tougher Economic Environment,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_12-growth-equity-investors-adapt-to-adjusting,2022-09-12
Fresenius Kabi Announces FDA Approval of Pegfilgrastim Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/09/fresenius-kabi-announces-fda-approval-of-pegfilgra,2022-09-09
Biocon and Alvotech Release Statements on FDA Inspections,https://www.goodwinlaw.com/en/insights/blogs/2022/09/biocon-and-alvotech-release-statements-on-fda-insp,2022-09-08
Foreign Private Issuers Presentation,https://www.goodwinlaw.com/en/insights/blogs/2022/09/foreign-private-issuers-presentation,2022-09-08
Back to Work: The FCA'S 2022-23 Priorities for Private Fund Managers,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_08-back-to-work-the-fcas,2022-09-08
Tanvex Answers Genentech’s Trastuzumab Complaint,https://www.goodwinlaw.com/en/insights/blogs/2022/09/tanvex-answers-genentechs-trastuzumab-complaint,2022-09-07
PTAB Institutes IPRs of Tocilzumab Patents Challenged by Celltrion,https://www.goodwinlaw.com/en/insights/blogs/2022/09/ptab-institutes-iprs-of-tocilzumab-patents-challen,2022-09-06
Central District of California Authorizes Service of John Doe Summons on Cryptocurrency Dealer,https://www.goodwinlaw.com/en/insights/blogs/2022/09/central-district-of-california-authorizes-service,2022-09-06
Late Filing Penalties Issued for the Non-fulfillment of the Luxembourg Real Estate Levy Reporting Obligation,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_06-late-filing-penalties-issued,2022-09-06
Abortion in a Post-Roe World,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_06-abortion-in-a-post-roe-world,2022-09-06
Outlook Therapeutics Re-Submits Its Ophthalmic Bevacizumab BLA,https://www.goodwinlaw.com/en/insights/blogs/2022/09/outlook-therapeutics-resubmits-its-ophthalmic-beva,2022-09-03
FTC Settles with Personal Finance Company for $3 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/09/ftc-settles-with-personal-finance-company-for-$3-million,2022-09-01
Amgen Announces Positive Top-Line Results from Phase 3 Study of Eculizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/09/amgen-announces-positive-topline-results-from-phas,2022-09-01
SEC Adopts Amendments to Whistleblower Program Rules,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_01-weekly-roundup,2022-09-01
Efforts to Elevate London as a Listing Venue of Choice for Growth Companies Continue - Publication of the UK Secondary Capital Raising Review,https://www.goodwinlaw.com/en/insights/publications/2022/09/09_01-efforts-to-elevate-london-as-a-listing-venue,2022-09-01
SEC Continues Scrutiny of Municipal Bond Offerings,https://www.goodwinlaw.com/en/insights/blogs/2022/08/sec-continues-scrutiny-of-municipal-bond-offerings,2022-08-31
The Sephora Case: Do Not Sell – But Are You Selling?,https://www.goodwinlaw.com/en/insights/blogs/2022/08/the-sephora-case-do-not-sell--but-are-you-selling,2022-08-31
Universal Proxy Developments: SEC Interpretations and ISS Special Situations Research Note,https://www.goodwinlaw.com/en/insights/blogs/2022/08/universal-proxy-developments-sec-interpretations-a,2022-08-30
SEC Adopts Final Rules Requiring Pay Versus Performance Disclosure in 2023 Proxy Statements,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_30-sec-adopts-final-rules-requiring-pay-versus,2022-08-30
Biosimilar Regulatory Approval Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/08/biosimilar-regulatory-approval-updates,2022-08-29
"Alvotech Initiates Confirmatory Patient Study for AVT03, a Proposed Denosumab Biosimilar",https://www.goodwinlaw.com/en/insights/blogs/2022/08/alvotech-initiates-confirmatory-patient-study-for,2022-08-26
FDIC Takes Action Against False or Misleading Crypto-Related Representations,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_25-weekly-roundup,2022-08-25
Central District of California Authorizes Service of John Doe Summons on Cryptocurrency Dealer,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_25-securities-snapshot,2022-08-25
ESG Themes in Proxy Contests & Shareholder Activism Campaigns,https://www.goodwinlaw.com/en/insights/blogs/2022/08/esg-themes-in-2022-shareholder-activism-campaigns,2022-08-23
"FDA Workshop on Sept. 19, 2022: Increasing the Efficiency of Biosimilar Development Programs",https://www.goodwinlaw.com/en/insights/blogs/2022/08/fda-workshop-on-sept-19-2022-increasing-the-effici,2022-08-23
Rulings Awaited Against Both Criteo and IAB Europe: Ongoing Uncertainty for Digital Advertising,https://www.goodwinlaw.com/en/insights/blogs/2022/08/rulings-awaited-against-both-criteo-and-iab-europe,2022-08-23
"Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free, High-Concentration Adalimumab Biosimilar",https://www.goodwinlaw.com/en/insights/blogs/2022/08/samsung-bioepis-and-organon-announce-fda-approval,2022-08-22
Congress Seeks to Protect Children by Allowing Parents and Regulators Access to What Minors Post and View on Social Media,https://www.goodwinlaw.com/en/insights/blogs/2022/08/congress-seeks-to-protect-children-by-allowing-par,2022-08-19
"CFPB Fines Bank for Accessing Customer Credit Reports and Opening Accounts, Credit Cards, and Lines of Credit Without Customers’ Permission",https://www.goodwinlaw.com/en/insights/blogs/2022/08/cfpb-fines-bank-for-accessing-customer-credit-repo,2022-08-18
"CFPB Fines Bank for Accessing Customer Credit Reports and Opening Accounts, Credit Cards, and Lines of Credit Without Customers’ Permission",https://www.goodwinlaw.com/en/insights/blogs/2022/08/cfpb-fines-bank-for-accessing-customer-credit-reports-and-opening-accounts-credit-cards-and-lines-of,2022-08-18
The FTC’s Privacy Rulemaking: Risks and Opportunities,https://www.goodwinlaw.com/en/insights/blogs/2022/08/the-ftcs-privacy-rulemaking-risks-and-opportunitie,2022-08-18
Formycon Announces Comparable Efficacy of Ustekinumab Biosimilar to Reference Product STELARA in Phase III Study,https://www.goodwinlaw.com/en/insights/blogs/2022/08/formycon-announces-comparable-efficacy-of-ustekinu,2022-08-18
Tillis Bill to Amend Section 101 of the Patent Act,https://www.goodwinlaw.com/en/insights/blogs/2022/08/tillis-bill-to-amend-section-101-of-the-patent-act,2022-08-18
The USPTO’s Increasing Focus on FDA Submissions and the Duty of Disclosure,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_18-the-usptos-increasing-focus,2022-08-18
BD and IA Conflicts of Interest: SEC Staff Says Don’t Set It (Them) and Forget It (Them),https://www.goodwinlaw.com/en/insights/publications/2022/08/08_18-bd-and-ia-conflicts-of-interest,2022-08-18
CFPB Publishes Circular Confirming Failure to Safeguard Consumer Data Could Be Unfair in Violation of CFPA,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_18-weekly-roundup,2022-08-18
FINRA Proposes Remote Inspection Pilot Program,https://www.goodwinlaw.com/en/insights/blogs/2022/08/finra-proposes-remote-inspection-pilot-program,2022-08-17
Adalimumab Clinical Trial Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/08/adalimumab-clinical-trial-updates,2022-08-17
TPC Bankruptcy and District Court Opinions Uphold Uptiering Transaction and Teach an Important Lesson on the Need for Express Lender Protections in Debt Documents,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_17-tpc-bankruptcy-and-district-court-opinions,2022-08-17
Private Equity Market Update,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_17-private-equity-market-updates-at-a-glance,2022-08-17
ESG Considerations for Public Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/08/esg-considerations-for-public-companies,2022-08-16
State AGs Sue Personal Lending Company Over Hidden Add-Ons,https://www.goodwinlaw.com/en/insights/blogs/2022/08/state-ags-sue-personal-lending-company-over-hidden-add-ons,2022-08-16
Antitrust + Competition Life Sciences Quarterly Update Q2 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/08/antitrust--competition-life-sciences-quarterly-upd,2022-08-15
Antitrust + Competition Technology Quarterly Update Q2 2022,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_15-antitrust-competition-technology-q2,2022-08-15
Antitrust + Competition Life Sciences Quarterly Update Q2 2022,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_15-antitrust-competition-life-sciences,2022-08-15
Amgen Moves to Dismiss and to Stay Regeneron’s Antitrust Case,https://www.goodwinlaw.com/en/insights/blogs/2022/08/amgen-moves-to-dismiss-and-to-stay-regenerons-anti,2022-08-14
Infliximab Clinical Trial Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/08/infliximab-clinical-trial-updates,2022-08-12
FTC Announces Advanced Notice of Proposed Rulemaking on Privacy and Data Security,https://www.goodwinlaw.com/en/insights/blogs/2022/08/ftc-announces-advance-notice-of-proposed-rulemakin,2022-08-12
CFPB Issues Interpretive Rule Clarifying Tech Service Providers Are Subject to CFPA,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_11-weekly-roundup,2022-08-11
CFPB Enters Into Consent Order with Fintech Company for $2.7 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/08/cfpb-enters-into-consent-order-with-fintech-company-for-27-million,2022-08-10
New EU Rules for Data Access and Sharing: What You Need to Know,https://www.goodwinlaw.com/en/insights/blogs/2022/08/new-eu-rules-for-data-access-and-sharing-what-you,2022-08-10
Significant Drug Pricing Reform Measures in the Inflation Reduction Act of 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/08/us-senate-passes-significant-drug-pricing-reform-i,2022-08-10
SEC Focuses on Insider Trading and Leverages Market Analytics in Recent Slew of Enforcement Cases,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_10-securities-snapshot,2022-08-10
What to Know: New Register for Overseas Entities Owning UK Property Launched,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_09-what-to-know-new-register-for-overseas,2022-08-10
Recent Court Decisions Shed Light on Enforceability of Electronic Contracts in the U.S.,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_10-recent-court-decisions-shed-light,2022-08-10
Denosumab Clinical Trial Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/08/denosumab-clinical-trial-updates,2022-08-09
Special Meeting Reminders,https://www.goodwinlaw.com/en/insights/blogs/2022/08/special-meeting-reminders,2022-08-09
Significant Drug Pricing Reform Measures in the Inflation Reduction Act of 2022,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_09-us-senate-passes-significant-drug-pricing,2022-08-09
U.S. Crypto Regulation and the Digital Commodities Consumer Protection Act,https://www.goodwinlaw.com/en/insights/blogs/2022/08/us-crypto-regulation-and-the-digital-commodities-c,2022-08-08
U.S. Crypto Regulation and the Digital Commodities Consumer Protection Act,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_08-the-future-of-us-crypto-regulation,2022-08-08
Celltrion Files IND with FDA for Adalimumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/08/celltrion-files-ind-with-fda-for-adalimumab-biosim,2022-08-05
Are the SEC and FINRA Moving to the Metaverse?,https://www.goodwinlaw.com/en/insights/blogs/2022/08/are-the-sec-and-finra-moving-to-the-metaverse,2022-08-05
Coherus Announces FDA Approval of CIMERLI (ranibizumab-eqrn),https://www.goodwinlaw.com/en/insights/blogs/2022/08/coherus-announces-fda-approval-of-cimerli-ranibizu,2022-08-04
Mandatory Licensing Regime for Virtual Asset Exchanges in Hong Kong,https://www.goodwinlaw.com/en/insights/blogs/2022/08/mandatory-licensing-regime-for-virtual-asset-excha,2022-08-04
"California Department of Financial Protection & Innovation Settles With “Buy Now, Pay Later” Company",https://www.goodwinlaw.com/en/insights/blogs/2022/08/california-department-of-financial-protection--inn,2022-08-04
"California Department of Financial Protection & Innovation Settles With “Buy Now, Pay Later” Company",https://www.goodwinlaw.com/en/insights/blogs/2022/08/california-department-of-financial-protection--innovation-settles-with-buy-now-pay-later-company,2022-08-04
CFPB and DOJ Order Mortgage Company to Pay Over $22 Million for Advertising and Marketing Discrimination,https://www.goodwinlaw.com/en/insights/blogs/2022/08/cfpb-and-doj-order-mortgage-company-to-pay-over-22-million-for-advertising-and-marketing-discriminat,2022-08-04
CFPB and DOJ Order Mortgage Company to Pay Over $22 Million for Advertising and Marketing Discrimination,https://www.goodwinlaw.com/en/insights/blogs/2022/08/cfpb-and-doj-order-mortgage-company-to-pay-over-22,2022-08-04
Pharma Manufacturer Federal Government Price Reporting: Recent Litigation and Settlements,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_04-pharma-manufacturer-federal-government,2022-08-04
The Federal Deposit Insurance Corporation (FDIC) Issued Guidance Regarding FDIC Insurance and Crypto Assets,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_04-weekly-roundup,2022-08-04
Mandatory Licensing Regime for Virtual Asset Exchanges in Hong Kong,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_04-mandatory-licensing-regime-for-virtual-asset,2022-08-04
A New Direction for ATAD III Proposal?,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_04-a-new-direction-for-atad-iii-proposal,2022-08-04
Regeneron Files First BPCIA Complaint Regarding Biosimilar Eylea Against Mylan in West Virginia District Court,https://www.goodwinlaw.com/en/insights/blogs/2022/08/regeneron-files-first-bpcia-complaint-regarding-bi,2022-08-03
FT Cryptofinance: US Regulators Vie for Crypto Control (Financial Times Article),https://www.goodwinlaw.com/en/insights/blogs/2022/08/ft-cryptofinance-us-regulators-vie-for-crypto-cont,2022-08-03
Tech Companies Need to Prepare for the Data Privacy Implications of Dobbs v. Jackson Women’s Health Organization,https://www.goodwinlaw.com/en/insights/blogs/2022/08/tech-companies-need-to-prepare-for-the-data-privac,2022-08-03
The Seventh Circuit Affirms Dismissal of the HUMIRA Antitrust Litigation,https://www.goodwinlaw.com/en/insights/blogs/2022/08/the-seventh-circuit-affirms-dismissal-of-the-humir,2022-08-03
FDA Accepts for Review Fresenius Kabi’s BLA for Tocilizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/08/fda-accepts-for-review-fresenius-kabis-bla-for-toc,2022-08-03
Are the SEC and FINRA Moving to the Metaverse?,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_03-are-the-sec-and-finra-moving,2022-08-03
"Pre-Marketing, Marketing and Discontinuation of Marketing — How to Notify in Luxembourg?",https://www.goodwinlaw.com/en/insights/publications/2022/08/08_03-pre-marketing-marketing-and-discontinuation,2022-08-03
Securities Law Issues In Volatile Markets,https://www.goodwinlaw.com/en/insights/blogs/2022/08/securities-law-issues-in-volatile-markets,2022-08-02
Goodwin Actively Hiring Associates for IP Litigation Group,https://www.goodwinlaw.com/en/insights/blogs/2022/08/goodwin-actively-hiring-associates-for-ip-litigati,2022-08-02
U.S. Department of Labor Issues Proposed Amendment to QPAM Exemption,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_02-us-department-of-labor-issues-proposed,2022-08-02
USPTO Publishes Notice Calling Out Pharmaceutical Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/08/uspto-publishes-notice-calling-out-pharmaceutical,2022-08-01
Luxembourg AIFMs — Post-Pandemic Teleworking Practices,https://www.goodwinlaw.com/en/insights/publications/2022/08/08_01-luxembourg-aifms-post-pandemic-teleworking,2022-08-01
SEC Proposes Amendments to Exchange Act Rule 15b9-1—Is FINRA Taking Over the Lease at 100 F Street NE?,https://www.goodwinlaw.com/en/insights/blogs/2022/07/sec-proposes-amendments-to-exchange-act-rule-15b91,2022-07-29
Updates on Pending Legislation: Citizen Petitions,https://www.goodwinlaw.com/en/insights/blogs/2022/07/updates-on-pending-legislation-citizen-petitions,2022-07-29
Sandoz & Polpharma Announce FDA and EMA Acceptance of Applications for Natalizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/07/sandoz--polpharma-announce-fda-and-ema-acceptance,2022-07-29
Delaware Adopts Control Share Acquisition Statute for Registered Closed-End Funds and Business Development Companies Organized In Delaware,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_29-delaware-adopts-control-share-acquisition,2022-07-29
CFPB Enters Into $37.5 Million Penalty With Large National Bank,https://www.goodwinlaw.com/en/insights/blogs/2022/07/cfpb-enters-into-375-million-penalty-with-large-national-bank,2022-07-28
Prestige Biopharma and Intas Pharmaceuticals Partner on Bevacizumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/07/prestige-biopharma-and-intas-pharmaceuticals-partn,2022-07-28
Chief Judge of Western District of Texas Changes Waco Patent Case Assignment System,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_28-chief-judge-of-the-western-district-of-texas,2022-07-28
OCC Solicits Research on Implications of Financial Technology for Banking,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_28-weekly-roundup,2022-07-28
OIG Alert and DOJ Enforcement Action Summary: Telemedicine Arrangements,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_28-oig-alert-and-doj-enforcement,2022-07-28
SEC Alleges “Crypto Asset Securities” Insider Trading; Case Has Significant Implications for the Digital Asset Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/07/sec-alleges-crypto-asset-securities-insider-trading-case-has-significant-implications-for-the-digita,2022-07-27
Nasdaq Board Diversity Matrix Deadline,https://www.goodwinlaw.com/en/insights/blogs/2022/07/nasdaq-board-diversity-matrix-deadline,2022-07-27
CFPB and DOJ Reach $24.4 Settlement with Mortgage Originator for Alleged Lending Discrimination,https://www.goodwinlaw.com/en/insights/blogs/2022/07/cfpb-and-doj-reach-244-settlement-with-mortgage-or,2022-07-27
CFPB and DOJ Reach $24.4 Million Settlement with Mortgage Originator for Alleged Lending Discrimination,https://www.goodwinlaw.com/en/insights/blogs/2022/07/cfpb-and-doj-reach-244-million-settlement-with-mortgage-originator-for-alleged-lending-discriminatio,2022-07-27
CFPB Settles with Auto Lender for $19 Million to Resolve Alleged FCRA Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/07/cfpb-settles-with-auto-lender-for-$19-million-to-resolve-alleged-fcra-violations,2022-07-26
FINRA Proposes to Publicly Identify “Restricted Firms” on BrokerCheck,https://www.goodwinlaw.com/en/insights/blogs/2022/07/finra-proposes-to-publicly-identify-restricted-fir,2022-07-26
Supreme Court Cert Petitions on Skinny Label Inducement and Written Description Issues,https://www.goodwinlaw.com/en/insights/blogs/2022/07/supreme-court-cert-petitions-on-skinny-label-induc,2022-07-26
Twitter Brings Suit Against Musk in Delaware Court of Chancery Seeking Specific Performance,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_26-securities-snapshot,2022-07-26
SEC Alleges “Crypto Asset Securities” Insider Trading; Case Has Significant Implications for the Digital Asset Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/07/sec-alleges-crypto-asset-securities-insider-tradin,2022-07-25
SEC Alleges “Crypto Asset Securities” Insider Trading; Case Has Significant Implications For The Digital Asset Industry,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_22-sec-alleges-crypto-asset-securities-insider,2022-07-22
FDIC Updates Brokered Deposits Information,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_21-weekly-roundup,2022-07-21
Hikma and Celltrion Announce Collaboration to Market Adalimumab Biosimilar YUFLYMA in Middle East and North Africa,https://www.goodwinlaw.com/en/insights/blogs/2022/07/hikma-and-celltrion-announce-collaboration-to-mark,2022-07-20
The Potential Impact of State Abortion Laws on Reproductive Health Apps,https://www.goodwinlaw.com/en/insights/blogs/2022/07/the-potential-impact-of-state-abortion-laws-on-rep,2022-07-20
Foreign Private Issuer Annual Assessment,https://www.goodwinlaw.com/en/insights/blogs/2022/07/foreign-private-issuer-annual-assessment,2022-07-19
Alvotech Begins Confirmatory Study on EYLEA® Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/07/alvotech-begins-confirmatory-study-on-eylea-biosim,2022-07-19
The Potential Impact of State Abortion Laws on Reproductive Health Apps,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_19-the-potential-impact-of-state-abortion-laws,2022-07-19
SEC Proposes Further Limitations on Proxy Statement Exclusion of Shareholder Proposals,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_18-sec-proposes-further-limitations-on-proxy,2022-07-18
Is the SEC’s Expansion of the “Exchange” and “Dealer” Definitions Part of the Agency’s Crypto and DeFi Strategy?,https://www.goodwinlaw.com/en/insights/blogs/2022/07/is-the-secs-expansion-of-the-exchange-and-dealer-d,2022-07-15
SEC Adopts Amendments to Rules Governing Proxy Voting Advice,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_15-sec-adopts-amendments-to-rules-governing,2022-07-15
Germany Introduces New Rules on Crypto Funds,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_13-germany-introduces-new-rules-on-crypto-funds,2022-07-14
CFPB Issues Advisory Opinion Affirming Obligations of Consumer Report Providers and Users Under FCRA,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_14-weekly-roundup,2022-07-14
Is the SEC’s Expansion of the “Exchange” and “Dealer” Definitions Part of the Agency’s Crypto and DeFi Strategy?,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_14-is-the-secs-expansion-of-the-exchange,2022-07-14
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2022/07/07_26-erisa-litigation-update,2022-07-14
Taking Security Interests in Human Reproductive Tissue: Clarifying Lender Options under Federal and State Law,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_14-taking-security-interests,2022-07-14
CA Gov. Newsom Announces Budget Approval for Biosimilar Insulin Initiative,https://www.goodwinlaw.com/en/insights/blogs/2022/07/ca-gov-newsom-announces-budget-approval-for-biosim,2022-07-13
Risk Factors for Form 10-Q Reports,https://www.goodwinlaw.com/en/insights/blogs/2022/07/risk-factors-for-form-10q-reports,2022-07-13
USPTO Outlines New Initiatives Regarding Drug Pricing,https://www.goodwinlaw.com/en/insights/blogs/2022/07/uspto-outlines-new-initiatives-regarding-drug-pric,2022-07-12
Third Circuit Rules that Caller Must Use An “Automatic Telephone Dialing System’s” Ability to Produce or Store Telephone Numbers Through Random or Sequential Number Generation to Trigger Potential Liability under the TCPA’s ATDS Provision,https://www.goodwinlaw.com/en/insights/blogs/2022/07/tcpas-atds-rules-for-automatic-dialing-systems--le,2022-07-12
Third Circuit Rules that Caller Must Use An “Automatic Telephone Dialing System’s” Ability to Produce or Store Telephone Numbers Through Random or Sequential Number Generation to Trigger Potential Liability under the TCPA’s ATDS Provision,https://www.goodwinlaw.com/en/insights/blogs/2022/07/third-circuit-rules-that-caller-must-use-an-automatic-telephone-dialing-systems-ability-to-produce-o,2022-07-12
Grayscale Investments Petitions D.C. Circuit For Review Of SEC’s Decision To Disapprove Proposed Bitcoin Exchange-Traded Product,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_12-securities-snapshot,2022-07-12
Mylan Files New IPR Petitions on Aflibercept Patents,https://www.goodwinlaw.com/en/insights/blogs/2022/07/mylan-files-new-ipr-petitions-on-aflibercept-paten,2022-07-11
Goodwin Actively Hiring Science Advisors for IP Litigation Group,https://www.goodwinlaw.com/en/insights/blogs/2022/07/goodwin-actively-hiring-science-advisors-for-ip-li,2022-07-11
Mylan Voluntarily Recalls Additional Batch of Biosimilar Insulin Glargine Pens Due to Potential Missing Labels,https://www.goodwinlaw.com/en/insights/blogs/2022/07/mylan-voluntarily-recalls-additional-batch-of-bios,2022-07-08
The Future of Patents for Patients: USPTO Temporarily Extends Cancer Immunotherapy Pilot Program (Patents for Patients) and Requests Public Input On Next Steps,https://www.goodwinlaw.com/en/insights/blogs/2022/07/the-future-of-patents-for-patients-uspto-temporari,2022-07-07
Update on Xbrane’s Ranibizumab Application,https://www.goodwinlaw.com/en/insights/blogs/2022/07/update-on-xbranes-ranibizumab-application,2022-07-07
Fintiv 2.0: USPTO Director Issues Guidance Softening Risk of Discretionary Denial,https://www.goodwinlaw.com/en/insights/publications/2022/07/07_07-uspto-director-issues-guidance-softening,2022-07-07
Amgen releases preview of 2022 biosimilars report,https://www.goodwinlaw.com/en/insights/blogs/2022/07/amgen-releases-preview-of-2022-trends-in-biosimila,2022-07-06
UK Government Issues Response to its Data Reform Consultation,https://www.goodwinlaw.com/en/insights/blogs/2022/07/uk-government-issues-response-to-its-data-reform-c,2022-07-05
Reassessing Exchange Act Filing Status,https://www.goodwinlaw.com/en/insights/blogs/2022/07/reassessing-exchange-act-filing-status,2022-07-05
EMA CHMP Recommends Three Biosimilars – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/07/ema-chmp-recommends-grant-of-marketing-authorizati,2022-07-01
SEC Publishes Spring Rulemaking Agenda: Torrid Pace Continues; Crypto Framework Noticeably Absent,https://www.goodwinlaw.com/en/insights/blogs/2022/07/sec-publishes-rulemaking-agenda--digital-currency,2022-06-30
New OIG Advisory Opinion Impacts Pharmaceutical & Medical Device Company Funding of Continuing Education Programs,https://www.goodwinlaw.com/en/insights/blogs/2022/07/oig-advisory-opinion-impacts-pharmaceutical--medic,2022-06-30
SEC Publishes Spring Rulemaking Agenda: Torrid Pace Continues; Crypto Framework Noticeably Absent,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sec-publishes-spring-rulemaking-agenda-torrid-pace,2022-06-30
DOJ Settles with Social Media Company to Resolve Fair Lending and Discriminatory Advertising Allegations,https://www.goodwinlaw.com/en/insights/blogs/2022/06/doj-settles-with-social-media-company-over-allegat,2022-06-30
DOJ Settles with Social Media Company to Resolve Fair Lending and Discriminatory Advertising Allegations,https://www.goodwinlaw.com/en/insights/blogs/2022/06/doj-settles-with-social-media-company-to-resolve-fair-lending-and-discriminatory-advertising-allegat,2022-06-30
Whistleblower Lawyers Use False Claims Act to Target Private Equity Firms Invested In Healthcare and Life Sciences,https://www.goodwinlaw.com/en/insights/blogs/2022/06/false-claims-act-used-to-target-private-equity-fir,2022-06-30
SEC Announces Spring 2022 Regulatory Agenda,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_30-weekly-roundup,2022-06-30
Massachusetts AG Resolves Allegations that Motor Vehicle Title Lender Issued Illegal Loans,https://www.goodwinlaw.com/en/insights/blogs/2022/06/massachusetts-ag-resolves-allegations-that-motor-vehicle-title-lender-issued-illegal-loans,2022-06-29
China NMPA Approves TYVYT (sintilimab) – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/china-nmpa-approves-tyvyt-sintilimab-in-combinatio,2022-06-29
SEC Publishes Spring Rulemaking Agenda: Torrid Pace Continues; Crypto Framework Noticeably Absent,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_29-sec-publishes-spring-rulemaking-agenda,2022-06-29
Whistleblower Lawyers Use False Claims Act to Target Private Equity Firms Invested In Healthcare and Life Sciences,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_29-whistleblower-lawyers-use-false-claims-act,2022-06-29
Common Bioresearch Monitoring Violations: Updates from FY 2021 to Now,https://www.goodwinlaw.com/en/insights/blogs/2022/06/common-bioresearch-monitoring-violations-updates-f,2022-06-28
SEC Brings First Ever Reg. BI Litigation Against Broker-Dealer and its Personnel,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sec-brings-first-ever-reg-bi-litigation-against-br,2022-06-28
Stock Buyback Considerations – Public Company Advisory Blog,https://www.goodwinlaw.com/en/insights/blogs/2022/06/stock-buybacks,2022-06-28
Formycon Q1 2022 Financial Results – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/formycon-q1-2022-financial-results-and-announcemen,2022-06-28
"Third Circuit Affirms Dismissal of Complaint, Finding Investors Failed to Sufficiently Allege Amarin’s Statements Were False or Misleading",https://www.goodwinlaw.com/en/insights/publications/2022/06/06_28-securities-snapshot,2022-06-28
SEC Brings First Ever Regulation Best Interest Litigation Against Broker-Dealer and Its Personnel,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_28-sec-brings-first-ever-regulation,2022-06-28
Sandoz’s Biosimilar Application Accepted – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sandozs-high-concentration-adalimumab-biosimilar-a,2022-06-24
The UK and Luxembourg Signed A New Double Tax Treaty,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_23-the-uk-and-luxembourg-signed,2022-06-23
Public Consultation on a Common EU-Wide System for Withholding Tax Claims on Dividend and Interest Payment,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_23-public-consultation-on-a-common,2022-06-23
“The Sower”: The Power of Coming Together,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_23_the-sower-the-power-of-coming-together,2022-06-23
Luxembourg Administrative Court Decision: Parent-Subsidiary Exemption and Account 115 Contributions,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_23-luxembourg-administrative-court-decision,2022-06-23
USAO Settles with California Lender for $1 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/06/usao-settles-with-california-lender-for-$1-million,2022-06-22
Huiya Wu speaks ACI’s 13th Annual Summit – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/huiya-wu-to-speak-at-acis-13th-annual-summit-on-bi,2022-06-22
"Canadian Patent Examination Will Soon Be More Expensive, Less Flexible and Require Additional Care in Prosecution to Avoid Loss of Rights",https://www.goodwinlaw.com/en/insights/blogs/2022/06/canadian-patent-examination-changes--life-sciences,2022-06-21
Reverse Stock Splits – ISS & Glass Lewis,https://www.goodwinlaw.com/en/insights/blogs/2022/06/reverse-stock-splits--iss--glass-lewis,2022-06-21
SEC Gets 2 New Commissioners; Agency to Advance its Aggressive (and Provocative) Rulemaking Agenda,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sec-gets-2-new-commissioners-agency-to-advance-its,2022-06-17
U.S. Senators Request PTO Action – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/us-senators-request-pto-action-on-patent-thickets,2022-06-17
Recent FTC Enforcement Action Signifies Increased Scrutiny of Private Equity Acquisitions and Imposition of More Onerous Settlement Terms,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_17-recent-ftc-enforcement-action,2022-06-17
"Canadian Patent Examination Will Soon Be More Expensive, Less Flexible and Require Additional Care in Prosecution to Avoid Loss of Rights",https://www.goodwinlaw.com/en/insights/publications/2022/06/06_17-canadian-patent-examination,2022-06-17
Negotiating Preferred Equity Recognition Rights in Hospitality Deals,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_17-negotiating-preferred-equity-recognition,2022-06-17
Goodwin’s Digital Currency & Blockchain Group to Host NFT NYC Cocktail Reception,https://www.goodwinlaw.com/en/insights/blogs/2022/06/goodwins-digital-currency--blockchain-group-to-hos,2022-06-16
Alvotech Debuted on Nasdaq – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/alvotech-a-global-pureplay-biosimilars-company-deb,2022-06-16
California Finalizes Commercial Financing Disclosure Regulations,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_16-weekly-roundup,2022-06-16
Delete My Account (And All My Personal Data): Apple’s App Requirement Takes Effect,https://www.goodwinlaw.com/en/insights/blogs/2022/06/delete-my-account-and-all-my-personal-data-apples,2022-06-15
“NFT Indictment” and The Trading of Digital Assets,https://www.goodwinlaw.com/en/insights/blogs/2022/06/nft-indictment--digital-currency--blockchain-persp,2022-06-15
"Deidentified Under HIPAA, But Regulated Under the CCPA",https://www.goodwinlaw.com/en/insights/blogs/2022/06/deidentified-under-hipaa-but-regulated-under-the-c,2022-06-15
Cybersecurity Remains a Key Focus Area for the SEC and FINRA,https://www.goodwinlaw.com/en/insights/blogs/2022/06/cybersecurity-remains-a-key-focus-area-for-the-sec,2022-06-15
Organon and Henlius license agreement – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/organon-and-henlius-entered-into-a-global-license,2022-06-14
Nasdaq Minimum Bid Price,https://www.goodwinlaw.com/en/insights/blogs/2022/06/nasdaq-minimum-bid-price,2022-06-14
Issue 37: PTAB Trial Tracker,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_14-issue-37-ptab-trial-tracker,2022-06-14
Delaware Court Of Chancery Dismisses Remainder 0f Claims Alleging that California Biotech Firm Profited From Nonpublic Information About Vaccine Development Efforts,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_14-securities-snapshot,2022-06-14
Alvotech and STADA Launch HUKYNDRA – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/alvotech-and-stada-launch-hukyndra-biosimilar-of-h,2022-06-13
Connecticut Becomes Latest State to Pass Comprehensive Data Privacy Law,https://www.goodwinlaw.com/en/insights/blogs/2022/06/connecticut-becomes-latest-state-to-pass-comprehen,2022-06-13
California Finalizes Commercial Financing Disclosure Regulations,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_13-california-finalizes-commercial-financing,2022-06-13
French Data Protection Authority Fined Medical Software Provider for GDPR Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/06/french-data-protection-authority-fined-medical-sof,2022-06-10
FDA Approves Amgen’s RIABNI™ (Rituximab-arrx) for Adults With Moderate to Severe Rheumatoid Arthritis,https://www.goodwinlaw.com/en/insights/blogs/2022/06/fda-approves-amgens-riabni-rituximabarrx-for-adult,2022-06-10
CFPB Bans Student Debt Relief Operator From Industry,https://www.goodwinlaw.com/en/insights/blogs/2022/06/cfpb-bans-student-debt-relief-operator-from-industry,2022-06-09
SEC Proposes ESG Disclosure Rules and Changes to the Names Rule,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_09-weekly-roundup,2022-06-09
PTAB Institutes Sixth IPR – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/ptab-institutes-sixth-ipr-on-a-tocilizumab-patent,2022-06-08
"SEC Adopts New Electronic Filing Requirements for “Glossy” Annual Reports, Form 144 Notices and Other Documents",https://www.goodwinlaw.com/en/insights/publications/2022/06/06_08-sec-adopts-new-requirements-for-glossy,2022-06-08
BYOOVIZ Launch – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/biogen-and-samsung-bioepis-launch-byooviz-ranibizu,2022-06-07
Sandoz New Global “Act4Biosimilars” Initiative – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sandoz-announces-new-global-act4biosimilars-initia,2022-06-07
CFPB’s Entry Into Cryptocurrency Arena,https://www.goodwinlaw.com/en/insights/blogs/2022/06/cfpbs-entry-into-cryptocurrency-arena--digital-cur,2022-06-07
UK Proposes New Insolvency Regime for Stablecoin Failures,https://www.goodwinlaw.com/en/insights/blogs/2022/06/insolvency-regime-for-stablecoin--digital-currency,2022-06-07
Additional Proxy Materials,https://www.goodwinlaw.com/en/insights/blogs/2022/06/additional-proxy-materials,2022-06-07
Goodwin REIT Alert: REIT M&A Trends Through the Pandemic (2020-2022),https://www.goodwinlaw.com/en/insights/publications/2022/06/06_06-goodwin-reit-alert-reit-ma-trends-through,2022-06-06
"CFPB Says Creditors Must Provide Reasons For Taking Adverse Action, Even When Relying On AI",https://www.goodwinlaw.com/en/insights/publications/2022/06/06_06-cfpb-says-creditors-must-provide--reasons,2022-06-06
New BPCIA Complaint – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/new-bpcia-complaint-genentech-files-suit-against-t,2022-06-03
Regeneron Files Antitrust Lawsuit – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/regeneron-files-antitrust-lawsuit-accusing-amgen-o,2022-06-02
SEC Proposes ESG Disclosure Rules for Investment Advisers and Investment Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/06/sec-proposes-esg-disclosure-rules-for-investment-a,2022-06-02
HUD Reaches Settlement with Mortgage Originator for Alleged Lending Discrimination,https://www.goodwinlaw.com/en/insights/blogs/2022/06/hud-reaches-settlement-with-mortgage-originator-for-alleged-lending-discrimination,2022-06-02
"FDIC Issues Final Rule on False Advertising, Misrepresentation of Insured Status, and Misuse of the FDIC’s Name or Logo",https://www.goodwinlaw.com/en/insights/blogs/2022/06/fdic-issues-final-rule-on-false-advertising--lende,2022-06-02
"FDIC Issues Final Rule on False Advertising, Misrepresentation of Insured Status, and Misuse of the FDIC’s Name or Logo",https://www.goodwinlaw.com/en/insights/blogs/2022/06/fdic-issues-final-rule-on-false-advertising-misrepresentation-of-insured-status-and-misuse-of-the-fd,2022-06-02
Ending LGBTQ Youth Suicide and Expanding LGBTQ Access to Crisis Support Services,https://www.goodwinlaw.com/en/insights/case-studies/ending-lgbtq-youth-suicide,2022-06-02
SEC Proposes ESG Disclosure Rules for Investment Advisers and Investment Companies,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_02-sec-proposes-esg-disclosure-rules,2022-06-02
FDA Annual Public Meeting – Big Molecule Watch,https://www.goodwinlaw.com/en/insights/blogs/2022/06/fda-annual-public-meeting-regarding-user-fees,2022-06-01
North Carolina AG Permanently Enjoins Debt Settlement Business,https://www.goodwinlaw.com/en/insights/blogs/2022/06/north-carolina-ag-permanently-enjoins-debt-settlem,2022-06-01
North Carolina AG Permanently Enjoins Debt Settlement Business,https://www.goodwinlaw.com/en/insights/blogs/2022/06/north-carolina-ag-permanently-enjoins-debt-settlement-business,2022-06-01
SEC Enforcement Weighs in on Variable Annuity Exchanges for the First Time,https://www.goodwinlaw.com/en/insights/publications/2022/06/06_01-sec-enforcement-weighs-in-on-variable,2022-06-01
Outlook Therapeutics to Revise Ophthalmic Bevacizumab BLA in Light of FDA Request,https://www.goodwinlaw.com/en/insights/blogs/2022/06/outlook-therapeutics-to-revise-ophthalmic-bevacizu,2022-05-31
Court Temporarily Shuts Down Alleged Credit Repair Pyramid Scheme Following FTC Complaint,https://www.goodwinlaw.com/en/insights/blogs/2022/05/court-temporarily-shuts-down-alleged-credit-repair-pyramid-scheme-following-ftc-complaint,2022-05-31
Glass Lewis Post-IPO Governance Policy,https://www.goodwinlaw.com/en/insights/blogs/2022/05/glass-lewis-postipo-governance-policy,2022-05-31
FemTech – A Market on the Rise,https://www.goodwinlaw.com/en/insights/blogs/2022/05/femtech--a-market-on-the-rise,2022-05-31
Florida’s Telephone Solicitation Act Survives First Constitutional Challenge,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_31-floridas-telephone-solicitation-act-survives,2022-05-31
Deal Watch: Henlius Licenses Rituximab and Trastuzumab Products to Abbott in Brazil,https://www.goodwinlaw.com/en/insights/blogs/2022/05/deal-watch--henlius-licenses-rituximab-and-trastuz,2022-05-27
CFPB and NY AG Reach $4 Million Settlement with Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/05/cfpb-and-ny-ag-reach-$4-million-settlement-with-debt-collectors,2022-05-27
CFPB and NY AG Reach $4 Million Settlement with Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/05/cfpb-and-ny-ag-reach-4-million-settlement-with-deb,2022-05-27
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA (pegfilgrastim-pbbk),https://www.goodwinlaw.com/en/insights/blogs/2022/05/amneal-achieves-third-us-biosimilar-approval-with,2022-05-27
Alvotech Announces Positive Top-Line Results from Clinical Trial for Ustekinumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/05/alvotech-announces-positive-topline-results-from-c,2022-05-26
Rhode Island Becomes the 19th State to Legalize Recreational Cannabis,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_26-rhode-island-becomes-the,2022-05-26
JSR Life Sciences Launches New “Similis Bio” Business Division to Accelerate Biosimilar Development,https://www.goodwinlaw.com/en/insights/blogs/2022/05/jsr-life-sciences-launches-new-similis-bio-busines,2022-05-25
California Law Requiring Female Directors on Public Company Boards Held Unconstitutional,https://www.goodwinlaw.com/en/insights/blogs/2022/05/california-law-requiring-female-directors-on-publi,2022-05-25
JOBS Act 4.0,https://www.goodwinlaw.com/en/insights/blogs/2022/05/jobs-act-40,2022-05-24
District Court Declines to Extend Debt Collector’s Reading of TransUnion v. Ramirez Standing Requirements,https://www.goodwinlaw.com/en/insights/blogs/2022/05/district-court-declines-to-extend-debt-collectors,2022-05-24
District Court Declines to Extend Debt Collector’s Reading of TransUnion v. Ramirez Standing Requirements,https://www.goodwinlaw.com/en/insights/blogs/2022/05/district-court-declines-to-extend-debt-collectors-reading-of-transunion-v-ramirez-standing-requireme,2022-05-24
Ninth Circuit Rules Delta-8 THC Is Legal,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_24-ninth-circuit-rules-delta-8-thc-is-legal,2022-05-24
Trial Scheduled for April 2024 in BMS Patent Case Against AstraZeneca Regarding Anti-PDL1 Antibodies,https://www.goodwinlaw.com/en/insights/blogs/2022/05/trial-scheduled-for-april-2024-in-bms-patent-case,2022-05-23
Brian Burgess to Speak on Emerging Legal Issues and Trends for Interchangeable Biosimilars at FDLI Annual Conference,https://www.goodwinlaw.com/en/insights/blogs/2022/05/brian-burgess-to-speak-on-emerging-legal-issues-an,2022-05-23
Fertility Services Market at Risk with New Oklahoma Abortion Bill,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_23-fertility-services-market-at-risk,2022-05-23
DAOS and Web3: Will New Technology Bring the Death of the C-Corp?,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_23-daos-and-web3,2022-05-23
Jumpstarting the Next JOBS Act — JOBS Act 4.0,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_23-jumpstarting-the-next-jobs,2022-05-23
FINRA 2022 Exam Report Spotlight: Communications with the Public,https://www.goodwinlaw.com/en/insights/blogs/2022/05/finra-2022-exam-report-spotlight-communications-wi,2022-05-20
Teva Receives Approval for First Ophthalmology Biosimilar in Europe,https://www.goodwinlaw.com/en/insights/blogs/2022/05/teva-receives-approval-for-first-ophthalmology-bio,2022-05-19
Viatris and Biocon Biologics Launch Bevacizumab Biosimilar ABEVMY in Canada,https://www.goodwinlaw.com/en/insights/blogs/2022/05/viatris-and-biocon-biologics-launch-bevacizumab-bi,2022-05-19
35 State AGs Reach $550 Million Settlement with Subprime Auto Lender,https://www.goodwinlaw.com/en/insights/blogs/2022/05/35-state-ags-reach-550-million-settlement-with-sub,2022-05-19
35 State AGs Reach $550 Million Settlement with Subprime Auto Lender,https://www.goodwinlaw.com/en/insights/blogs/2022/05/35-state-ags-reach-$550-million-settlement-with-subprime-auto-lender,2022-05-19
California Law Requiring Female Directors on Public Company Boards Held Unconstitutional,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_19-california-law-requiring-female-directors,2022-05-19
SEC Extends and Reopens Comment Periods for Three Proposed Rules,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_19-weekly-roundup,2022-05-19
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for Ustekinumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/05/alvotech-announces-positive-results-from-a-pharmac,2022-05-18
Brian Burgess to speak at FDLI Annual Conference,https://www.goodwinlaw.com/en/insights/blogs/2022/05/brian-burgess-to-speak-at-fdli-annual-conference,2022-05-18
Cryptocurrencies As Investment Options In 401(k) Plans,https://www.goodwinlaw.com/en/insights/blogs/2022/05/cryptocurrencies-as-investment-options-in-401k-pla,2022-05-18
Q1 2022 Earnings Roundup: Biologics and Biosimilars Update,https://www.goodwinlaw.com/en/insights/blogs/2022/05/q1-2022-earnings-roundup-biologics-and-biosimilars,2022-05-17
Not GAAP Is Not Always Non-GAAP,https://www.goodwinlaw.com/en/insights/blogs/2022/05/not-gaap-is-not-always-nongaap,2022-05-17
Delaware Chancery Court Clears Musk of Breach of Fiduciary Duty Claim,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_17-securities-snapshot,2022-05-17
Arizona AG Announces $1.6 Million Settlement with Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/05/arizona-ag-announces-16-million-settlement-with-de,2022-05-16
Arizona AG Announces $1.6 Million Settlement with Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/05/arizona-ag-announces-16-million-settlement-with-debt-collectors,2022-05-16
Arman Oruc Speaking at KPMG’s 2022 Global Life Sciences Summit,https://www.goodwinlaw.com/en/insights/blogs/2022/05/arman-oruc-speaking-at-kpmgs-2022-global-life-scie,2022-05-16
Formycon AG Acquires Biosimilar Assets Ustekinumab and Ranibuzumab,https://www.goodwinlaw.com/en/insights/blogs/2022/05/formycon-ag-acquires-biosimilar-assets-ustekinumab,2022-05-13
Clinical Trials and Collaborations: Managing Health Data and Data Protection,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_13-clinical-trials-and-collaborations,2022-05-13
Cryptocurrencies As Investment Options In 401(k) Plans,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_13-cryptocurrencies-as-investment-options,2022-05-13
Pfizer Files Lawsuit in Australia to Halt Sales of BRENZYS (etanercept),https://www.goodwinlaw.com/en/insights/blogs/2022/05/pfizer-files-lawsuit-in-australia-to-halt-sales-of,2022-05-12
Henlius and Eurofarma Entered into a License Agreement for Henlius’ 3 Products in Latin America,https://www.goodwinlaw.com/en/insights/blogs/2022/05/henlius-and-eurofarma-entered-into-a-license-agree,2022-05-12
Agencies Issue Joint Proposal to Strengthen and Modernize CRA Regulations,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_12-weekly-roundup,2022-05-12
SEC Enforcement Broadens its Crypto Focus,https://www.goodwinlaw.com/en/insights/blogs/2022/05/sec-enforcement-broadens-its-crypto-focus,2022-05-11
CFPB Orders Debt-Relief Payment Processors to Pay $11 Million in Redress and Penalties,https://www.goodwinlaw.com/en/insights/blogs/2022/05/cfpb-orders-debtrelief-payment-processors-to-pay-1,2022-05-11
CFPB Orders Debt-Relief Payment Processors to Pay $11 Million in Redress and Penalties,https://www.goodwinlaw.com/en/insights/blogs/2022/05/cfpb-orders-debt-relief-payment-processors-to-pay-$11-million-in-redress-and-penalties,2022-05-11
SEC Extends Comment Periods for Recent Rulemakings. Applaud the Move or Criticize the Need To Take Action At All?,https://www.goodwinlaw.com/en/insights/blogs/2022/05/sec-extends-comment-periods-for-recent-rulemakings,2022-05-11
Metaverse in China: Beware of these Potential Legal Issues,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_11-metaverse-in-china,2022-05-11
U.S. Blocks Additional Russian Interests and Restricts Certain Management and Related Services and the Export of Certain Non-Dual Use Items in Latest Actions Against Russia,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_11-us-blocks-additional-russian-interests,2022-05-11
Four Lessons from Two FINRA Enforcement Actions against Crowdfunding Portals,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_11-four-lessons-from-two-finra-enforcement,2022-05-11
From Heavy Equipment to Cyber – 30 years of MD&A Enforcement,https://www.goodwinlaw.com/en/insights/blogs/2022/05/from-heavy-equipment-to-cyber--30-years-of-mda-enf,2022-05-10
SEC Enforcement Broadens Its Crypto Focus,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_10-sec-enforcement-broadens,2022-05-10
CFPB to Supervise Fintechs Based on Consumer Risk,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_10-cfpb-to-supervise-fintechs,2022-05-10
SEC’s Proposals to Modernize Beneficial Ownership Reporting May Complicate Enforcement of REIT Charter Ownership Limitations,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_09-secs-proposals-to-modernize-beneficial,2022-05-09
FTC Obtains Temporary Restraining Order Against Credit Repair Operation,https://www.goodwinlaw.com/en/insights/blogs/2022/05/ftc-obtains-temporary-restraining-order-against-credit-repair-operation,2022-05-06
United States to Join Cross-Border Privacy Effort,https://www.goodwinlaw.com/en/insights/blogs/2022/05/united-states-to-join-crossborder-privacy-effort,2022-05-06
U.S. Government Authorizes Transactions Related to Patent Protection in Russia,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_06-us-government-authorizes-transactions,2022-05-06
OCC Acting Comptroller Issues Statement on Stablecoin Standards,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_05-weekly-roundup,2022-05-05
ITC Institutes Investigation of Hugel’s Botulinum Toxin Product,https://www.goodwinlaw.com/en/insights/blogs/2022/05/itc-institutes-investigation-of-hugels-botulinum-t,2022-05-04
SEC and FINRA Spotlight Net Capital Requirements and Financial Management Practices,https://www.goodwinlaw.com/en/insights/blogs/2022/05/sec-and-finra-spotlight-net-capital-requirements-a,2022-05-04
Antitrust + Competition Life Sciences Quarterly Update Q1 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/05/antitrust--competition-life-sciences-quarterly-upd,2022-05-03
Furnishing Proxy Statements To All Shareholders,https://www.goodwinlaw.com/en/insights/blogs/2022/05/furnishing-proxy-statements-to-all-shareholders,2022-05-03
Antitrust + Competition Technology Quarterly Update Q1 2022,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_03-technology-q1-quarterly-update,2022-05-03
Antitrust + Competition Life Sciences Quarterly Update Q1 2022,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_03-life-sciences-quarterly-update-q1-2022,2022-05-03
SEC Obtains Consent Judgments Against Biotechnology Company and CEO for False COVID-19 Product Claims,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_03-securities-snapshot,2022-05-03
SEC’s Division of Examinations Issues Risk Alert Regarding MNPI and Code of Ethics Compliance,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_02-secs-division-of-examinations-issues-risk,2022-05-02
Private Equity Market Update,https://www.goodwinlaw.com/en/insights/publications/2022/05/05_02-private-equity-market-updates-at-a-glance,2022-05-02
CFPB Settles Lawsuit With Student Loan Debt Relief Company,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-settles-lawsuit-with-student-loan-debt-relief-company,2022-04-29
Clinical Trial Diversity Planning for Sponsors: What to Know About FDA’s Recent Draft Guidance,https://www.goodwinlaw.com/en/insights/blogs/2022/04/clinical-trial-diversity-planning-for-sponsors-wha,2022-04-29
FDA Testimony Before the U.S. Senate Regarding Reauthorization of the Biosimilar User Fee Act,https://www.goodwinlaw.com/en/insights/blogs/2022/04/fda-testimony-before-the-us-senate-regarding-reaut,2022-04-29
Clinical Trial Diversity Planning for Sponsors: What to Know About FDA's Recent Draft Guidance,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_29-clinical-trial-diversity-planning,2022-04-29
Delaware Chancery Court Reemphasizes Importance of Properly Handling Board Conflicts in Ruling for Elon Musk in SolarCity Case,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_29-delaware-chancery-court-reemphasizes,2022-04-29
New Federal Law Mandates Cyber Incident and Ransomware Payment Reporting for Critical Infrastructure Industries,https://www.goodwinlaw.com/en/insights/blogs/2022/04/new-federal-law-mandates-cyber-incident-and-ransom,2022-04-28
Celltrion to Enter U.S. Humira Biosimilar Market Following Patent Agreement with AbbVie,https://www.goodwinlaw.com/en/insights/blogs/2022/04/celltrion-to-enter-us-humira-biosimilar-market-fol,2022-04-28
CFPB Announces Supervision of Nonbanks and Seeks Comment on Risk-Determination Procedures,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_28-weekly-roundup,2022-04-28
Federal Circuit Clarifies Standard for Fair and Reasonable Exercise of Jurisdiction Based on Demand Letters,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_27-federal-circuit-clarifies-standard-for,2022-04-27
New York Insurance Regulator Sets Sights on Private Equity Investments,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_27-new-york-insurance-regulator-sets-sights,2022-04-27
Samsung Biologics Completes Full Acquisition of Samsung Bioepis,https://www.goodwinlaw.com/en/insights/blogs/2022/04/samsung-biologics-completes-full-acquisition-of-sa,2022-04-26
CFBP and NY AG Sue Global Payment Company,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfbp-and-ny-ag-sue-global-payment-company,2022-04-26
Nasdaq Board Diversity Website Disclosure,https://www.goodwinlaw.com/en/insights/blogs/2022/04/nasdaq-board-diversity-website-disclosure,2022-04-26
Wall Street Firms Make Crypto Push to Catch Up With ‘Cool Kids’,https://www.goodwinlaw.com/en/insights/blogs/2022/04/wall-street-firms-make-crypto-push-to-catch-up-wit,2022-04-25
Amgen Announces Positive Results for Phase 3 Study of Ustekinumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/04/amgen-announces-positive-results-for-phase-3-study,2022-04-22
Texas Securities Sheriff Wrangles Metaverse Gambles,https://www.goodwinlaw.com/en/insights/blogs/2022/04/texas-securities-sheriff-wrangles-metaverse-gambles,2022-04-22
Ninth Circuit: Web Scraping Does Not Violate CFAA,https://www.goodwinlaw.com/en/insights/blogs/2022/04/ninth-circuit-web-scraping-does-not-violate-cfaa,2022-04-22
SEC Staff Provides Guidance on Broker-Dealer and Investment Adviser Standards of Conduct for Account and Rollover Recommendations to Retail Investors,https://www.goodwinlaw.com/en/insights/blogs/2022/04/sec-staff-provides-guidance-on-brokerdealer-and-in,2022-04-22
Texas Securities Sheriff Wrangles Metaverse Gamblers,https://www.goodwinlaw.com/en/insights/blogs/2022/04/texas-securities-sheriff-wrangles-metaverse-gamble,2022-04-22
Texas Securities Sheriff Wrangles Metaverse Gamblers,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_22-texas-securities-sheriff-wrangles,2022-04-22
Purple Book Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/04/purple-book-updates,2022-04-21
CFPB Sues TransUnion and Senior Executive for Violating Law Enforcement Order Prohibiting Deceptive Marketing,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-sues-transunion-and-senior-executive-for-viol,2022-04-21
CFPB Sues TransUnion and Senior Executive for Violating Law Enforcement Order Prohibiting Deceptive Marketing,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-sues-transunion-and-senior-executive-for-violating-law-enforcement-order-prohibiting-deceptive,2022-04-21
"Open Licenses: An Overview of Open Licenses for Images, Photos, Videos, and Software",https://www.goodwinlaw.com/en/insights/publications/2022/04/04_21-open-licenses-an-overview-of-open-licenses,2022-04-21
FinCEN Issues Advisory For Financial Institutions to Look Out for Kleptocracy and Foreign Corrupt Activity,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_21-weekly-roundup,2022-04-21
FDA Approves Amneal’s ALYMSYS (bevacizumab-maly),https://www.goodwinlaw.com/en/insights/blogs/2022/04/fda-approves-amneals-alymsys-bevacizumabmaly,2022-04-20
FTC Obtains Permanent Injunction Against For-Profit Medical School,https://www.goodwinlaw.com/en/insights/blogs/2022/04/ftc-obtains-permanent-injunction-against-forprofit,2022-04-20
FTC Obtains Permanent Injunction Against For-Profit Medical School,https://www.goodwinlaw.com/en/insights/blogs/2022/04/ftc-obtains-permanent-injunction-against-for-profit-medical-school,2022-04-20
Federal Circuit Reverses PTAB Decision in Amgen Biosimilar-Related IPR Appeal,https://www.goodwinlaw.com/en/insights/blogs/2022/04/federal-circuit-reverses-ptab-decision-in-amgen-bi,2022-04-20
CFPB Proposes Rule to Assist Survivors of Human Trafficking in Obtaining Credit,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-proposes-rule-to-assist-survivors-of-human-tr,2022-04-20
CFPB Proposes Rule to Assist Survivors of Human Trafficking in Obtaining Credit,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-proposes-rule-to-assist-survivors-of-human-trafficking-in-obtaining-credit,2022-04-20
"Ninth Circuit Limits CFAA to Digital ""Breaking and Entering,"" Finds LinkedIn Likely Has No CFAA Claim Against Web Scraper",https://www.goodwinlaw.com/en/insights/publications/2022/04/04_20-ninth-circuit-limits,2022-04-20
The Unified Patent Court is (Finally) Coming to Europe and Bringing Some Pretty Fundamental Changes with It,https://www.goodwinlaw.com/en/insights/blogs/2022/04/the-unified-patent-court-is-finally-coming-to-euro,2022-04-19
Form 10-Q Reminders,https://www.goodwinlaw.com/en/insights/blogs/2022/04/form-10q-reminders,2022-04-19
The Unified Patent Court is (Finally) Coming to Europe and Bringing Some Pretty Fundamental Changes with It,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_19-the-unified-patent-court,2022-04-19
Delaware Chancery Court Dismisses Cigna Derivative Suit Over Failed Anthem Merger,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_19-securities-snapshot,2022-04-19
Expanding Operations in Biologics,https://www.goodwinlaw.com/en/insights/blogs/2022/04/expanding-operations-in-biologics,2022-04-18
"Celltrion’s CT-P6 Demonstrates Equivalent Safety, Efficacy With HERCEPTIN",https://www.goodwinlaw.com/en/insights/blogs/2022/04/celltrions-ctp6-demonstrates-equivalent-safety-eff,2022-04-15
SEC Proposes Sweeping New Climate-Related Disclosure Rules,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_15-sec-proposes-sweeping-new-climate-related,2022-04-15
International Biosimilar Approval and Launch Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/04/international-biosimilar-approval-and-launch-updat,2022-04-14
SEC Staff Provides Guidance on Broker-Dealer and Investment Adviser Standards of Conduct For Account and Rollover Recommendations to Retail Investors,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_14-sec-staff-provides-guidance-on-broker-dealer,2022-04-14
President Biden Signs Executive Order Banning New Investments in Russia,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_14-weekly-roundup,2022-04-14
FDA Accepts Regeneron and Sanofi’s DUPIXENT (Dupilumab) sBLA for Priority Review,https://www.goodwinlaw.com/en/insights/blogs/2022/04/fda-accepts-regeneron-and-sanofis-dupixent-dupilum,2022-04-13
CFPB Files Lawsuit Against TransUnion for Deceptive Marketing,https://www.goodwinlaw.com/en/insights/blogs/2022/04/cfpb-files-lawsuit-against-transunion-for-deceptive-marketing,2022-04-12
Nasdaq Board Diversity Disclosure: The Results Are In!,https://www.goodwinlaw.com/en/insights/blogs/2022/04/nasdaq-board-diversity-disclosure-the-results-are,2022-04-12
European Life Sciences Deal Trends,https://www.goodwinlaw.com/en/insights/blogs/2022/04/european-life-sciences-deal-trends,2022-04-12
European Life Sciences Deals Trends,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_12-european-life-sciences-deals-trends,2022-04-12
SEC Examinations Division Publishes 2022 Priorities,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_11-sec-examinations-division-publishes,2022-04-11
SEC Examinations Division Publishes 2022 Priorities,https://www.goodwinlaw.com/en/insights/blogs/2022/04/sec-examinations-division-publishes-2022-prioritie,2022-04-08
Goodwin Webinar on CFPB Supervisory and Enforcement Priorities,https://www.goodwinlaw.com/en/insights/blogs/2022/04/goodwin-webinar-on-cfpb-supervisory-and-enforcemen,2022-04-08
Goodwin Webinar on CFPB Supervisory and Enforcement Priorities,https://www.goodwinlaw.com/en/insights/blogs/2022/04/goodwin-webinar-on-cfpb-supervisory-and-enforcement-priorities,2022-04-08
Alvotech and AbbVie Resolve Disputes Relating to Alvotech’s Adalimumab Biosimilar in Europe,https://www.goodwinlaw.com/en/insights/blogs/2022/04/alvotech-and-abbvie-resolve-disputes-relating-to-a,2022-04-07
Clinical Trial Updates: Insulin Glargine and Trastuzumab Biosimilars,https://www.goodwinlaw.com/en/insights/blogs/2022/04/clinical-trial-updates-insulin-glargine-and-trastu,2022-04-07
Newly Appointed Federal Watchdogs Warn they are Focused on Private Funds,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_07-newly-appointed-federal-watchdogs,2022-04-07
No Safe Harbor for Late Payments to Massachusetts Employees: Pay on Time or Pay Triple,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_07-no-safe-harbor-for-late-payments,2022-04-07
Board Diversity — An Overview for Nonprofits,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_07-board-diversity-an-overview-for-nonprofits,2022-04-07
FDIC Requests Comments to Draft Principles for Climate-Related Financial Risk Management,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_07-weekly-roundup,2022-04-07
Regeneron’s Disclaimer of Aflibercept Formulation Patent Causes PTAB Denial of Institution of Celltrion PGR,https://www.goodwinlaw.com/en/insights/blogs/2022/04/regenerons-disclaimer-of-aflibercept-formulation-p,2022-04-06
ERISA Litigation Update,https://www.goodwinlaw.com/en/insights/newsletters/2022/04/erisa--litigation-update,2022-04-06
CFPB Targets Unfair Discrimination in Consumer Finance Webinar,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_06-cfpb-targets-unfair,2022-04-06
Spotlight to Get Brighter on Private Fund Advisers for SEC Exams in 2022,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_06-spotlight-to-get-brighter-on-private-fund,2022-04-06
Nonprofit Organizations and Data Security Incidents — How to Manage and Respond,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_06-nonprofit-organizations-and-data-security,2022-04-06
Medytox Files ITC Complaint Against Hugel to Block Import of Botox Follow-On,https://www.goodwinlaw.com/en/insights/blogs/2022/04/medytox-files-itc-complaint-against-hugel-to-block,2022-04-05
Form 10-Q Form Check Table,https://www.goodwinlaw.com/en/insights/blogs/2022/04/form-10q-form-check-table,2022-04-05
SEC Proposes Rule Amendments Requiring Climate — Related Disclosures,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_05-securities-snapshot,2022-04-05
What to Know; High Court Bars Use of Bitcoin as Security,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_04-what-to-know-high-court-bars,2022-04-04
Celltrion Announces Agreement with Brazilian Government to Supply Infliximab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/04/celltrion-announces-agreement-with-brazilian-gover,2022-04-01
FTC Announces $10 Million Settlement With Auto Dealers for Alleged Junk Fees and Discriminatory Practices,https://www.goodwinlaw.com/en/insights/blogs/2022/04/ftc-announces-10-million-settlement-with-auto-dealers-for-alleged-junk-fees-and-discriminatory-pract,2022-04-01
New York City Issues Guidance on Required Salary Disclosures in Job Postings,https://www.goodwinlaw.com/en/insights/publications/2022/04/04_01-new-york-city-issues-guidance,2022-04-01
CFPB Orders Student-Loan Servicer to Pay $1 Million Penalty and Remedy Miscommunications,https://www.goodwinlaw.com/en/insights/blogs/2022/03/cfpb-orders-studentloan-servicer-to-pay-1-million,2022-03-31
CFPB Orders Student-Loan Servicer to Pay $1 Million Penalty and Remedy Miscommunications,https://www.goodwinlaw.com/en/insights/blogs/2022/03/cfpb-orders-student-loan-servicer-to-pay-$1-million-penalty-and-remedy-miscommunications,2022-03-31
CFPB Issues Report Highlighting Medical Bills on Credit Reports,https://www.goodwinlaw.com/en/insights/blogs/2022/03/cfpb-issues-report-highlighting-medical-bills-on-c,2022-03-31
CFPB Issues Report Highlighting Medical Bills on Credit Reports,https://www.goodwinlaw.com/en/insights/blogs/2022/03/cfpb-issues-report-highlighting-medical-bills-on-credit-reports,2022-03-31
SEC Proposes New Rules Applicable To SPACs And Certain Reverse Mergers,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_31-sec-proposes-new-rules-applicable,2022-03-31
Pro Bono Prose: David Brekke,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_31-pro-bono-prose-david-brekke,2022-03-31
SEC Proposes Rules to Include Certain Significant Market Participants as “Dealers” or “Government Securities Dealers”,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_31-weekly-roundup,2022-03-31
New Data Protection Rights Coming Soon to Saudi Arabia – Just Not as Soon as Expected,https://www.goodwinlaw.com/en/insights/blogs/2022/03/new-data-protection-rights-coming-soon-to-saudi-ar,2022-03-30
British Columbia Announces Coverage of Three New Biosimilars for Blood Clot Prevention and Treatment,https://www.goodwinlaw.com/en/insights/blogs/2022/03/british-columbia-announces-coverage-of-three-new-b,2022-03-29
U.S. and EU Reach Political Agreement On a New Trans-Atlantic Data Privacy Framework: The Implications for Businesses,https://www.goodwinlaw.com/en/insights/blogs/2022/03/us-and-eu-reach-political-agreement-on-a-new-trans,2022-03-29
Securities Law Issues for De-SPAC Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/03/securities-law-issues-for-despac-companies,2022-03-29
Court Enjoins Credit Repair Company From Making Misrepresentations to Consumers,https://www.goodwinlaw.com/en/insights/blogs/2022/03/court-enjoins-credit-repair-company-from-making-mi,2022-03-29
Court Enjoins Credit Repair Company From Making Misrepresentations to Consumers,https://www.goodwinlaw.com/en/insights/blogs/2022/03/court-enjoins-credit-repair-company-from-making-misrepresentations-to-consumers,2022-03-29
U.S. And EU Reach Political Agreement on a New Trans-Atlantic Data Privacy Framework: The Implications for Businesses,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_29-us-and-eu-reach-political-agreement,2022-03-29
CFPB Broadens Scope of UDAAP Authority to Discrimination and Consumer Reviews,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_29-cfpb-broadens-scope-of-udaap-authority,2022-03-29
Utah Passes Comprehensive Consumer Privacy Legislation,https://www.goodwinlaw.com/en/insights/blogs/2022/03/utah-passes-comprehensive-consumer-privacy-legisla,2022-03-28
JHL Biotech Co-Founders Sentenced to Jail for Theft of Trade Secrets,https://www.goodwinlaw.com/en/insights/blogs/2022/03/jhl-biotech-cofounders-sentenced-to-jail-for-theft,2022-03-25
Draft Implementing Rules of China’s Human Genetic Resources Regulations as Applied to Foreign Persons,https://www.goodwinlaw.com/en/insights/blogs/2022/03/draft-implementing-rules-of-chinas-human-genetic-r,2022-03-25
FINRA Reminds CCOs About Potential Supervisory Liability,https://www.goodwinlaw.com/en/insights/blogs/2022/03/finra-reminds-ccos-about-potential-supervisory-lia,2022-03-25
Safety First! Much-Anticipated FDA Draft Guidance Provides Additional Advice on the Development of Human Genome Editing Products,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_25-safety-first-much-anticipated,2022-03-25
FINRA Reminds Firms About CCO Supervisory Liability,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_24-weekly-roundup,2022-03-24
Draft Implementing Rules of China’s Human Genetic Resources Regulations as Applied to Foreign Persons,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_24-draft-implementing-rules-of-chinas-human,2022-03-24
UK Data Transfer Mechanism Comes Into Force,https://www.goodwinlaw.com/en/insights/blogs/2022/03/uk-data-transfer-mechanism-comes-into-force,2022-03-23
OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico,https://www.goodwinlaw.com/en/insights/blogs/2022/03/ocyonbio-announces-biosimilar-solutions-to-begin-g,2022-03-23
National Security and Investment Act 2021 and Restructuring and Insolvency,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_23-national-security-and-investment-act,2022-03-23
Parties in Amgen v. Hospira Pegfilgrastim Litigation Stipulate to Dismissal of All Claims,https://www.goodwinlaw.com/en/insights/blogs/2022/03/parties-in-amgen-v-hospira-pegfilgrastim-litigatio,2022-03-22
Proxy Statement Voting Disclosures,https://www.goodwinlaw.com/en/insights/blogs/2022/03/proxy-statement-voting-disclosures,2022-03-22
Northern District of Illinois Grants Motion for Partial Reconsideration of Summary Judgment Decision Regarding Whether Former Walgreens CFO’s Statements Were Actionable,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_22-securities-snapshot,2022-03-22
FDA to Hold Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act,https://www.goodwinlaw.com/en/insights/blogs/2022/03/fda-to-hold-final-assessment-of-the-program-for-en,2022-03-21
FTC Stops Alleged Credit Repair Scheme that Filed False Identify Theft Complaints,https://www.goodwinlaw.com/en/insights/blogs/2022/03/ftc-stops-alleged-credit-repair-scheme-that-filed-false-identify-theft-complaints,2022-03-21
"JAMA Oncology Publishes Results of Phase III Study for Prestige BioPharma’s HERCEPTIN Biosimilar, HD201",https://www.goodwinlaw.com/en/insights/blogs/2022/03/jama-oncology-publishes-results-of-phase-iii-study,2022-03-21
White House Issues Crypto Executive Order,https://www.goodwinlaw.com/en/insights/blogs/2022/03/white-house-issues-crypto-executive-order,2022-03-21
Extra Time in The Supreme Court: Updated February 2022,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_21-extra-time-in-the-supreme-court,2022-03-21
FDA Announces Biosimilar Funding Opportunity,https://www.goodwinlaw.com/en/insights/blogs/2022/03/fda-announces-biosimilar-funding-opportunity,2022-03-18
California DFPI Issues Guidance to Financial Institutions Regarding Russia Sanctions,https://www.goodwinlaw.com/en/insights/blogs/2022/03/california-dfpi-issues-guidance-to-financial-insti,2022-03-17
California DFPI Issues Guidance to Financial Institutions Regarding Russia Sanctions,https://www.goodwinlaw.com/en/insights/blogs/2022/03/california-dfpi-issues-guidance-to-financial-institutions-regarding-russia-sanctions,2022-03-17
Reps & Warranties Claim Disputes in the Courts,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_17-reps-and-warranties-claim-disputes,2022-03-17
CFPB Launches New Initiative Focused on Rural Communities,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_17-weekly-roundup,2022-03-17
SEC Commissioner Allison Herren Lee Announces Departure (Sorta),https://www.goodwinlaw.com/en/insights/blogs/2022/03/sec-commissioner-allison-herren-lee-announces-depa,2022-03-16
SEC Proposes Expanded and Accelerated Cybersecurity Disclosures for Public Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/03/sec-proposes-expanded-and-accelerated-cybersecurit,2022-03-16
President Biden Signs Into Law Medicare Telehealth Coverage Extension Post-Public Health Emergency,https://www.goodwinlaw.com/en/insights/blogs/2022/03/president-biden-signs-into-law-medicare-telehealth,2022-03-16
White House Issues Crypto Executive Order: Appears to Acknowledge Crypto and Blockchain Are Critical and Here to Stay; Studies and Reports to Follow,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_16-white-house-issues-crypto-executive-order,2022-03-16
Women’s History Month Spotlight: Rosalyn Yalow,https://www.goodwinlaw.com/en/insights/blogs/2022/03/womens-history-month-spotlight-rosalyn-yalow,2022-03-15
Remote-Only Company SEC Filings,https://www.goodwinlaw.com/en/insights/blogs/2022/03/remoteonly-company-sec-filings,2022-03-15
SEC Proposes Expanded and Accelerated Cybersecurity Disclosure by Public Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/03/sec-proposes-expanded-and-accelerated-cybersecurit,2022-03-15
PTAB Institutes Another IPR on a Tocilizumab Patent Challenged by Fresenius,https://www.goodwinlaw.com/en/insights/blogs/2022/03/ptab-institutes-another-ipr-on-a-tocilizumab-paten,2022-03-14
U.S. Senators Introduce New Bill to Protect Minors Online – The Kids Online Safety Act,https://www.goodwinlaw.com/en/insights/blogs/2022/03/us-senators-introduce-new-bill-to-protect-minors-o,2022-03-14
"Yet Further Export, Import and Investment Sanctions on Russia and Belarus, Phase IV",https://www.goodwinlaw.com/en/insights/publications/2022/03/03_14-yet-further-export-import-and-investment,2022-03-14
SEC Proposes Expanded and Accelerated Cybersecurity Disclosure by Public Companies,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_14-sec-proposes-expanded-and-accelerated,2022-03-14
Credit Union Enters Into Consent Order with U.S. Attorney’s Office Over Alleged SCRA Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/03/credit-union-enters-into-consent-order-with-us-att,2022-03-12
Credit Union Enters Into Consent Order with U.S. Attorney’s Office Over Alleged SCRA Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/03/credit-union-enters-into-consent-order-with-us-attorneys-office-over-alleged-scra-violations,2022-03-12
Delaware Law Allows Buyers to “Sandbag” Sellers,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_11-delaware-law-allows-buyers,2022-03-11
Alvotech and AbbVie Settle Patent Dispute,https://www.goodwinlaw.com/en/insights/blogs/2022/03/alvotech-and-abbvie-settle-patent-dispute,2022-03-10
RELEUKO Receives FDA Approval,https://www.goodwinlaw.com/en/insights/blogs/2022/03/releuko-receives-fda-approval,2022-03-10
Lender Settles Fraud Claims with Arizona AG for $4.8 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/03/lender-settles-fraud-claims-with-arizona-ag-for-48,2022-03-10
Lender Settles Fraud Claims with Arizona AG for $4.8 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/03/lender-settles-fraud-claims-with-arizona-ag-for-48-million,2022-03-10
FinCEN Warns Against Evasion of Russian Sanctions,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_10-weekly-roundup,2022-03-10
UK Sanctions Russia — What To Know About Financial Impacts,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_09-uk-sanctions-russia,2022-03-09
Adalimumab biosimilar wins NMPA approval,https://www.goodwinlaw.com/en/insights/blogs/2022/03/adalimumab-biosimilar-wins-nmpa-approval,2022-03-08
Virtual Annual Meeting Disclosures,https://www.goodwinlaw.com/en/insights/blogs/2022/03/virtual-annual-meeting-disclosures,2022-03-08
Eleventh Circuit Overturns Dismissal of Cryptocurrency Ponzi Scheme Class Action Suit,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_08-securities-snapshot,2022-03-08
UK Government Seeking to Introduce a Register of Overseas Entities,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_07-uk-government-seeking,2022-03-07
DOJ False Claims Act Recoveries Exceed $5.6 Billion in 2021,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_07-doj-false-claims-act-recoveries,2022-03-07
Biocon Biologics Ltd. To Acquire Viatris Biosimilars Portfolio,https://www.goodwinlaw.com/en/insights/blogs/2022/03/biocon-biologics-ltd-to-acquire-viatris-biosimilar,2022-03-04
The DOJ Goes Phishing: The Rise of False Claims Act Cybersecurity Litigation,https://www.goodwinlaw.com/en/insights/blogs/2022/03/the-doj-goes-phishing-the-rise-of-false-claims-act,2022-03-04
"FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®",https://www.goodwinlaw.com/en/insights/blogs/2022/03/fda-accepts-alvotechs-bla-supporting-interchangeab,2022-03-04
FINRA Reminds Firms of Evolving Definition of “Prompt” Order Execution,https://www.goodwinlaw.com/en/insights/blogs/2022/03/finra-reminds-firms-of-evolving-definition-of-prom,2022-03-04
"New Sanctions and Export Controls for Russia and Belarus, Phase III",https://www.goodwinlaw.com/en/insights/publications/2022/03/03_04-new-sanctions-and-export-controls-for-russia,2022-03-04
Switching Study Concludes That Transition From Humira To Samsung Bioepis’s Adalimumab Biosimilar Is Safe and Effective,https://www.goodwinlaw.com/en/insights/blogs/2022/03/switching-study-concludes-that-transition-from-hum,2022-03-03
SEC Proposes Short Sale Disclosure Rule and Reopens Comment Period for Reporting on Securities Loans,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_03-weekly-roundup,2022-03-03
E&S Risk Oversight Proxy Statement Disclosure,https://www.goodwinlaw.com/en/insights/blogs/2022/03/es-risk-oversight-proxy-statement-disclosure,2022-03-01
CFPB Increases Scrutiny on Student Loan Servicers,https://www.goodwinlaw.com/en/insights/blogs/2022/03/cfpb-increases-scrutiny-on-student-loan-servicers,2022-03-01
Regulators Continue to Scrutinize Private Equity Investments in Insurance,https://www.goodwinlaw.com/en/insights/publications/2022/03/03_01-regulators-continue-to-scrutinize,2022-03-01
Regulation Best Interest and Form CRS: Spotlight on FINRA’s 2022 Exam and Risk Monitoring Program Report,https://www.goodwinlaw.com/en/insights/blogs/2022/02/regulation-best-interest-and-form-crs-spotlight-on,2022-02-27
PTAB Institutes Two More IPRs on Tocilizumab Patents Challenged by Fresenius,https://www.goodwinlaw.com/en/insights/blogs/2022/02/ptab-institutes-two-more-iprs-on-tocilizumab-paten,2022-02-25
"Substantial Enhancement of Sanctions and Export Controls Targeting Russia and Belarus, Phase II",https://www.goodwinlaw.com/en/insights/publications/2022/02/02_25-substantial-enhancement-of-sanctions,2022-02-25
Regulation Best Interest and Form CRS: Spotlight on FINRA’s 2022 Exam and Risk Monitoring Program Report,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_25-regulation-best-interest,2022-02-25
Goodwin’s 2021 Consumer Financial Services Year In Review,https://www.goodwinlaw.com/en/insights/blogs/2022/02/goodwins-2021-consumer-financial-services-year-in,2022-02-24
Goodwin’s 2021 Consumer Financial Services Year In Review,https://www.goodwinlaw.com/en/insights/blogs/2022/02/goodwins-2021-consumer-financial-services-year-in-review,2022-02-24
AbbVie Moves to Strike Alvotech’s Final Invalidity and Unenforceability Contentions,https://www.goodwinlaw.com/en/insights/blogs/2022/02/abbvie-moves-to-strike-alvotechs-final-invalidity,2022-02-24
Distress in the Hotel Sector,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_24-distress-in-the-hotel-sector,2022-02-24
"New Sanctions Imposed in Response to Russia’s Incursions in Ukraine, Phase I",https://www.goodwinlaw.com/en/insights/publications/2022/02/02_23-new-sanctions-imposed-in-response-to-russia,2022-02-23
CMS Continues to Modernize by Expanding Reimbursement for Digital Health Services,https://www.goodwinlaw.com/en/insights/blogs/2022/02/cms-continues-to-modernize-by-expanding-reimbursem,2022-02-22
SEC Penalizes 12 Additional BDs and IAs with CRS Failures,https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-penalizes-12-additional-bds-and-ias-with-crs-f,2022-02-22
Navigating Loss of WKSI Status on 10-K Filing Date,https://www.goodwinlaw.com/en/insights/blogs/2022/02/navigating-loss-of-wksi-status-on-10k-filing-date,2022-02-22
CMS Continues to Modernize by Expanding Reimbursement for Digital Health Services,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_22-cms-continues-to-modernize-by-expanding,2022-02-22
District Court Denies Payday Lender's Bid To Dismiss SEC Enforcement Action,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_22-securities-snapshot,2022-02-22
"A Primer on Patenting Ranges — All About ""About""",https://www.goodwinlaw.com/en/insights/publications/2022/02/02_22-a-primer-on-patenting,2022-02-22
Use of Google Analytics by EU Websites Violates GDPR,https://www.goodwinlaw.com/en/insights/blogs/2022/02/use-of-google-analytics-by-eu-websites-violates-gd,2022-02-18
FINRA to Permit Temporary Transaction Holds and Longer Disbursement Holds to Prevent Financial Exploitation of Elders and Other Specified Adults,https://www.goodwinlaw.com/en/insights/blogs/2022/02/finra-to-permit-temporary-transaction-holds-and-lo,2022-02-18
FinCEN Issues Report Addressing NFTs,https://www.goodwinlaw.com/en/insights/blogs/2022/02/fincen-issues-report-addressing-nfts,2022-02-17
CFPB Issues Request for Information Regarding Junk Fees,https://www.goodwinlaw.com/en/insights/blogs/2022/02/cfpb-issues-request-for-information-regarding-junk,2022-02-17
CFPB Issues Request for Information Regarding Junk Fees,https://www.goodwinlaw.com/en/insights/blogs/2022/02/cfpb-issues-request-for-information-regarding-junk-fees,2022-02-17
Stress Test Scenarios Released for 2022,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_17-weekly-roundup,2022-02-17
FINRA to Permit Temporary Transaction Holds and Longer Disbursement Holds to Prevent Financial Exploitation of Elders and Other Specified Adults,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_17-finra-to-permit-temporary-transaction-holds,2022-02-17
International Biosimilar Approval and Launch Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/02/international-biosimilar-approval-and-launch-updat,2022-02-16
Nova Scotia Announces Shift to Biosimilar Drugs,https://www.goodwinlaw.com/en/insights/blogs/2022/02/nova-scotia-announces-shift-to-biosimilar-drugs,2022-02-16
SEC Proposes Radical Changes to Private Fund Regulation,https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-proposes-radical-changes-to-private-fund-regul,2022-02-15
Biogen and Xbrane Enter into Worldwide Commercialization and License Agreement for Certolizumab Pegol Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/02/biogen-and-xbrane-enter-into-worldwide-commerciali,2022-02-15
Proxy Statement Form Check Table,https://www.goodwinlaw.com/en/insights/blogs/2022/02/proxy-statement-form-check-table,2022-02-15
SEC Focus on Cybersecurity Begins To Take Shape,https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-focus-on-cybersecurity-begins-to-take-shape,2022-02-15
SEC Focus on Cybersecurity Begins To Take Shape,https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-focus-on-cybersecurity-begins-to-take-shape,2022-02-15
Draft Senate Legislation Expands FDA’s QIDP Designation,https://www.goodwinlaw.com/en/insights/blogs/2022/02/draft-senate-legislation-expands-fdas-qidp-designa,2022-02-14
Alvotech and BiosanaPharma Enter Exclusive Global Licensing Agreement for AVT23,https://www.goodwinlaw.com/en/insights/blogs/2022/02/alvotech-and-biosanapharma-enter-exclusive-global,2022-02-14
SEC Proposes Changes To Whistleblower Program Rules,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_14-sec-proposed-changes-to-whistleblower,2022-02-14
Propsci in France: An Emerging Market,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_14-propsci-in-france-an-emerging-market,2022-02-14
SEC Focus on Cybersecurity Begins to Take Shape,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_14-sec-focus-on-cybersecurity,2022-02-14
SEC Cybersecurity Rules Target Investment Advisers and Investment Companies,https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-cybersecurity-rules-target-investment-advisers,2022-02-11
FINRA Publishes 2022 Examination and Risk Monitoring Report,https://www.goodwinlaw.com/en/insights/blogs/2022/02/finra-publishes-2022-examination-and-risk-monitori,2022-02-11
Private Equity Market Update,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_11-private-equity-market-updates-at-a-glance,2022-02-11
2022 Real Estate Capital Markets Conference Recap,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_11-recm-2022-recap,2022-02-11
FDA Approves Genentech’s VABYSMO for Wet AMD and Diabetic Macular Edema,https://www.goodwinlaw.com/en/insights/blogs/2022/02/fda-approves-genentechs-vabysmo-for-wet-amd-and-di,2022-02-10
Commerce Adds 33 Chinese Companies to the Unverified List,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_10-commerce-adds-33-chinese,2022-02-10
SEC Proposes Changes to Private Fund Regulation,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_10-weekly-roundup,2022-02-10
SEC Cybersecurity Rules Target Investment Advisers and Investment Companies,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_10-sec-cybersecurity-rules-target-investment,2022-02-10
Key Issues From a Summary of the Findings in the Claim Brought by HP Following the Troubled Purchase of Autonomy,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_09-key-issues-from-a-summary-of-the,2022-02-09
SEC Proposes Radical Changes to Private Fund Regulation,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_09-sec-proposes-radical-changes-to-private,2022-02-09
Massachusetts AG Settles Claims Against Subprime Auto Lender for $5.56 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/02/massachusetts-ag-settles-claims-against-subprime-a,2022-02-08
Massachusetts AG Settles Claims Against Subprime Auto Lender for $5.56 Million,https://www.goodwinlaw.com/en/insights/blogs/2022/02/massachusetts-ag-settles-claims-against-subprime-auto-lender-for-556-million,2022-02-08
DC AG Reaches $4 Million Settlement with Online Lender,https://www.goodwinlaw.com/en/insights/blogs/2022/02/dc-ag-reaches-4-million-settlement-with-online-len,2022-02-08
DC AG Reaches $4 Million Settlement with Online Lender,https://www.goodwinlaw.com/en/insights/blogs/2022/02/dc-ag-reaches-$4-million-settlement-with-online-lender,2022-02-08
Universal Proxy Disclosure in 2022 Proxy Statements,https://www.goodwinlaw.com/en/insights/blogs/2022/02/universal-proxy-disclosure-in-2022-proxy-statement,2022-02-08
CFPB Encourages Consumers To “Hold Accountable” Consumer Reporting Companies By Filing Disputes and FCRA Lawsuits,https://www.goodwinlaw.com/en/insights/blogs/2022/02/cfpb-encourages-consumers-to-hold-accountable-cons,2022-02-08
CFPB Encourages Consumers To “Hold Accountable” Consumer Reporting Companies By Filing Disputes and FCRA Lawsuits,https://www.goodwinlaw.com/en/insights/blogs/2022/02/cfpb-encourages-consumers-to-hold-accountable-consumer-reporting-companies-by-filing-disputes-and-fc,2022-02-08
International Trade Commission Institutes Investigation of Alvotech’s Adalimumab Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/02/international-trade-commission-institutes-investig,2022-02-08
Delaware Chancery Court Dismisses Derivative Claim for Failure to Show Demand Futility,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_08-securities-snapshot,2022-02-08
Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologics,https://www.goodwinlaw.com/en/insights/blogs/2022/02/biogen-sells-bioepis-stake-for-23-billion-to-samsu,2022-02-04
China is Entering a New Era in Data Protections,https://www.goodwinlaw.com/en/insights/blogs/2022/02/china-is-entering-a-new-era-in-data-protections,2022-02-04
Mixed-Use: Assembling the Jigsaw,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_04-mixed-use-assembling-the-jigsaw,2022-02-04
Mississippi Becomes 37th State to Legalize Medical Cannabis,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_04-mississippi-becomes-37th-state-to-legalize,2022-02-04
Federal Reserve Proposes New Supervisory Framework for Certain Holding Companies Engaged in Insurance Activities,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_03-weekly-roundup,2022-02-03
China is Entering a New Era in Data Protections,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_03-china-is-entering-a-new-era-in-data,2022-02-03
"SEC Proposes Broad Expansion of Regulation ATS, Regulation SCI, and Exchange Definition",https://www.goodwinlaw.com/en/insights/blogs/2022/02/sec-proposes-broad-expansion-of-regulation-ats-reg,2022-02-02
"SEC Filing Fee Exhibit, Payment and Related Changes",https://www.goodwinlaw.com/en/insights/publications/2022/02/02_02-sec-filing-fee-exhibit-payment-changes,2022-02-02
A Primer on Patenting Ranges,https://www.goodwinlaw.com/en/insights/blogs/2022/02/a-primer-on-patenting-ranges,2022-02-01
Form 10-K Form Check Table,https://www.goodwinlaw.com/en/insights/blogs/2022/02/form-10k-form-check-table,2022-02-01
"For Clinical Trial Recruiting, Words Matter",https://www.goodwinlaw.com/en/insights/blogs/2022/02/for-clinical-trial-recruiting-words-matter,2022-02-01
A Primer On Patenting Ranges,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_01-a-primer-on-patenting-ranges,2022-02-01
"SEC Proposes Broad Expansion of Regulation ATS, Regulation SCI, and Exchange Definition",https://www.goodwinlaw.com/en/insights/publications/2022/02/02_01-sec-proposes-broad-expansion-of-regulation,2022-02-01
Pro Bono Prose: Alexandra Valenti,https://www.goodwinlaw.com/en/insights/publications/2022/02/02_01-pro-bono-prose-alexandra-valenti,2022-02-01
"SEC Proposes Rules that Could Regulate DeFi, Extend to Aspects of Centralized Crypto Exchanges",https://www.goodwinlaw.com/en/insights/blogs/2022/01/sec-proposes-rules-that-could-regulate-defi-extend,2022-01-31
An Overview of the Latest Human Genetic Resources Regime in China,https://www.goodwinlaw.com/en/insights/blogs/2022/01/an-overview-of-the-latest-human-genetic-resources,2022-01-28
China Passes Extensive Regulations Governing Artificial Intelligence Algorithms,https://www.goodwinlaw.com/en/insights/blogs/2022/01/china-passes-extensive-regulations-governing-artif,2022-01-28
"SEC Eyeing Rulemaking to Combat Market Volatility, Modernize Market Structure",https://www.goodwinlaw.com/en/insights/blogs/2022/01/sec-eyeing-rulemaking-to-combat-market-volatility,2022-01-28
How the Proposed Amendments to Form PF Would Affect Private Fund Sponsors,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_28-how-the-proposed-amendments,2022-01-28
"SEC Proposes Rules That Could Regulate DeFi, Extend to Aspects of Centralized Crypto Exchanges",https://www.goodwinlaw.com/en/insights/publications/2022/01/01_28-sec-proposes-rules-to-regulate-defi,2022-01-28
The Princeton University Data Access Research: A Timely Reminder to Revisit Data Subject Request Processes,https://www.goodwinlaw.com/en/insights/blogs/2022/01/the-princeton-university-data-access-research-a-ti,2022-01-27
Hughes et al v. Northwestern University et al – Supreme Court Urges Courts to Undertake a Context-Specific Scrutiny of Excessive-Fee Claims in ERISA Cases and Pay Heed to the “Range of Reasonable Judgments a Fiduciary May Make”,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_27-supreme-court-urges-courts-to-undertake,2022-01-27
FinCEN Proposes Rule for SARs Sharing Pilot Program,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_27-weekly-roundup,2022-01-27
An Overview of the Latest Human Genetic Resources Regime in China,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_27-an-overview-of-the-latest-human-genetic,2022-01-27
Private Equity Coalition Advances Convergence on ESG Data,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_27_22-private-equity-coalition-advances,2022-01-27
FTC Announces Settlement With Remaining Defendants in Student Loan Debt Relief Action,https://www.goodwinlaw.com/en/insights/blogs/2022/01/ftc-announces-settlement-with-remaining-defendants,2022-01-26
FTC Announces Settlement With Remaining Defendants in Student Loan Debt Relief Action,https://www.goodwinlaw.com/en/insights/blogs/2022/01/ftc-announces-settlement-with-remaining-defendants-in-student-loan-debt-relief-action,2022-01-26
California Physicians Allege PE-Backed Provider Violates Corporate Practice Law,https://www.goodwinlaw.com/en/insights/blogs/2022/01/california-physicians-allege-pebacked-provider-vio,2022-01-26
Cannabis 2022 – Updates on the Legal and Regulatory Landscape,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_26-cannabis-2022,2022-01-26
2022 Goodwin CLE Day Program – #BigTechBreakUp: What’s to Come in Antitrust for the Tech Sector in 2022,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_26-2022-goodwin-cle-day-program-bigtechbreakup,2022-01-26
"Commercial Leasing in Massachusetts: Contractual Limitation of Liability Provisions Unenforceable for Willful or Knowing Violations of Chapter 93A, Section 11",https://www.goodwinlaw.com/en/insights/publications/2022/01/01_26-commercial-leasing-in-massachusetts,2022-01-26
FDA Completes Safety Review of Lannett’s IND for Insulin Glargine Biosimilar,https://www.goodwinlaw.com/en/insights/blogs/2022/01/fda-completes-safety-review-of-lannetts-ind-for-in,2022-01-25
Form 10-K Checklist & Guide,https://www.goodwinlaw.com/en/insights/blogs/2022/01/form-10k-checklist--guide,2022-01-25
Guidelines on Marketing Communications Under the Regulation on Cross-Border Distribution of Funds,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_25-guidelines-on-marketing-communications,2022-01-25
Northern District of California Validates SEC’s “Shadow Trading” Theory of Insider Trading Liability,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_25-securities-snapshot,2022-01-25
SEC Proposes Securities Lending Transaction Reporting Requirements,https://www.goodwinlaw.com/en/insights/blogs/2022/01/sec-proposes-securities-lending-transaction-report,2022-01-24
Propsci Perspectives: SmartLabs,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_24-propsci-perspectives-smartlabs,2022-01-24
China Issues Revised Measures on Cybersecurity Review Over Network Operators,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_24-china-issues-revised-measures,2022-01-24
Extra Time in the Supreme Court: Updated January 2022,https://www.goodwinlaw.com/en/insights/publications/2022/01/11_12-extra-time-in-the-supreme-court,2022-01-24
2022 HSR Thresholds Announced: $101 Million,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_21-2022-hsr-thresholds-announced-$101-million,2022-01-21
DOJ and FTC Start Joint Effort To “Strengthen Enforcement Against Illegal Mergers”,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_21-doj-and-ftc-start-joint-effort,2022-01-21
Pro Bono Prose: Rebecca Wardle,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_21-pro-bono-prose-rebecca-wardle,2022-01-21
SEC Proposes Securities Lending Transaction Reporting Requirements,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_21-sec-proposes-securities-lending-transaction,2022-01-21
Massachusetts Court Holds Notice of TCPA Exclusions Sufficient to Avoid TCPA Violation,https://www.goodwinlaw.com/en/insights/blogs/2022/01/massachusetts-court-holds-notice-of-tcpa-exclusions-sufficient-to-avoid-tcpa-violation,2022-01-20
Massachusetts Court Holds Notice of TCPA Exclusions Sufficient to Avoid TCPA Violation,https://www.goodwinlaw.com/en/insights/blogs/2022/01/massachusetts-court-holds-notice-of-tcpa-exclusion,2022-01-20
Acting Comptroller Discusses Crypto-Assets and Regulation,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_20-weekly-roundup,2022-01-20
International Generic and Biosimilar Medicines Association (IGBA) Appoints Vivian Fritelli to IGBA Chair for 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/01/international-generic-and-biosimilar-medicines-ass,2022-01-19
CFPB Settles With Chicago-Based Payment Processer Over Services Provided to Telemarketers,https://www.goodwinlaw.com/en/insights/blogs/2022/01/cfpb-settles-with-chicago-based-payment-processer-over-services-provided-to-telemarketers,2022-01-18
CFPB Settles With Chicago-Based Payment Processer Over Services Provided to Telemarketers,https://www.goodwinlaw.com/en/insights/blogs/2022/01/cfpb-settles-with-chicagobased-payment-processer-o,2022-01-18
Earnings Release Checklist & Guide,https://www.goodwinlaw.com/en/insights/blogs/2022/01/earnings-release-checklist--guide,2022-01-18
ESMA Cloud Outsourcing Guidelines – Practical Points for Cloud Service Providers and Regulated Entities,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_18-esma-cloud-outsourcing-guidelines-practical,2022-01-18
Medicare Agrees to Limited Payment for New Alzheimer’s Drug,https://www.goodwinlaw.com/en/insights/blogs/2022/01/medicare-agrees-to-limited-payment-for-new-alzheim,2022-01-14
Student Loan Servicer Reaches $8 Million Agreement with DOJ to Resolve False Claims Allegations,https://www.goodwinlaw.com/en/insights/blogs/2022/01/student-loan-servicer-reaches-8-million-agreement,2022-01-14
Student Loan Servicer Reaches $8 Million Agreement with DOJ to Resolve False Claims Allegations,https://www.goodwinlaw.com/en/insights/blogs/2022/01/student-loan-servicer-reaches-$8-million-agreement-with-doj-to-resolve-false-claims-allegations,2022-01-14
CNIL Sets Parameters for Processors’ Reuse of Data for Product Improvement,https://www.goodwinlaw.com/en/insights/blogs/2022/01/cnil-sets-parameters-for-processors-reuse-of-data,2022-01-14
Alvotech and JAMP Pharma Receive Marketing Authorization for SIMLANDI in Canada,https://www.goodwinlaw.com/en/insights/blogs/2022/01/alvotech-and-jamp-pharma-receive-marketing-authori,2022-01-14
Planning for the End: FDA Issues Draft Guidance for Transitioning EUA and Enforcement Policy Medical Devices Marketed During the Pandemic,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_14-planning-for-the-end-fda-issues-draft,2022-01-14
Supreme Court Stays Enforcement of OSHA’s Vaccine or Test Rule — Next Steps for Employers,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_14-supreme-court-stays-enforcement-of-osha,2022-01-14
39 State Attorneys General Reach $1.85 Billion Settlement With Student Loan Servicer,https://www.goodwinlaw.com/en/insights/blogs/2022/01/39-state-attorneys-general-reach-185-billion-settl,2022-01-13
39 State Attorneys General Reach $1.85 Billion Settlement With Student Loan Servicer,https://www.goodwinlaw.com/en/insights/blogs/2022/01/39-state-attorneys-general-reach-185-billion-settlement-with-student-loan-servicer,2022-01-13
The Irish DPC Publishes Final Version of its Children’s Fundamentals,https://www.goodwinlaw.com/en/insights/blogs/2022/01/the-irish-dpc-publishes-final-version-of-its-child,2022-01-13
Second Circuit Disagrees With Third Circuit TCPA Ruling Regarding Unsolicited Advertisements,https://www.goodwinlaw.com/en/insights/blogs/2022/01/second-circuit-disagrees-with-third-circuit-tcpa-ruling-regarding-unsolicited-advertisements,2022-01-13
Second Circuit Disagrees With Third Circuit TCPA Ruling Regarding Unsolicited Advertisements,https://www.goodwinlaw.com/en/insights/blogs/2022/01/second-circuit-disagrees-with-third-circuit-tcpa-r,2022-01-13
3rd Annual JPMorgan Symposium – Fireside Chat: Antitrust Expansion in Life Sciences Collaborations,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_13-3rd-jpmorgan-symposium-fireside-chat,2022-01-13
Agencies Launch Digital Identity Tech Sprint,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_13-weekly-roundup,2022-01-13
AbbVie Inc. et al. v. Alvotech hf. Updates,https://www.goodwinlaw.com/en/insights/blogs/2022/01/abbvie-inc-et-al-v-alvotech-hf-updates,2022-01-12
"FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA (Adalimumab) Biosimilar Candidate",https://www.goodwinlaw.com/en/insights/blogs/2022/01/fda-accepts-samsung-bioepis-and-organons-sbla-for,2022-01-11
Second Circuit Affirms Dismissal of Securities Fraud Class Action Against Alkermes,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_11-securities-snapshot,2022-01-11
PTAB Institutes Two IPRs on Tocilizumab Patents,https://www.goodwinlaw.com/en/insights/blogs/2022/01/ptab-institutes-two-iprs-on-tocilizumab-patents,2022-01-10
CFPB Files Complaint Against New York-Based Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/01/cfpb-files-complaint-against-new-yorkbased-debt-co,2022-01-10
CFPB Files Complaint Against New York-Based Debt Collectors,https://www.goodwinlaw.com/en/insights/blogs/2022/01/cfpb-files-complaint-against-new-york-based-debt-collectors,2022-01-10
Unshell Directive Proposal: How to Navigate New Substance Requirements,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_10-unshell-directive-proposal-how-to-navigate,2022-01-10
Deadline Approaching for Reporting 2021 ISO Exercises and ESPP Transfers,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_10-deadline-approaching-for-reporting-2021,2022-01-10
Israel Privacy Protection Bill Includes Steep Sanctions – and a DPO,https://www.goodwinlaw.com/en/insights/blogs/2022/01/israel-privacy-protection-bill-includes-steep-sanc,2022-01-09
FTC Settles With Lead Generator Over Alleged FTC Act and FCRA Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/01/ftc-settles-with-lead-generator-over-alleged-ftc-a,2022-01-07
FTC Settles With Lead Generator Over Alleged FTC Act and FCRA Violations,https://www.goodwinlaw.com/en/insights/blogs/2022/01/ftc-settles-with-lead-generator-over-alleged-ftc-act-and-fcra-violations,2022-01-07
SEC Proposes Alternative to “WORM” Books and Records Retention for Broker-Dealers and Security-Based Swap Entities,https://www.goodwinlaw.com/en/insights/blogs/2022/01/sec-proposes-alternative-to-worm-books-and-records,2022-01-06
China Accepts Innovent Biologics’ Supplemental New Drug Application for Sintilimab Plus Bevacizumab Biosimilar Injection,https://www.goodwinlaw.com/en/insights/blogs/2022/01/china-accepts-innovent-biologics-supplemental-new,2022-01-06
"SPAC 2021 Year-End Review and 2022 Preview: Tailwinds, Headwinds, and Regulatory Landscape",https://www.goodwinlaw.com/en/insights/publications/2022/01/01_06-spac-2021-year,2022-01-06
SEC Proposes Alternative to “WORM” Books and Records Retention for Broker-Dealers and Security-Based Swap Entities,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_06-sec-proposes-alternative-to-worm-books,2022-01-06
OCC Seeks Feedback on Principles for Climate-Related Financial Risk Management,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_06-weekly-roundup,2022-01-06
Review of FDA’s 2021 Drug Approvals – Small Molecules Dominate,https://www.goodwinlaw.com/en/insights/blogs/2022/01/review-of-fdas-2021-drug-approvals--small-molecule,2022-01-05
Israel’s Privacy Regulator Relaxes Onward Transfers Restriction,https://www.goodwinlaw.com/en/insights/blogs/2022/01/israels-privacy-regulator-relaxes-onward-transfers,2022-01-04
On Remote Control: FDA Issues Draft Guidance to Facilitate Use of Digital Health Technologies for Remote Data Acquisition in Clinical Trials,https://www.goodwinlaw.com/en/insights/blogs/2022/01/on-remote-control-fda-issues-draft-guidance-to-fac,2022-01-04
"Health Canada Approves Celltrion’s Adalimumab Biosimilar, YUFLYMA",https://www.goodwinlaw.com/en/insights/blogs/2022/01/health-canada-approves-celltrions-adalimumab-biosi,2022-01-04
The Year Ahead: Privacy Developments in 2022,https://www.goodwinlaw.com/en/insights/blogs/2022/01/the-year-ahead-privacy-developments-in-2022,2022-01-03
Providing A Brighter Future Through Financial Aid,https://www.goodwinlaw.com/en/insights/case-studies/providing-a-brighter-future,2022-01-03
European Commission’s Proposal to End the Misuse of Shell Entities for Tax Purposes within the EU,https://www.goodwinlaw.com/en/insights/publications/2022/01/01_03-european-commissions-proposal-to-end,2022-01-03
Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2021,https://www.goodwinlaw.com/en/insights/blogs/2021/12/year-in-review-top-us-biosimilarsrelated-regulator,2021-12-31
